<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">Futur J Pharm Sci</journal-id><journal-id journal-id-type="iso-abbrev">Futur J Pharm Sci</journal-id><journal-id journal-id-type="pmc-domain-id">3814</journal-id><journal-id journal-id-type="pmc-domain">phenaturepg</journal-id><journal-title-group><journal-title>Future Journal of Pharmaceutical Sciences</journal-title></journal-title-group><issn pub-type="ppub">2314-7245</issn><issn pub-type="epub">2314-7253</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Springer Nature - PMC COVID-19 Collection</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC8196934</article-id><article-id pub-id-type="pmcid-ver">PMC8196934.1</article-id><article-id pub-id-type="pmcaid">8196934</article-id><article-id pub-id-type="pmcaiid">8196934</article-id><article-id pub-id-type="pmid">34150912</article-id><article-id pub-id-type="doi">10.1186/s43094-021-00269-5</article-id><article-id pub-id-type="publisher-id">269</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Substantial effect of phytochemical constituents against the pandemic disease influenza&#8212;a review</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Devi</surname><given-names initials="AB">A. Brindha</given-names></name><address><email>raghabrins@gmail.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sarala</surname><given-names initials="R">R.</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><institution-wrap><institution-id institution-id-type="GRID">grid.411678.d</institution-id><institution-id institution-id-type="ISNI">0000 0001 0941 7660</institution-id><institution>Department of Botany, Periyar EVR College (Autonomous), </institution><institution>(Affiliated to Bharathidasan University, Trichy-24), </institution></institution-wrap>Trichy-620 023, Tamil Nadu, India </aff></contrib-group><pub-date pub-type="epub"><day>12</day><month>6</month><year>2021</year></pub-date><pub-date pub-type="ppub"><year>2021</year></pub-date><volume>7</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">383650</issue-id><elocation-id>120</elocation-id><history><date date-type="received"><day>29</day><month>12</month><year>2020</year></date><date date-type="accepted"><day>20</day><month>5</month><year>2021</year></date></history><pub-history><event event-type="pmc-release"><date><day>12</day><month>06</month><year>2021</year></date></event><event event-type="pmc-live"><date><day>15</day><month>06</month><year>2021</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-01-07 00:25:15.707"><day>07</day><month>01</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2021</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="43094_2021_Article_269.pdf"/><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Influenza is an acute respiratory tract infection caused by the influenza virus. Vaccination and antiviral drugs are the two methods opted to control the disease. Besides their efficiency, they also cause adverse side effects. Hence, scientists turned their attention to powerful herbal medicines. This review put focus on various proven, scientifically validated anti-influenza compounds produced by the plants suggested for the production of newer drugs for the better treatment of influenza and its related antiviral diseases too.</p></sec><sec><title>Main body</title><p id="Par2">In this review, fifty medicinal herb phytochemical constituents and their anti-influenza activities have been documented. Specifically, this review brings out the accurate and substantiates mechanisms of action of these constituents. This study categorizes the phytochemical constituents into primary and secondary metabolites which provide a source for synthesizing and developing new drugs.</p></sec><sec><title>Conclusion</title><p id="Par3">This article provides a summary of the actions of the herbal constituents. Since the mechanisms of action of the components are elucidated, the pandemic situation arising due to influenza and similar antiviral diseases can be handled promisingly with greater efficiency. However, clinical trials are in great demand. The formulation of usage may be a single drug compound or multi-herbal combination. These, in turn, open up a new arena for the pharmaceutical industries to develop innovative drugs.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Influenza</kwd><kwd>Medicinal herb</kwd><kwd>Phytochemical</kwd><kwd>Primary metabolite</kwd><kwd>Secondary metabolite</kwd><kwd>Drug</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; The Author(s) 2021</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par106">Influenza virus infections remain a major formidable disease of man defying control. It is a widespread disease of man occurring in epidemics and pandemic forms [<xref ref-type="bibr" rid="CR1">1</xref>]. Influenza severity varies from mild to extreme and is determined by the virus type and its host [<xref ref-type="bibr" rid="CR2">2</xref>].</p><p id="Par107">Influenza viruses belong to the Orthomyxoviridae family which comprises seven genera Alpha influenza virus, Beta influenza virus, Delta influenza virus, Gamma influenza virus, Isa virus, Quaranja virus, and Thogotovirus [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. Influenza A, B, D, and C viruses belong to Alpha, Beta, Delta, and Gamma genera respectively.</p><p id="Par108">Influenza A virus (IAV) hosted a wide range of species including wild aquatic birds, humans, poultry, pigs, horses, and sea mammals [<xref ref-type="bibr" rid="CR5">5</xref>] which cause epidemics and pandemic conditions [<xref ref-type="bibr" rid="CR6">6</xref>]. Influenza B virus (IBV) infects humans and seals [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. Influenza C virus (ICV) infections have been documented in humans and swine [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. Influenza B and C viruses create epidemics but lack pandemic potential [<xref ref-type="bibr" rid="CR8">8</xref>]. Influenza D virus (IDV) infection was observed in farmed cattle, goats, pigs, and buffalo [<xref ref-type="bibr" rid="CR9">9</xref>]. Serological evidence detects the presence of the virus in humans [<xref ref-type="bibr" rid="CR10">10</xref>] but the investigation of transmission remains unclear [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR11">11</xref>].</p><p id="Par109">The World Health Organization (WHO) along with the National Influenza Centers (NIC) and Centers for Disease Control and Prevention (CDC) strengthen global influenza surveillance during every seasonal outbreak [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. These authorized centers monitor global influenza circulation, detecting the emergence of new strains followed by the recommendation of vaccine usage [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. Many ongoing research activities like vaccine preparation, clinical trial of new drugs, and Traditional and Complementary medicine (T&amp;CM) using herbs are carried worldwide to anticipate their work. Traditional and Complementary medicine (T&amp;CM) role is indispensable for the prevention and management of chronic diseases [<xref ref-type="bibr" rid="CR14">14</xref>] and WHO estimates 65&#8211;80% of the world population rely on it [<xref ref-type="bibr" rid="CR15">15</xref>]. Interestingly, 34 countries include herbal medicines in their national essential medicines list (NEML) [<xref ref-type="bibr" rid="CR14">14</xref>]. Hence, herbal medicines are always in great demand for the ailment of severe diseases.</p><p id="Par110">This review article enlists several anti-influenza potential herbs along with their phytochemical constituents showing multi-targeted action against influenza. This study significantly provides experimentally validated phytoconstituents showing the evidence of efficacy against influenza.</p></sec><sec id="Sec2"><title>Main text</title><sec id="Sec3"><title>Influenza viruses&#8212;an overview</title><p id="Par111">Influenza viruses are spherical (100 nm in diameter) or filamentous (300 nm in length) in shape [<xref ref-type="bibr" rid="CR16">16</xref>]. They have a central core surrounded by an envelope. The central core region has RNA segments covered with a nucleocapsid protein (NP). The entire core is surrounded by a matrix protein (M1) consequently covered by a lipid bilayer from which two spiked surface glycoproteins hemagglutinin (HA) and neuraminidase (NA) arise. The glycoprotein HA is a tetramer whereas NA is a trimeric molecule [<xref ref-type="bibr" rid="CR16">16</xref>].</p><p id="Par112">IAV contains 8 RNA segments coding 7 structural proteins (PB1, PB2, PA, HA, NA, NP, and M1) and 3 nonstructural proteins (NS1, NS2, and M2) [<xref ref-type="bibr" rid="CR17">17</xref>]. The structural proteins HA and NA are the antigenic determinants [<xref ref-type="bibr" rid="CR18">18</xref>] and the main targets for antiviral drugs [<xref ref-type="bibr" rid="CR17">17</xref>]. Based on these proteins, influenza A is classified into different subtypes hemagglutinin (H1&#8211;H18) and neuraminidase (N1&#8211;N11).</p><p id="Par113">IBV contains 8 RNA genome segments where the nonstructural protein M2 is replaced by BM2. Influenza B has 2 lineages B/Yamagata and B/Victoria and they are not classified into subtypes [<xref ref-type="bibr" rid="CR19">19</xref>].</p><p id="Par114">ICV has 7 genome segments with a single trimeric glycoprotein called hemagglutinin esterase fusion [HEF] which equalize the function of HA and NA protein [<xref ref-type="bibr" rid="CR20">20</xref>] along with a minor envelope protein CM2 [<xref ref-type="bibr" rid="CR21">21</xref>]. Currently, the influenza C virus has 6 lineages [<xref ref-type="bibr" rid="CR22">22</xref>].</p><p id="Par115">IDV is a newly emerging virus with 7 genome segments with a matrix protein DM1 and ion channel protein DM2 [<xref ref-type="bibr" rid="CR23">23</xref>] in association with glycoprotein hemagglutinin esterase fusion (HEF) like influenza C virus. At present, it has 2 distinct co-circulating lineages [<xref ref-type="bibr" rid="CR24">24</xref>]. Figure <xref rid="Fig1" ref-type="fig">1</xref> displays the structural description of influenza viruses.
<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><p>Structure of influenza viruses A, B, C, and D with their genomic arrangements</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO1" position="float" orientation="portrait" xlink:href="43094_2021_269_Fig1_HTML.jpg"/></fig></p></sec><sec id="Sec4"><title>Antigenic variation</title><p id="Par116">Influenza viruses profoundly alter their surface glycoprotein resulting in an antigenic variation [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>] which exhibits in two forms antigenic drift and antigenic shift [<xref ref-type="bibr" rid="CR26">26</xref>]. Antigenic drift is a small, gradual change of the surface antigen due to genomic point mutations [<xref ref-type="bibr" rid="CR27">27</xref>] forming new strains of the virus, cause epidemics [<xref ref-type="bibr" rid="CR28">28</xref>]. Random occurrence of antigenic drift is observed in influenza A, B [<xref ref-type="bibr" rid="CR24">24</xref>], and C viruses [<xref ref-type="bibr" rid="CR29">29</xref>]. In contrast, drastic antigenic change has not been recorded for the IDV [<xref ref-type="bibr" rid="CR23">23</xref>]. Hence, its epidemic nature also remains undetermined. Antigenic shift occurs when a sudden extreme and profound change in genome reassortment results in the formation of a new subtype [<xref ref-type="bibr" rid="CR28">28</xref>]. It is observed only in influenza A virus which leads to the pandemic condition [<xref ref-type="bibr" rid="CR30">30</xref>].</p></sec><sec id="Sec5"><title>Vaccination remains challenge</title><p id="Par117">Vaccines are substances that provide immunity and protection against a particular infectious disease. Introducing vaccines into the body refers to vaccination and getting immunity through vaccination is immunization [<xref ref-type="bibr" rid="CR31">31</xref>]. Every year, 3 million deaths are prevented by vaccines, and through vaccinations, the human life span has increased [<xref ref-type="bibr" rid="CR32">32</xref>]. This shows the promising notice that vaccinations are the best way of preventing the serious effect of the dangerous disease.</p><p id="Par118">Influenza is often called flu and flu vaccination is a principal tool for the prevention of influenza severity. Influenza A viruses cause pandemics whereas influenza A and B viruses cause seasonal epidemics. The World Health Organization [WHO] assisted with the National Influenza Centers [NIC] and Centers for Disease Control and Prevention (CDC) makes the recommendation for two different vaccine formulations every year, one for the Northern and one for the Southern Hemisphere [<xref ref-type="bibr" rid="CR33">33</xref>].</p><p id="Par119">In general, influenza vaccines are prepared in two forms as inactivated influenza vaccines (IIV) and live attenuated influenza vaccines (LAIV) [<xref ref-type="bibr" rid="CR34">34</xref>]. Intramuscular injection of the flu vaccine is referred to as a flu shot which may be in trivalent inactivated (TIV) or quadrivalent inactivated form (QIV). The TIV is comprised of two influenza A strains and one influenza B lineage while QIV includes two influenza A strains and two influenza B lineages [<xref ref-type="bibr" rid="CR35">35</xref>]. Figure <xref rid="Fig2" ref-type="fig">2</xref> displays influenza vaccine types and drug brand names recommended by the CDC.
<fig id="Fig2" position="float" orientation="portrait"><label>Fig. 2</label><caption><p>Influenza vaccine types and drug brand names recommended by CDC</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO2" position="float" orientation="portrait" xlink:href="43094_2021_269_Fig2_HTML.jpg"/></fig></p><p id="Par120">TIV is a standard vaccine recorded as safe and creates immunogenicity among children of 6 through 35 months of age and elderly of 65 and above [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>]. QIV under the brand names of AFLURIA Quadrivalent, Fluarix Quadrivalent, and FluLaval Quadrivalent consists of embryonated egg-grown medium vaccines, recommended for children of 6 months to 3 years, and older. People with egg allergy adapt egg-free quadrivalent vaccines like quadrivalent recombinant vaccine and quadrivalent cell-based vaccine. Quadrivalent recombinant vaccines are produced by recombinant technology where the vaccines obtained from mammalian cell culture produce quadrivalent cell&#8211;based vaccine [<xref ref-type="bibr" rid="CR38">38</xref>]. Recently, the U.S. Food and Drug Administration (FDA) approved Flublok Quadrivalent recombinant vaccine and Flucelvax Quadrivalent cell&#8211;based vaccine for use in adults 18 years and older [<xref ref-type="bibr" rid="CR39">39</xref>].</p><p id="Par121">The High-Dose Quadrivalent vaccine with the brand name Fluzone contains four times the antigen intended to give protection for elderly people [<xref ref-type="bibr" rid="CR40">40</xref>]. A recent study reveals that the high-dose vaccine increases the immune response [<xref ref-type="bibr" rid="CR41">41</xref>]. AFLURIA Quadrivalent&#174; is the only vaccine approved for use with a jet injector that comes in multi-dose vials recommend for 18- to 64-year-old people [<xref ref-type="bibr" rid="CR42">42</xref>].</p><p id="Par122">Adjuvants are the compounds that enhance immunity. Currently, adjuvants like Alum, MF59 (oil-in-water emulsion), AS03 (oil-in-water adjuvant), AF03 (oil-in-water adjuvant containing squalene, montane 80, and eumulgin b1 ph), virosomes (phospholipids), and heat-labile enterotoxin (LT) [<xref ref-type="bibr" rid="CR43">43</xref>] are used in TIV and QIV as FLUAD and FLUAD Quadrivalent.</p><p id="Par123">The Nasal Spray Flu Vaccine under the brand name of FluMist Quadrivalent is a live attenuated influenza vaccine [LAIV] is recommended by FDA in 2012 for people ages 2 to 49. Even though the nasal vaccine stimulates the long-standing immune response, CDC not recommends it during the 2016&#8211;2017 and 2017&#8211;2018 flu seasons. This is due to its less effectiveness than IIV during the 2009 pandemic. After obtaining positive protection data of LAIV, CDC recommends it for the 2018&#8211;2019 season [<xref ref-type="bibr" rid="CR44">44</xref>].</p><p id="Par124">Mutations make the influenza viruses change over time. Hence, the genetic materials also change and new subtypes are evolved [<xref ref-type="bibr" rid="CR45">45</xref>] which often replace the older strain [<xref ref-type="bibr" rid="CR46">46</xref>]. It is a fact that influenza vaccines save countless lives and prevent pandemics but annual reformulation in vaccine preparation for the new emerging strains remains a challenge for the scientist [<xref ref-type="bibr" rid="CR47">47</xref>].</p><p id="Par125">Vaccine preparation takes a long time since it relies on the official declaration of the prevailing viral strain by WHO [<xref ref-type="bibr" rid="CR48">48</xref>]. Marketing vaccine strains do not give enough protection against novel emerging strains [<xref ref-type="bibr" rid="CR49">49</xref>]. At present, vaccines are prepared by three production technologies: egg-based, cell culture, and recombinant methods. The majority of the vaccine production is egg-based which is time-consuming and mismatching from the available and prevailing strains [<xref ref-type="bibr" rid="CR48">48</xref>]. To overcome this, cell culture and recombinant methods of vaccine production are recently adapted, which are still in need of appropriate infrastructure to attain the goal.</p><p id="Par126">Global demand for vaccines and shortage of production are growing exponentially. This is noted from the recent survey indicating that the requirement of seasonal vaccine is 1.504 billion doses but the production capacity is decreased to 1.467 billion doses [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR50">50</xref>]. The selectivity of vaccines for elderly people is also biased since vaccine efficacy differs by age and chronic diseases [<xref ref-type="bibr" rid="CR51">51</xref>]. Hence, these conditions make developing universal influenza vaccines a big task.</p></sec><sec id="Sec6"><title>Conventional drugs for the disease</title><p id="Par127">Antiviral drugs are another alternative way to control and manage seasonal and post-exposure influenza [<xref ref-type="bibr" rid="CR52">52</xref>]. They are classified into three broad categories as M2 inhibitors, neuraminidase inhibitors, and nucleoprotein inhibitors [<xref ref-type="bibr" rid="CR53">53</xref>]. The antiviral drugs Amantadine and Rimantadine fall under M2 inhibitors, Rapivab (Peramivir), Relenza (Zanamivir), and Tamiflu (Oseltamivir Phosphate) are the neuraminidase inhibitor drugs whereas Xovluza (baloxavir marboxil) is a Nucleoprotein-inhibitor drug.</p><p id="Par128">The M2 ion channel&#8211;inhibitor drugs (Amantadine and Rimantadine) are specifically used to treat influenza A infection. Currently, CDC has not recommended these drugs since they create resistance against many strains [<xref ref-type="bibr" rid="CR52">52</xref>].</p><p id="Par129">In the present scenario, CDC recommends four FDA (Food and Drug Administration)-approved anti-influenza drugs, namely Rapivab (Peramivir), Relenza (Zanamivir), Tamiflu (Oseltamivir Phosphate), and Xovluza (baloxavir marboxil) [<xref ref-type="bibr" rid="CR54">54</xref>]. These drugs are effective against both influenza A and B viruses [<xref ref-type="bibr" rid="CR55">55</xref>&#8211;<xref ref-type="bibr" rid="CR57">57</xref>].</p><p id="Par130">The Neuraminidase-inhibitor drugs showed ineffectiveness against influenza C infection [l]. However, Baloxavir exhibits broad-spectrum antiviral activity, including influenza C and D viruses [<xref ref-type="bibr" rid="CR58">58</xref>].</p><p id="Par131">Generally, antiviral drugs are targeting the viral components that are not able to combat the genetically altered emerging strains [<xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR60">60</xref>] so drug-resistant strains emerge. Recent studies show neuraminidase inhibitor drug Oseltamivir also generates resistant viruses [<xref ref-type="bibr" rid="CR17">17</xref>] like the M2-inhibitor drugs. Excessive dosages of the antiviral drugs [<xref ref-type="bibr" rid="CR61">61</xref>] and selection pressure due to global Oseltamivir administration [<xref ref-type="bibr" rid="CR62">62</xref>] unlikely contribute to the emergence of drug-resisting viruses.</p></sec><sec id="Sec7"><title>Need for new remedy</title><p id="Par132">The drawback in vaccine preparation and conventional therapies makes scientists turn their attention to powerful herbal medicines that are in great demand in the developing world [<xref ref-type="bibr" rid="CR63">63</xref>]. A substantial increase in the consumption of herbal medicines for chronic diseases like influenza is growing exponentially [<xref ref-type="bibr" rid="CR64">64</xref>, <xref ref-type="bibr" rid="CR65">65</xref>]. They are the promising alternatives reckoned for their safety, compatibility, efficacy, and minimum side effects [<xref ref-type="bibr" rid="CR66">66</xref>]. Hence, in this review, we highlight the potent herb exhibits anti-influenza activities for the control and management of influenza.</p></sec></sec><sec id="Sec8"><title>Methods</title><p id="Par133">An intense database search conduct by using the keywords like herbs used against influenza, traditional medicines for influenza, and ethno medicines for influenza. Through this, we get the relevant literature up to October 2020 from scientific databases like Google Scholar, Springer, Elsevier, Sage, Taylor &amp; Francis, Hindawi, Wiley, Research Gate, PubMed, Scopus, Web of Science, and Shodhganga. The required data were obtained from both research and review articles published in national and international reputed journals.</p></sec><sec id="Sec9"><title>Alternate therapies</title><p id="Par134">Complementary and traditional medicines have been utilized for several years in various parts of the world to reduce human diseases [<xref ref-type="bibr" rid="CR67">67</xref>]. For all these medicines, plants are the richest source. They have the active constituent phytochemical metabolites produced by the process called metabolism. This metabolism is categorized into two types as primary and secondary. Table <xref rid="Tab1" ref-type="table">1</xref> is a list of various herbs with phytochemical constituents with anti-influenza activity.
<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>List of herbs and their phytochemical constituents active against influenza</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1"> S. no</th><th colspan="1" rowspan="1">Herbal plant</th><th colspan="1" rowspan="1">Family</th><th colspan="1" rowspan="1">Parts of plant</th><th colspan="1" rowspan="1">Phytochemical constituents or compounds showing anti-influenza activity</th><th colspan="1" rowspan="1">Activity</th><th colspan="1" rowspan="1">Influenza virus type</th><th colspan="1" rowspan="1">Strain</th><th colspan="1" rowspan="1">Reference</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1"><italic toggle="yes">Albizia julibrissin</italic></td><td colspan="1" rowspan="1">Leguminosae</td><td colspan="1" rowspan="1">Dry stem bark</td><td colspan="1" rowspan="1">Saponin: AJS75</td><td colspan="1" rowspan="1"><p>i. Potent adjuvant</p><p>ii. Induce cellular and humoral response</p><p>iii. Stimulate cytokines and chemokines</p></td><td colspan="1" rowspan="1">Avian influenza</td><td colspan="1" rowspan="1">Recombinant fowl pox virus vector&#8211;based avian influenza vaccine (rFPV)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR68">68</xref>]</td></tr><tr><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1"><italic toggle="yes">Aloe vera</italic></td><td colspan="1" rowspan="1">Asphodelaceae</td><td colspan="1" rowspan="1">Roots</td><td colspan="1" rowspan="1">Anthraquinones:3-(2&#180;,3&#180;,4&#180;,6&#180;-Tetra-O-acetyl-&#946;-<sc>d</sc>-glucopyranosyl-aloesaponarin-I (5) and 3-(2&#180;,3&#180;,4&#180;,6&#180;-Tetra-O-acetyl-&#946;-<sc>d</sc>-glucopyranosyl- aloesaponarin-II (7)</td><td colspan="1" rowspan="1">Inhibit virus replication</td><td colspan="1" rowspan="1">Influenza A H1N1</td><td colspan="1" rowspan="1">A/Yucat&#225;n/2370/09, A/Mexico/InDRE797/10 (H1N1)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR69">69</xref>]</td></tr><tr><td rowspan="2" colspan="1">3</td><td rowspan="2" colspan="1"><italic toggle="yes">Alpinia officinarum</italic></td><td rowspan="2" colspan="1">Zingiberaceae</td><td rowspan="2" colspan="1">Rhizomes</td><td colspan="1" rowspan="1">Diarylheptanoids: 7-4&#8243;-hydroxy-3&#8243;-methoxyphenyl)-1-phenyl-4E-hepen-3-one (3) and (5S)-5-hydroxy-7-(4&#8243;-hydroxyphenyl)-1-phenyl-3-heptanone (8)</td><td colspan="1" rowspan="1">Potent anti-influenza activity</td><td colspan="1" rowspan="1">Influenza A H1N1</td><td colspan="1" rowspan="1">A/PR/8/34( H1N1)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR70">70</xref>]</td></tr><tr><td colspan="1" rowspan="1">Diarylheptanoids: 7-4&#8243;-hydroxy-3&#8243;-methoxyphenyl)-1-phenyl-4E-hepen-3-one (AO-0002) and (5S)-5-hydroxy-7-(4&#8243;-hydroxyphenyl)-1-phenyl-3-heptanone (AO-0011)</td><td colspan="1" rowspan="1"><p>AO-0002:</p><p>i. Suppress the expression of viral antigen and mRNA synthesis</p><p>ii.Reduce the bodyweight loss and</p><p>iii. Enhance the survival period of infected mice, iv.Reduces the virus titer in lungs BALF</p></td><td colspan="1" rowspan="1">Influenza A H1N1, H3N2 and B</td><td colspan="1" rowspan="1">A/PR/8/34, oseltamivir-resistant A/PR/8/34, A/Bangkok/93/03 ( H1N1), A/Ishikawa/7/82, A/Fukushima/13/43 ( H3N2) and B/Singapore/222/79, B/Fukushima/15/93 (B)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR71">71</xref>]</td></tr><tr><td rowspan="2" colspan="1">4</td><td rowspan="2" colspan="1"><italic toggle="yes">Andrographis paniculata</italic></td><td rowspan="2" colspan="1">Acanthaceae</td><td rowspan="2" colspan="1">Not mentioned</td><td rowspan="2" colspan="1">Diterpenoid: 14-a-lipoyl andrographolide (AL-1),14-deoxy-11,12-dehydroandrographolide (DAP)</td><td colspan="1" rowspan="1"><p>AL-1:</p><p>i. HA inhibition ii. Prevents virus adsorption</p><p>iii. Increase survivality of infected mice</p></td><td colspan="1" rowspan="1">Influenza A H9N2, H5N1, H1N1</td><td colspan="1" rowspan="1">A/Chicken/Guangdong/96 (H9N2), A/Duck/Guangdong/99 (H5N1), and A/PR/8/34 (H1N1))</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR72">72</xref>]</td></tr><tr><td colspan="1" rowspan="1"><p>DAP:</p><p>i. Inhibits viral progeny</p><p>ii. Inhibit viral nucleoprotein (NP) mRNA, NP, and NS1proteins</p><p>iii. Inhibit nuclear export of viral ribonucleoprotein (vRNP) complexes</p><p>iv. Reduction of proinflammatory cytokines and chemokines</p></td><td colspan="1" rowspan="1">Influenza A H5N1 H1N1,H3N2</td><td colspan="1" rowspan="1">A/chicken/Hubei/327/2004, A/duck/Hubei/XN/2007 (H5N1), A/PR/8/34, A/NanChang/08/2010 (H1N1), and A/HuNan/01/2014 (H3N2)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR73">73</xref>]</td></tr><tr><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1"><italic toggle="yes">Arctium lappa</italic></td><td colspan="1" rowspan="1">Compositae</td><td colspan="1" rowspan="1">Fruits</td><td colspan="1" rowspan="1">Liganan: Arctiin and arctigenin</td><td colspan="1" rowspan="1"><p>Arctiin:</p><p>i. Enhance virus specific antibody production</p><p>ii. Reduce virus yield along with oselatamivir</p><p>Arctigenin: i. Interact with the early stage of viral replication but not inhibit its cellular penetration,</p><p>ii. Inhibits viral progeny and release</p></td><td colspan="1" rowspan="1">Influenza A H1N1</td><td colspan="1" rowspan="1">A/NWS/33( H1N1)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR74">74</xref>]</td></tr><tr><td colspan="1" rowspan="1">6</td><td colspan="1" rowspan="1"><italic toggle="yes">Aronia melanocarpa</italic></td><td colspan="1" rowspan="1">Rosaceae</td><td colspan="1" rowspan="1">Fruits</td><td colspan="1" rowspan="1"><p>Phenolic acid: Ellagic acid</p><p>Flavone: Myricetin</p></td><td colspan="1" rowspan="1">Araonia extract: HA inhibitors; Ellagic acid: Increase the survival rate by 37.5% of rPR8-GFP virus&#8211;infected mice; Myricetin: Provide 50% survival rate of rPR8-GFP virus&#8211;infected mice</td><td colspan="1" rowspan="1">Influenza A H1N1, H3N2, recombinant H1N1, and influenza B</td><td colspan="1" rowspan="1">A/Korea/01/2009, A/Korea/2785/2009(H1N1), A/Perth/16/2009(H3N2), B/Brisbane/60/2008(B) and A/Puerto Rico/8/34(recombinant H1/PR8 expressing green fluorescent protein (rPR8-GFP)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR75">75</xref>]</td></tr><tr><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1"><italic toggle="yes">Astragalus sp</italic></td><td colspan="1" rowspan="1">Fabaceae</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Polysaccharide: <italic toggle="yes">Astragalus</italic> polysaccharide (APS)</td><td colspan="1" rowspan="1"><p>APS:</p><p>i. Stimulation of CEF Proliferation</p><p>ii. Pre-addition (321.25&#956;g/mL), post-addition, and simultaneous addition shows virus reduction</p><p>iii. Upregulated IL-4, IL-10, LITAF, and IL-12 cytokine expression</p><p>iv. CD3+, CD4+, and CD8+ T cell surface markers were increased</p></td><td colspan="1" rowspan="1">Influenza A H9N2</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR76">76</xref>]</td></tr><tr><td colspan="1" rowspan="1">8</td><td colspan="1" rowspan="1"><italic toggle="yes">Azadirachta indica</italic></td><td colspan="1" rowspan="1">Meliaceae</td><td colspan="1" rowspan="1">Leaf</td><td colspan="1" rowspan="1">Flavonols: Hyperoside</td><td colspan="1" rowspan="1">Show best interactions with conserved residues of nucleoprotein</td><td colspan="1" rowspan="1">Influenza A H1N1 ( PDB ID:3RO5)</td><td colspan="1" rowspan="1">A/Wilson-Smith/1933</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR77">77</xref>]</td></tr><tr><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1"><italic toggle="yes">Bupleurum chinense</italic></td><td colspan="1" rowspan="1">Apiaceae</td><td colspan="1" rowspan="1">Aerial part and root</td><td colspan="1" rowspan="1">Polysaccharide: Bupleurum chinense polysaccharide (BCPS)</td><td colspan="1" rowspan="1">BCPS: Immunostimulating agent enhance antibody</td><td colspan="1" rowspan="1">Influenza virus</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR78">78</xref>]</td></tr><tr><td rowspan="2" colspan="1">10</td><td rowspan="2" colspan="1"><italic toggle="yes">Caesalpinia sappan</italic></td><td rowspan="2" colspan="1">Leguminosae</td><td rowspan="2" colspan="1">Dried heartwood</td><td rowspan="2" colspan="1"><p>Chalcone: 3-deoxysappanchalcone, and sappanchalcone</p><p>Homoisoflavonoids: Sappanone A, Brazilin</p></td><td colspan="1" rowspan="1">Chalcone: Show high inhibition against H3N2</td><td colspan="1" rowspan="1">Influenza A H1N1, H3N2 and B</td><td colspan="1" rowspan="1">A/PR/8/34 (H1N1), A/Guangdong/243/72 (H3N2), and B/Jiangsu/10/2003</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR79">79</xref>]</td></tr><tr><td colspan="1" rowspan="1">Homoisoflavonoids: Contain &#945;, &#946;-unsaturated carbonyl group in A-ring critical role in NA inhibition</td><td colspan="1" rowspan="1">Influenza A H1N1, H3N2,H9N2</td><td colspan="1" rowspan="1">A/PR/8/34(H1N1), A/Hong Kong/8/68 (H3N2), and A/Chicken/Korea/MS96/96 (H9N2)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR80">80</xref>]</td></tr><tr><td rowspan="7" colspan="1">11</td><td rowspan="7" colspan="1"><italic toggle="yes">Camellia sinensis</italic></td><td rowspan="7" colspan="1">Theaceae</td><td rowspan="7" colspan="1">Leaves</td><td rowspan="7" colspan="1"><p>Amino acid: Theanine</p><p>Flavon-3-ol: (-) epigallocatechin (EGC), (&#8722;)-epigallocatechin gallate (EGCG), (&#8722;)-epicatechin gallate (ECG), EGCG-C-16, (&#8722;) Epigallocatechin gallate (EGCg) and theaflavin digallate (TF3), Theaflavin, Tannin: Strictinin</p></td><td colspan="1" rowspan="1">Theanine and Catechin: Effective prophylaxis</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR81">81</xref>]</td></tr><tr><td colspan="1" rowspan="1">EGC: Acidification of ELS inhibition</td><td colspan="1" rowspan="1">Influenza A H1N1, H3N2 and B</td><td colspan="1" rowspan="1">A/PR/8/34 (H1N1),A/Aichi/2/68(H3N2), B/Singapore/222 Sing (B)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR82">82</xref>]</td></tr><tr><td colspan="1" rowspan="1">EGCG,ECG: HI, NI activity and suppression of viral RNA synthesis</td><td colspan="1" rowspan="1">Influenza A H1N1, H3N2 and B</td><td colspan="1" rowspan="1">Influenza A/Chile/1/83( HIN1), A/Sydney/5/97 (H3N2) and B/Yamagata/16/88 (B)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR83">83</xref>]</td></tr><tr><td colspan="1" rowspan="1">EGCG-C-16: Potent infection inhibitor</td><td colspan="1" rowspan="1">Influenza A H1N1, H3N2,H5N2, and B</td><td colspan="1" rowspan="1">A/Puerto Rico/8/34, A/Beijing/262/95, Yokohama/77/2008,Yokohama/63/2007,A/Yokohama/91/2008(H1N1), A/Panama/2007/99 (H3N2), A/Duck/HongKong/342/78 (H5N2) and B/Yamanashi/166/98 (B)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR84">84</xref>]</td></tr><tr><td colspan="1" rowspan="1">EGCg, TF3: Virus agglutination, prevent adsorption, HA inhibition</td><td colspan="1" rowspan="1">Influenza A H1N1 and B</td><td colspan="1" rowspan="1">A/Yamagata/120/86( H1N1), B/USSR/100/83 (B)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR85">85</xref>]</td></tr><tr><td colspan="1" rowspan="1">Theaflavin: Potent natural inhibitor</td><td colspan="1" rowspan="1">Influenza A H1N1 NA</td><td colspan="1" rowspan="1">Predicted structure for in silico study</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR86">86</xref>]</td></tr><tr><td colspan="1" rowspan="1"><p>Strictinin:</p><p>i.Acts directly with the viral particles</p><p>ii. Inhibit the early stage of viral entry and virus-induced hemifusion</p></td><td colspan="1" rowspan="1">Influenza A H1N1,H3N2,H5N3, and B</td><td colspan="1" rowspan="1">A/PuertoRico/8/34 , A/WSN/33 (H1N1), A/Memphis/1/71, A/Aichi/2/68, A/swine/Hokkaido/10/85 (H3N2), A/duck/HK/313/4/78 (H5N3), and B/Lee/40 (B)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR87">87</xref>]</td></tr><tr><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1"><italic toggle="yes">Chaenomeles speciosa</italic></td><td colspan="1" rowspan="1">Rosaceae</td><td colspan="1" rowspan="1">Dried fruit</td><td colspan="1" rowspan="1"><italic toggle="yes">Benzoic acid derivative: 3,4-dihydroxybenzoic acid, flavonol: quercetin, ester: methyl 3-hydroxybutanedioic ester</italic></td><td colspan="1" rowspan="1"><p><italic toggle="yes">i. Inhibits TNF-&#945; production</italic></p><p><italic toggle="yes">ii. 3, 4-dihydroxybenzoic acid and quercetin</italic>: Dose dependent DPPH radical scavenging activity</p><p>iii. <italic toggle="yes">methyl 3-hydroxybutanedioic ester: IL-6 production inhibition</italic></p><p><italic toggle="yes">iv. 3, 4-dihydroxybenzoic acid and methyl 3-hydroxybutanedioic ester : NA inhibition</italic></p></td><td colspan="1" rowspan="1">Influenza A H1N1</td><td colspan="1" rowspan="1">H1N1 (<italic toggle="yes">A/PR/8/34)</italic></td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR88">88</xref>]</td></tr><tr><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1"><italic toggle="yes">Cinnamomum cassia</italic></td><td colspan="1" rowspan="1">Lauraceae</td><td colspan="1" rowspan="1">Cortex</td><td colspan="1" rowspan="1"><p>Aldehyde: Trans cinnamaldehyde (CA)</p><p>Coumarin: 7-hydroxycoumarin (7HC)</p><p>Cinnamyl derivatives: 4-allylanisole, cinnamic acid ethylester, acetic acid cinnamylester, 2X-hydroxyacetophenone, and 2-hydroxycinnamic acid</p></td><td colspan="1" rowspan="1"><p>Aldehyde:</p><p>i. Dose-dependent inhibition of virus</p><p>ii. Affects protein synthesis at post-transcriptional level</p><p>iii. Increase survival rate with reduced viral titer in virus-infected mice</p></td><td colspan="1" rowspan="1">Influenza A H1N1, H3N2, and B</td><td colspan="1" rowspan="1">H1N1 (A/PR/8/34, A/USSR/92/77), H3N2 (A/Aichi/2/68), and B (B /Lee/40)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR89">89</xref>]</td></tr><tr><td rowspan="2" colspan="1"/><td rowspan="2" colspan="1"/><td rowspan="2" colspan="1"/><td rowspan="2" colspan="1"/><td rowspan="2" colspan="1"/><td colspan="1" rowspan="1">Cinnamyl derivatives: Anti-pyretic, suppress the rise of interleukin-1&#945; production</td><td colspan="1" rowspan="1">Influenza A H1N1</td><td colspan="1" rowspan="1">A/PR/8/34( H1N1)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR90">90</xref>]</td></tr><tr><td colspan="1" rowspan="1">7HC: Anti-pyretic, suppression of pro-inflammatory cytokine,interleukin-1&#945; and Th1 cytokine (IL-12 and interferon-gamma), Reduce virus load in BALF</td><td colspan="1" rowspan="1">Influenza A H1N1</td><td colspan="1" rowspan="1">A/PR/8/34( H1N1)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR91">91</xref>]</td></tr><tr><td rowspan="2" colspan="1">14</td><td rowspan="2" colspan="1"><italic toggle="yes">Curcuma longa</italic></td><td rowspan="2" colspan="1">Zingiberaceae</td><td rowspan="2" colspan="1">Rhizome</td><td rowspan="2" colspan="1"><p>Sesquiterpenoids: germacrone</p><p>Diarylheptanoids: curcumin, curcuminoids</p></td><td colspan="1" rowspan="1">Germacrone: Reduction of viral protein expression, RNA synthesis, and the progeny viruses</td><td colspan="1" rowspan="1">Influenza A H1N1, H3N2 and B</td><td colspan="1" rowspan="1">A/PuertoRico/8/34, A/human/Hubei/1/2009, A/human/WSN/33 (H1N1), A/human/Hubei/3/2005 (H3N2), and B/human/Hubei/1/2007 (B)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR92">92</xref>]</td></tr><tr><td colspan="1" rowspan="1">Curcumin: HA inhibitors</td><td colspan="1" rowspan="1">Influenza A H1N1, H6N1</td><td colspan="1" rowspan="1">A/Puerto Rico/8/34( H1N1), A/chicken/Taiwan/NCHU0507/99( H6N1)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR93">93</xref>]</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Curcuminoids: NA inhibitors</td><td colspan="1" rowspan="1">Influenza A H1N1,H9N2</td><td colspan="1" rowspan="1">A/California/08/2009, A/Sw/Kor/CAH1/04, H274Y mutant (H1N1) A/Chicken/Korea/O1310/2001 (H9N2)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR94">94</xref>]</td></tr><tr><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1"><italic toggle="yes">Dendrobium nobile</italic></td><td colspan="1" rowspan="1">Orchidaceae</td><td colspan="1" rowspan="1">Stem</td><td colspan="1" rowspan="1">Alkaloid: dendrobine</td><td colspan="1" rowspan="1">Inhibit early stage of viral replication, binding with the viral NP suppress its export, deactivation vRNP complex</td><td colspan="1" rowspan="1">Influenza A H1N1, H3N2</td><td colspan="1" rowspan="1">A/FM-1/1/47, A/Puerto Rico/8/34 H274Y ( H1N1) and A/Aichi/2/68 ( H3N2)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR95">95</xref>]</td></tr><tr><td colspan="1" rowspan="1"> 16</td><td colspan="1" rowspan="1"><italic toggle="yes">Elsholtzia rugulosa</italic></td><td colspan="1" rowspan="1">Lamiaceae</td><td colspan="1" rowspan="1">Whole plants</td><td colspan="1" rowspan="1">Flavonoids: Apigenin and Luteolin</td><td colspan="1" rowspan="1">Exhibited the highest NA inhibition against H3N2.</td><td colspan="1" rowspan="1">Influenza A H1N1, H3N2, and B</td><td colspan="1" rowspan="1">H1N1 (A/PR/8/34), H3N2 (A/Jinan/15/90), and B (B/Jiangsu/10/2003)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR96">96</xref>]</td></tr><tr><td colspan="1" rowspan="1">17</td><td colspan="1" rowspan="1"><italic toggle="yes">Ephedra sinica</italic></td><td colspan="1" rowspan="1">Ephedraceae</td><td colspan="1" rowspan="1">Whole plant</td><td colspan="1" rowspan="1">Flavan-3-ol: (+)-catechin</td><td colspan="1" rowspan="1">Acidification of ELS, Dose-dependent inhibition of virus growth</td><td colspan="1" rowspan="1">Influenza A H1N1</td><td colspan="1" rowspan="1">APR/8/34(H1N1)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR97">97</xref>]</td></tr><tr><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1"><italic toggle="yes">Ginkgo biloba</italic></td><td colspan="1" rowspan="1">Ginkgoaceae</td><td colspan="1" rowspan="1">Leaf</td><td colspan="1" rowspan="1">Biflavonoid: Ginkgetin, and its conjugates (6R, 6S, 7R, 7S, 8R, 8S, 9R, 9S)</td><td colspan="1" rowspan="1">8R and 8S: Low cytotoxic effect, high sialidase activity with increased survival rate</td><td colspan="1" rowspan="1">Influenza A H1N1, H3N2 and B</td><td colspan="1" rowspan="1">A/PR/8/34 (H1N1), A/Guizhou/54/89 (H3N2), B/Ibaraki/2/85 (B)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR98">98</xref>]</td></tr><tr><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1"><italic toggle="yes">Glycyrrhiza inflata</italic></td><td colspan="1" rowspan="1">Fabaceae</td><td colspan="1" rowspan="1">Root</td><td colspan="1" rowspan="1">Chalcone: Echinantin and isoliquiritigenin</td><td colspan="1" rowspan="1"><p>Echinantin and Isoliquiritigenin without prenyl group: Strong NA inhibitor</p><p>Echinantin: Synergistic effects against NA of H274Y virus</p></td><td colspan="1" rowspan="1">Influenza A H1N1, H9N2, H1N1 (WT), and H1N1 (H274Y))</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR99">99</xref>]</td></tr><tr><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1"><italic toggle="yes">Glycyrrhiza uralensis</italic></td><td colspan="1" rowspan="1">Fabaceae</td><td colspan="1" rowspan="1">Root</td><td colspan="1" rowspan="1">Chalcone: Isoliquiritigenin</td><td colspan="1" rowspan="1">Strong NA inhibitor</td><td colspan="1" rowspan="1">Influenza A H1N1</td><td colspan="1" rowspan="1">rvH1N1 (A/Bervig_Mission/1/18)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR100">100</xref>]</td></tr><tr><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1"><italic toggle="yes">Hamamelis virginiana</italic></td><td colspan="1" rowspan="1">Hamamelidaceae</td><td colspan="1" rowspan="1">Bark</td><td colspan="1" rowspan="1"><p>Phenolic acid: Gallic acid, hamamelitannin</p><p>Tannin: Tannic acid, and pentagalloylglucose</p><p>Catechin: epigallocatechin gallate</p></td><td colspan="1" rowspan="1"><p>Gallic acid, Epigallocatechin gallate, Hamamelitannin :NA inhibition</p><p>Tannic acid: Inhibition of viral binding and neuraminidase</p></td><td colspan="1" rowspan="1">Influenza A H1N1, H3N2, H7N9</td><td colspan="1" rowspan="1">A/Puerto Rico/8/34, A/Luxembourg/46/2009 (H1N1), A/Luxembourg/01/2005 ( H3N2), A/Anhui/01/2013 ( H7N9)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR101">101</xref>]</td></tr><tr><td rowspan="3" colspan="1">22</td><td rowspan="3" colspan="1"><italic toggle="yes">Houttuynia cordata</italic></td><td rowspan="3" colspan="1">Saururaceae</td><td rowspan="3" colspan="1">Aerial parts, Whole plant</td><td colspan="1" rowspan="1"><p>Aldehyde: Lauryl aldehyde, and Capryl aldehyde</p><p>Ketone: Methyl n-nonyl ketone</p></td><td colspan="1" rowspan="1">Exerts virucidal activity by interfere with viral envelope</td><td colspan="1" rowspan="1">Influenza A H1N1</td><td colspan="1" rowspan="1">NWS</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR102">102</xref>]</td></tr><tr><td colspan="1" rowspan="1">Polysaccharide: <italic toggle="yes">Houttuynia cordata</italic> polysaccharide [HCP]</td><td colspan="1" rowspan="1"><p>HCP:</p><p>i. Inhibits pulmonary inflammatory cytokine and expression of TLR4-NF-&#954;B</p><p>ii. Lessens the severity of organ injury</p></td><td colspan="1" rowspan="1">Influenza A H1N1</td><td colspan="1" rowspan="1">A/FM/1/47( H1N1)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR103">103</xref>]</td></tr><tr><td colspan="1" rowspan="1">Flavone: Quercetin 3-rhamnoside (Q3R)</td><td colspan="1" rowspan="1">Reduction in viral mRNA synthesis, Inhibit initial stage of replication</td><td colspan="1" rowspan="1">Influenza A H1N1</td><td colspan="1" rowspan="1">A/WS/33 (H1N1)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR104">104</xref>]</td></tr><tr><td rowspan="3" colspan="1">23</td><td rowspan="3" colspan="1"><italic toggle="yes">Isatis indigotica</italic></td><td rowspan="3" colspan="1">Brassicaceae</td><td rowspan="3" colspan="1">Root</td><td rowspan="3" colspan="1">Polysaccharide: <italic toggle="yes">Isatis indigotica</italic> root polysaccharide (IRPS), Alkaloid: Indirubin, Lignan: Clemastanin</td><td colspan="1" rowspan="1"><p>IRPS:</p><p>i. Inhibit RNA and Protein synthesis</p><p>ii. Induce cytokine production</p><p>iii. Reduce pulmonary inflammation</p></td><td colspan="1" rowspan="1">Influenza A H3N2</td><td colspan="1" rowspan="1">A/swine/Henan/2010 (H3N2)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR105">105</xref>]</td></tr><tr><td colspan="1" rowspan="1">Indirubin: Inhibition of RANTES in virus-infected H292 cells. Interrupts virus-induced NF-&#954;B translocation, p38 MAP kinase activation.</td><td colspan="1" rowspan="1">Influenza A H1N1</td><td colspan="1" rowspan="1">A/NWS/33 (H1N1)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR106">106</xref>]</td></tr><tr><td colspan="1" rowspan="1"><p>Clemastanin:</p><p>i. Early stage of replication</p><p>ii. Interfere with RNP export</p><p>iii. Not create drug resistance</p></td><td colspan="1" rowspan="1">Influenza A H1N1</td><td colspan="1" rowspan="1">A/PR/8/34 (H1N1)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR107">107</xref>]</td></tr><tr><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1"><italic toggle="yes">Lycoris radiate</italic></td><td colspan="1" rowspan="1">Amaryllidaceae</td><td colspan="1" rowspan="1">Bulb</td><td colspan="1" rowspan="1">Alkaloid: Lycorine and Hemanthamine</td><td colspan="1" rowspan="1">Block vRNP nuclear export, Resist pro-apoptotic stimuli and cytoskeleton disruption</td><td colspan="1" rowspan="1">Influenza A H5N1, H3N2, H1N1, H9N2</td><td colspan="1" rowspan="1">A /Chicken/GuangDong /178 /2004, A/CK/GD/178/04, A/DK/GD/212/04 (H5N1), A/Swine/GD/166/06 (H3N2), A/CK/HN/170/03, A/PuertoRico/8/34 (H1N1), A/CK/GD/400/07, A/CK/GD/228/04 (H9N2)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR108">108</xref>, <xref ref-type="bibr" rid="CR109">109</xref>]</td></tr><tr><td rowspan="2" colspan="1">25</td><td rowspan="2" colspan="1"><italic toggle="yes">Narcissus tazetta</italic></td><td rowspan="2" colspan="1">Amaryllidaceae</td><td rowspan="2" colspan="1">Bulbs</td><td rowspan="2" colspan="1">Proteins: Narcissus tazetta lectin [NTL], NTP</td><td colspan="1" rowspan="1"><p>NTL:</p><p>i.Inhibit early phase of replication</p><p>ii. Interacting with surface glycoproteins</p><p>iii. Avoid the virus adherence and fusion</p></td><td colspan="1" rowspan="1">Influenza A H1N1, H3N2,H5N1 and B</td><td colspan="1" rowspan="1">A/HongKong/CUHK-13003/2002 (H1N1), A/HongKong/CUHK 22910/2004 (H3N2), A/HongKong/483/1997 (H5N1), and B/HongKong/CUHK-24964/2004 (B)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR110">110</xref>, <xref ref-type="bibr" rid="CR111">111</xref>]</td></tr><tr><td colspan="1" rowspan="1">NTP: NA inhibitor</td><td colspan="1" rowspan="1">Influenza A H1N1</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR112">112</xref>]</td></tr><tr><td colspan="1" rowspan="1">26</td><td colspan="1" rowspan="1"><italic toggle="yes">Olea eurolaea</italic></td><td colspan="1" rowspan="1">Oleaceae</td><td colspan="1" rowspan="1">Leaves and fruits</td><td colspan="1" rowspan="1"><bold>Catechol:</bold> Hydroxytyrosol (HT)</td><td colspan="1" rowspan="1"><p>i. Inactivates the viruses</p><p>ii. Affects NP protein synthesis</p><p>iii. Suppresses mRNA synthesis</p><p>iv. Structural disruption</p></td><td colspan="1" rowspan="1">Influenza A H1N1, H3N2, H5N1, H9N2</td><td colspan="1" rowspan="1">A/Hokkaido/30/2000 (H1N1), A/Hokkaido/52/98 (H3N2), A/chicken/Yamaguchi/7/04 (H5N1), and A/chicken/Yokohama/aq55/01 (H9N2)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR113">113</xref>]</td></tr><tr><td colspan="1" rowspan="1">27</td><td colspan="1" rowspan="1"><italic toggle="yes">Panax ginseng</italic></td><td colspan="1" rowspan="1">Araliaceae</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1"><p>Polysaccharide: <italic toggle="yes">Panax ginseng</italic> polysaccharide [GP]</p><p>Glycosides: Ginsenoside PPT, Re</p></td><td colspan="1" rowspan="1"><p>GP:</p><p>i. Reduce inflammatory cytokine (IL-6)</p><p>ii. regular consumption protects against heterosubtypic lethal challenges</p></td><td colspan="1" rowspan="1">Influenza A H1N1,H3N2</td><td colspan="1" rowspan="1">A/PR/8/34 ,A/California/04/2009 (H1N1) and A/Philippines/82 ( H3N2)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR114">114</xref>]</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"><p>PPT:</p><p>i. Inhibits IP-10 production</p><p>ii. Regulating the micro RNA, miR-15b</p><p>Re:</p><p>i. Partially reduced the virus-adapted apoptosis</p><p>ii. Provide cytoprotection</p><p>iii. Increase cell viability effect</p></td><td colspan="1" rowspan="1">Influenza A H9N2</td><td colspan="1" rowspan="1">A/Quail/Hong Kong/G1/97 (H9N2)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR115">115</xref>]</td></tr><tr><td colspan="1" rowspan="1">28</td><td colspan="1" rowspan="1"><italic toggle="yes">Panax quinquefolium</italic></td><td colspan="1" rowspan="1">Araliaceae</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Glycosides: Ginsenoside</td><td colspan="1" rowspan="1"><p>i. Prevent lethal lung damage</p><p>ii. Interact with HA of virus</p><p>iii. Prevents virus attachment with &#945; 2&#8211;3&#8242; sialic acid receptors</p></td><td colspan="1" rowspan="1">Influenza A H1N1</td><td colspan="1" rowspan="1">A/Nanchang/8002/2009 H1N1 (NC2) (H1N1)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR116">116</xref>]</td></tr><tr><td rowspan="2" colspan="1">29</td><td rowspan="2" colspan="1"><italic toggle="yes">Pandanus amaryllifolius</italic></td><td rowspan="2" colspan="1">Pandanaceae</td><td rowspan="2" colspan="1">Leaves</td><td rowspan="2" colspan="1"><p>Proteins: <italic toggle="yes">Pandanus amaryllifolius</italic> (PYM2)</p><p>Lectin: Pandanin</p></td><td colspan="1" rowspan="1">Pandanin: Hemagglutinator</td><td colspan="1" rowspan="1">Influenza A H1N1</td><td colspan="1" rowspan="1">Not mention</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR117">117</xref>]</td></tr><tr><td colspan="1" rowspan="1">PYM2: Upregulation of cytokines IL-1&#946;, IL-12, IFN-&#947;, and TNF-&#945;</td><td colspan="1" rowspan="1">Influenza A H1N1, H3N2, H5N1, and B</td><td colspan="1" rowspan="1">Not mention</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR110">110</xref>]</td></tr><tr><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1"><italic toggle="yes">Perilla frutescens</italic></td><td colspan="1" rowspan="1">Lamiaceae</td><td colspan="1" rowspan="1">Seeds</td><td colspan="1" rowspan="1"><p>Flavones: Luteolin</p><p>Phenolic acid: Rosmarinic acid</p></td><td colspan="1" rowspan="1">NA inhibitor</td><td colspan="1" rowspan="1">Influenza A H1N1 NA</td><td colspan="1" rowspan="1">Recombinant virus H1N1 neuraminidase (rvH1N1 NA E.C. 3.2.1.18)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR118">118</xref>]</td></tr><tr><td rowspan="2" colspan="1">31</td><td rowspan="2" colspan="1"><italic toggle="yes">Pithecellobium clypearia</italic></td><td rowspan="2" colspan="1">Fabaceae</td><td rowspan="2" colspan="1">Leaves and twigs</td><td rowspan="2" colspan="1">Flavan-3-ol: (2R,3R)-7-O-galloylplumbocatechin A (1), (&#8722;)-5,3&#8242;,4&#8242;,5&#8242;-tetrahydroxyflavan-7-gallate (2), (+)-3,5,3&#8242;,4&#8242;,5&#8242;-penta-hydroxyflavan-7-gallate (3), and (&#8722;)-7,4&#8242;-di-O-galloyltricetiflavan (4), gallocatechin-7-gallate (J10688)</td><td colspan="1" rowspan="1"><p>Flavan-3-ol compounds 1&#8211;4: Inhibit the expression of proinflammatory cytokines IL-6 or MCP-1</p><p>Compound 1 and 2: Moderate NA activity</p></td><td colspan="1" rowspan="1">Influenza A H1N1, H3N2, and B</td><td colspan="1" rowspan="1">A/PR/8/34 (H1N1), A/Sydney/5/97 (H3N2), B/Jiangsu/10/2003 (B)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR119">119</xref>]</td></tr><tr><td colspan="1" rowspan="1"><p>J10688: i. Effective CLK1 inhibitor regulates M2 alternative splicing</p><p>ii.Inhibit pro-inflammatory cytokines IFN-&#947;, IL-6, TNF-&#945;, and IL-1&#946;</p><p>iii. Increase survival rate by prevent viral infection and lung injury</p><p>iv. Decrease viral NP, M2, and RNA synthesis</p></td><td colspan="1" rowspan="1">Influenza A H1N1, H3N2 and B</td><td colspan="1" rowspan="1">A/PR/8/34 (H1N1), A/Sydney/5/97 (H3N2), and B/Jiangsu/10/2003</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR120">120</xref>]</td></tr><tr><td rowspan="3" colspan="1">32</td><td rowspan="3" colspan="1"><italic toggle="yes">Pogostemon cablin</italic></td><td rowspan="3" colspan="1">Lamiaceae</td><td rowspan="3" colspan="1">Dried aerial part</td><td rowspan="3" colspan="1">Sesquiterpene: Patchouli alcohol</td><td colspan="1" rowspan="1"><p>i. Target virus particles and cellular PI3K/Akt and ERK/MAPK signaling pathways</p><p>ii. Reduction of a viral nucleoprotein</p><p>iii. Increased survival and decreased pneumonia symptoms in virus-infected mice</p><p>iv. Reduced viral multiplication</p></td><td colspan="1" rowspan="1">Influenza A H1N1</td><td colspan="1" rowspan="1">Influenza A viruses H1N1 (A/Puerto Rico/8/34), H1N1 (A/NWS/33), and H1N1 (A/Virginia/ATCC1/2009)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR121">121</xref>]</td></tr><tr><td colspan="1" rowspan="1"><p>i. Elevation of IgA, IgM, and IgG antibodies</p><p>ii. Increased CD3+ and CD4+ T cell levels</p><p>iii. Reduce lung inflammation by secreting anti-inflammatory cytokines IL-10 and IFN-&#947;</p></td><td colspan="1" rowspan="1">Influenza A H1N1</td><td colspan="1" rowspan="1">A/FM/1/47(H1N1)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR122">122</xref>]</td></tr><tr><td colspan="1" rowspan="1"><p>i. Inhibit viral penetration</p><p>ii. Protect the infected mice from lethal effect</p><p>iii. Perfect binding with virus NA</p></td><td colspan="1" rowspan="1">Influenza A H2N2</td><td colspan="1" rowspan="1">A/Leningrad/134/17/1957(H2N2)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR123">123</xref>]</td></tr><tr><td colspan="1" rowspan="1">33</td><td colspan="1" rowspan="1"><italic toggle="yes">Polygonatum odoratum</italic></td><td colspan="1" rowspan="1">Asparagaceae</td><td colspan="1" rowspan="1">Rhizomes</td><td colspan="1" rowspan="1">Proteins: Polygonatum odoratum Lectin (POL)</td><td colspan="1" rowspan="1"><p>POL:</p><p>i. Antiviral activity against H1N1 and H5N1 ii. Produce immunomodulatory effects by upregulation of several cytokines like IL-1&#946;, IL-12p35, IFN-&#947;, and TNF-&#945;</p><p>Lectin:</p><p>Antiviral activity against H1N1 and H5N1</p></td><td colspan="1" rowspan="1">Influenza A H1N1, H3N2,H5N1 and B</td><td colspan="1" rowspan="1">Not mention</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR110">110</xref>]</td></tr><tr><td colspan="1" rowspan="1">34</td><td colspan="1" rowspan="1"><italic toggle="yes">Polygonum cuspidatum</italic></td><td colspan="1" rowspan="1">Polygonaceae</td><td colspan="1" rowspan="1">Rhizome, dried roots</td><td colspan="1" rowspan="1"><p>Stilbenes: Resveratrol, (E)-3, 5, 12-trihydroxystilbene-3-O-beta-<sc>d</sc>-glucopyranoside-2&#8242;-(3&#8243;, 4&#8243;, 5&#8243;-trihydroxybenzoate)</p><p>Flavan-3-ol: Catechin-3-O-gallate</p></td><td colspan="1" rowspan="1">Virus and neuraminidase inhibitor</td><td colspan="1" rowspan="1">Influenza A H1N1</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR124">124</xref>]</td></tr><tr><td colspan="1" rowspan="1">35</td><td colspan="1" rowspan="1"><italic toggle="yes">Psoralea carylifolia</italic></td><td colspan="1" rowspan="1">Fabaceae</td><td colspan="1" rowspan="1">Seeds</td><td colspan="1" rowspan="1">Meroterpene: (+)-(<italic toggle="yes">S</italic>)-bakuchiol, and its enantiomer, (&#8722;)-(<italic toggle="yes">R</italic>)-bakuchiol</td><td colspan="1" rowspan="1"><p>(+)-(S)-bakuchiol:</p><p>i. Inhibited the H1N1 strains</p><p>ii. Decreased viral mRNAs and protein expression</p><p>iii. Induce Nrf2 activation and upregulated <italic toggle="yes">NQO1</italic>, p53 and <italic toggle="yes">GSTA3</italic> mRNA levels thereby inhibit viral growth</p></td><td colspan="1" rowspan="1">Influenza A H1N1, H3N2</td><td colspan="1" rowspan="1">A/PR/8/34, A/CA/7/09 (H1N1), and A/Aichi/2/68 (H3N2)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR125">125</xref>]</td></tr><tr><td colspan="1" rowspan="1">36</td><td colspan="1" rowspan="1">Punica granatum</td><td colspan="1" rowspan="1">Lythraceae</td><td colspan="1" rowspan="1">Fruit</td><td colspan="1" rowspan="1">Hydrolysable tannin: punicalagin</td><td colspan="1" rowspan="1"><p>i. Produce direct inhibitory and virucidal effect.</p><p>ii. Affect viral replication by target its attachment</p></td><td colspan="1" rowspan="1">Influenza A H1N1, H3N2, and influenza B</td><td colspan="1" rowspan="1">A/USSR/90/77 (H1N1), A/Hong Kong/2/68, A/HK (H3N2), B/Harbin/07/94 (B)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR126">126</xref>]</td></tr><tr><td colspan="1" rowspan="1">37</td><td colspan="1" rowspan="1"><italic toggle="yes">Rhodiola rosea</italic></td><td colspan="1" rowspan="1">Crassulaceae</td><td colspan="1" rowspan="1">Dried Roots</td><td colspan="1" rowspan="1">Flavonols: Gossypetin, kaempferol</td><td colspan="1" rowspan="1">NI inhibition with Potent anti-influenza activity</td><td colspan="1" rowspan="1">Influenza A H1N1,H9N2</td><td colspan="1" rowspan="1">A/PR/8/34 (H1N1) A/Chicken/Korea/MS96/96 (H9N2)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR127">127</xref>]</td></tr><tr><td rowspan="2" colspan="1">38</td><td rowspan="2" colspan="1"><italic toggle="yes">Ribes nigrum</italic></td><td rowspan="2" colspan="1">Grossulariaceae</td><td rowspan="2" colspan="1">Fruits</td><td rowspan="2" colspan="1">Crude extracts, anthocyanin</td><td colspan="1" rowspan="1">Extract inhibits the virus release and suppress late stage of growth</td><td colspan="1" rowspan="1">Influenza A H1N1 and B</td><td colspan="1" rowspan="1">A/PR/8/34 (H1N1), B/Gifu/2/73 (B)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR128">128</xref>]</td></tr><tr><td colspan="1" rowspan="1"><p>Anthocyanin: Responsible for anti-influenza activity in crude extract</p><p>Fractions D&#8242; to G&#8242;: Potent against influenza A and B</p><p>E&#8242; and F&#8242;: Show Additive antiviral effects</p><p>F&#8242;: Inhibit virus adsorption and release</p></td><td colspan="1" rowspan="1">Influenza A H1N1 and B</td><td colspan="1" rowspan="1">A/PR/8/34 (H1N1), B/Gifu/2/73 (B)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR129">129</xref>]</td></tr><tr><td colspan="1" rowspan="1">39</td><td colspan="1" rowspan="1"><italic toggle="yes">Sambucus nigra</italic></td><td colspan="1" rowspan="1">Adoxaceae</td><td colspan="1" rowspan="1">Fruits (Berries)</td><td colspan="1" rowspan="1">Flavone: 5,7,3&#8242;,4&#8242;-tetra-O-methylquercetin (1) and 5,7-dihydroxy-4-oxo-2-(3,4,5-trihydroxyphenyl) chroman-3-yl-3,4,5-trihydroxycyclohexanecarboxylate (2)</td><td colspan="1" rowspan="1"><p>i. Virion binding</p><p>ii. Prevent host cell entry and/or recognition</p></td><td colspan="1" rowspan="1">Influenza A H1N1</td><td colspan="1" rowspan="1">A/PR/8/34 (H1N1)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR130">130</xref>]</td></tr><tr><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1"><italic toggle="yes">Schefflera heptaphylla</italic></td><td colspan="1" rowspan="1">Araliaceae</td><td colspan="1" rowspan="1">Leaf stalk</td><td colspan="1" rowspan="1">Triterpenoids: 3&#945;-hydroxylup-20 (29)-ene-23, 28-dioic acid and 3-epi -betulinic acid 3-O-sulfate.</td><td colspan="1" rowspan="1">Inhibit virus infection</td><td colspan="1" rowspan="1">Influenza A H1N1</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR131">131</xref>]</td></tr><tr><td rowspan="5" colspan="1">49</td><td rowspan="5" colspan="1"><italic toggle="yes">Scutellaria baicalensis</italic></td><td rowspan="5" colspan="1">Lamiaceae</td><td rowspan="5" colspan="1">Leaves and roots</td><td rowspan="5" colspan="1">Flavones:Baicalin, 5, 7, 4&#8242;-trihydroxy-8-methoxyflavone (F36), Isoscutellarein (5,7,8,4&#8242;-tetrahydroxyflavone), wogonin, baicalein</td><td colspan="1" rowspan="1"><p>Baicalin:</p><p>i. Neuraminidase inhibitor</p><p>ii. Affects the virus budding</p><p>iii. Increased survival rate</p></td><td colspan="1" rowspan="1">Influenza A H1N1, H3N2</td><td colspan="1" rowspan="1">i. A/FM1/1/47 (H1N1) and ii. A/Beijing/32/92 (H3N2)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR132">132</xref>]</td></tr><tr><td colspan="1" rowspan="1"><p>F36:</p><p>i. Inhibit infection replication</p><p>ii. Prevent virus proliferation</p><p>iii. Reduce lung virus titers</p><p>iv. Endosome/lysososme fusion inhibition</p></td><td colspan="1" rowspan="1">Influenza A H1N1, H3N2, and B</td><td colspan="1" rowspan="1"><p>i. <italic toggle="yes">A/PR/8/34 (H1N1)</italic></p><p>ii. <italic toggle="yes">A/Guizhou/54/89 (H3N2) and iii.B/Ibaraki/2/85 (B)</italic></p></td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR133">133</xref>, <xref ref-type="bibr" rid="CR134">134</xref>]</td></tr><tr><td colspan="1" rowspan="1"><p>Isoscutellarein (5,7,8,4&#8242;-tetrahydroxyflavone:</p><p>i. Sialidase inhibitory effect</p><p>ii. Replication inhibition</p></td><td colspan="1" rowspan="1">Influenza A H1N1</td><td colspan="1" rowspan="1">A/WSN/33 and A/PR/ 8/34 (H1N1)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR135">135</xref>, <xref ref-type="bibr" rid="CR136">136</xref>]</td></tr><tr><td colspan="1" rowspan="1"><p>Wogonin:</p><p>i. Replication suppression</p><p>ii. Induce IFN response and AMPK phosphorylation</p></td><td colspan="1" rowspan="1">Influenza A H1N1, seasonal H1N1, H3N2, and B of Yamagata lineage</td><td colspan="1" rowspan="1">A/Puerto-Rico/8/34(H1N1), seasonal H1N1, H3N2, and B of Yamagata lineage (Clinical influenza strains)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR137">137</xref>]</td></tr><tr><td colspan="1" rowspan="1"><p>Baicalein:</p><p>i.Interact with NA1 active sites</p><p>ii.Inhibit replication</p></td><td colspan="1" rowspan="1">Influenza A H1N1 (pandemic and seasonal)</td><td colspan="1" rowspan="1">A/Taiwan/CMUH/2009 (pandemic 2009 H1N1), A/Taiwan//CMUH/2007(seasonal 2007 H1N1)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR138">138</xref>]</td></tr><tr><td colspan="1" rowspan="1"> 42</td><td colspan="1" rowspan="1"><italic toggle="yes">Solanum tuberosum</italic></td><td colspan="1" rowspan="1">Solanaceae</td><td colspan="1" rowspan="1">Root tuber</td><td colspan="1" rowspan="1">Anthocyanin</td><td colspan="1" rowspan="1">Additive or synergistic effect of the constituents produce antiviral effect</td><td colspan="1" rowspan="1">Influenza A H1N1 and B</td><td colspan="1" rowspan="1">H1N1 (A/PR/8/34) and B(B/Gifu/2/73)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR139">139</xref>]</td></tr><tr><td rowspan="5" colspan="1">43</td><td rowspan="5" colspan="1"><italic toggle="yes">Sophora flavescens</italic></td><td rowspan="5" colspan="1">Leguminosae</td><td rowspan="5" colspan="1">Root, dried heart wood</td><td rowspan="5" colspan="1"><p>Alkaloids:</p><p>i. Aloperine and its derivatives</p><p>ii.Matrine, Pterocarpans, Homoisoflavonoid: Sappanone A and Brazilin, Prenylflavonoid: 8-Prenylkaempferol (8-PK), Prenylflavanones</p></td><td colspan="1" rowspan="1"><p>Alkaloids:</p><p>i. Target NP</p><p>ii. Reduce cytotoxic effect and HI inhibition similar to Oseltamivir.</p></td><td colspan="1" rowspan="1">Influenza A H1N1, H3N2, H9N2</td><td colspan="1" rowspan="1">A/Puerto Rico/8/34 (H1N1), oseltamivir-sensitive virus VR1679 (H3N2) A/Goose/Dalian/3/2001( H9N2)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR140">140</xref>, <xref ref-type="bibr" rid="CR141">141</xref>]</td></tr><tr><td colspan="1" rowspan="1">Pterocarpan: In silico studies shows NA binding near to active site</td><td colspan="1" rowspan="1">Influenza A</td><td colspan="1" rowspan="1">PDB ID 1L7F</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR142">142</xref>]</td></tr><tr><td colspan="1" rowspan="1">Sappanone A and Brazilin: Strong NA inhibitors</td><td colspan="1" rowspan="1">Influenza A H1N1, H3N2, H9N2</td><td colspan="1" rowspan="1">A/PR/8/34 (H1N1), A/HongKong/8/68 (H3N2), a/Chicken/Korea/MS96/96 (H9N2)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR80">80</xref>]</td></tr><tr><td colspan="1" rowspan="1"><p>8-PK:</p><p>i.Block PI3K pathway ii.Prevent NF-&#954;B, IRF-3 activation and I&#954;B degradation</p><p>ii.Reduction of RANTES accumulation</p></td><td colspan="1" rowspan="1">Influenza A H1N1</td><td colspan="1" rowspan="1">A/PR/8/34 (H1N1)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR143">143</xref>]</td></tr><tr><td colspan="1" rowspan="1"><p>Prenylflavanones:</p><p>Active against influenza infection</p></td><td colspan="1" rowspan="1">Influenza A H1N1</td><td colspan="1" rowspan="1">A/WSN/33/2009(H1N1)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR144">144</xref>]</td></tr><tr><td colspan="1" rowspan="1">44</td><td colspan="1" rowspan="1"><italic toggle="yes">Strobilanthes cusia</italic></td><td colspan="1" rowspan="1"><italic toggle="yes">Acanthaceae</italic></td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">Alkaloid: Indirubin</td><td colspan="1" rowspan="1"><p>Inhibition of RANTES in virus-infected H292 cells</p><p>Interrupts virus-induced NF-&#954;B translocation, p38 MAP kinase activation</p></td><td colspan="1" rowspan="1">Influenza A H1N1</td><td colspan="1" rowspan="1">A/NWS/33 (H1N1)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR106">106</xref>]</td></tr><tr><td colspan="1" rowspan="1">45</td><td colspan="1" rowspan="1"><italic toggle="yes">Taxodium distichum</italic></td><td colspan="1" rowspan="1">Cupressaceae</td><td colspan="1" rowspan="1">Stem</td><td colspan="1" rowspan="1">Shikimic acid</td><td colspan="1" rowspan="1">NA inhibitor</td><td colspan="1" rowspan="1">Influenza A H1N1</td><td colspan="1" rowspan="1">A/WSN/33 (H1N1)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR145">145</xref>]</td></tr><tr><td rowspan="2" colspan="1">46</td><td rowspan="2" colspan="1"><italic toggle="yes">Thallasodendron ciliatum</italic></td><td rowspan="2" colspan="1">Cymodoceaceae</td><td rowspan="2" colspan="1">Whole plant</td><td rowspan="2" colspan="1"><p>Ester: Asebotin</p><p>Chalcone: Thalassodendrone (dihydrochalcone diglycoside)</p></td><td colspan="1" rowspan="1">Asebotin: Virus inhibition</td><td colspan="1" rowspan="1">Influenza A H5N1</td><td colspan="1" rowspan="1">A/chicken/Egypt/1055/2010 (H5N1)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR146">146</xref>]</td></tr><tr><td colspan="1" rowspan="1">Inhibit virus with low cytotoxic effect</td><td colspan="1" rowspan="1">Influenza A H1N1</td><td colspan="1" rowspan="1">A virus /WSN/33 ( H1N1)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR147">147</xref>]</td></tr><tr><td colspan="1" rowspan="1">47</td><td colspan="1" rowspan="1"><italic toggle="yes">Wasabi japonica</italic></td><td colspan="1" rowspan="1">Brassicaceae</td><td colspan="1" rowspan="1">Rhizome, fibrous root, and petiole</td><td colspan="1" rowspan="1">Isothiocyanate</td><td colspan="1" rowspan="1">Virucidal effect</td><td colspan="1" rowspan="1">Influenza virus</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR148">148</xref>]</td></tr><tr><td colspan="1" rowspan="1">48</td><td colspan="1" rowspan="1"><italic toggle="yes">Withania somnifera</italic></td><td colspan="1" rowspan="1">Solanaceae</td><td colspan="1" rowspan="1">Fresh leaves</td><td colspan="1" rowspan="1">Ester: Withaferin A</td><td colspan="1" rowspan="1">High binding affinity with NA (Docking study)</td><td colspan="1" rowspan="1">Influenza A H1N1</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR149">149</xref>]</td></tr><tr><td colspan="1" rowspan="1">49</td><td colspan="1" rowspan="1"><italic toggle="yes">Zizyphus jujuba</italic></td><td colspan="1" rowspan="1">Rhamnaceae</td><td colspan="1" rowspan="1">Leaves, Fruit, and dried roots</td><td colspan="1" rowspan="1">Triterpene: Betulinic acid</td><td colspan="1" rowspan="1"><p>i. Proliferation inhibition</p><p>ii. Attenuation of increased necrosis, numbers of inflammatory cells, and pulmonary edema</p><p>iii. Decreases inflammatory cytokine IFN-&#947;</p></td><td colspan="1" rowspan="1">Influenza A H1N1</td><td colspan="1" rowspan="1">A/PR/8 (H1N1)</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR150">150</xref>]</td></tr><tr><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Monoterpenes: Menthol, Eucalyptol</td><td colspan="1" rowspan="1">Strong interactions with HA (Docking study)</td><td colspan="1" rowspan="1">Influenza A H5N1</td><td colspan="1" rowspan="1">Not mentioned</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR151">151</xref>]</td></tr></tbody></table></table-wrap></p><sec id="Sec10"><title>Primary metabolism</title><p id="Par135">Primary metabolism is the group of all metabolic pathways synthesizing essential compounds for plant survival. Primary metabolites perform physiological functions, and these include nucleic acids, amino acids, proteins, carbohydrates, lipids, alcohol, and other natural products [<xref ref-type="bibr" rid="CR152">152</xref>] like ester and shikimic acid.
<list list-type="simple"><list-item><label>i.</label><p id="Par136">Amino acid: The amino acid glutamine is essential for the synthesis of proteins and plays a critical role in the immune system. Theanine is one of the derivatives of glutamine that enhances gammadelta T cell function in influenza infection. Matsumoto et al. conducted a randomized, double-blind, placebo-controlled trial among 197 healthcare workers to evaluate the efficacy of <italic toggle="yes">Camellia sinensis</italic> Theanine and Catechin. The author divided the participants into two groups. The first group of 98 members receives catechin (378 mg) and theanine (210 mg) daily whereas the second group of 99 members act as the control group receives placebos. The main source of outcome is the incidence of clinically defined influenza infection, laboratory-confirmed influenza with viral antigen, and the time patient is free from clinically defined infection. From this study, the authors observed 4 participants in the first group and 13 from the control group report clinically defined influenza infection, whereas the laboratory-confirmed infection prevails in 1 member of the first group and 5 from the control group and they are statistically insignificant. From this, they concluded Theanine and Catechin might be an effective prophylaxis against influenza infection [<xref ref-type="bibr" rid="CR81">81</xref>].</p></list-item><list-item><label>ii.</label><p id="Par137">Proteins: Lectins are the carbohydrate-binding protein noted in plants like <italic toggle="yes">Pandanus amaryllifolius</italic> [<xref ref-type="bibr" rid="CR110">110</xref>, <xref ref-type="bibr" rid="CR117">117</xref>], <italic toggle="yes">Narcissus tazetta</italic>, and <italic toggle="yes">Polygonatum odoratum</italic> which exerts antiviral activity against influenza viruses [<xref ref-type="bibr" rid="CR110">110</xref>].</p></list-item></list></p><p id="Par138">Pandanin, a new antiviral lectin protein, shows its antiviral activity against the H1N1 virus at EC<sub>50</sub> of 15.63 &#956;M with hemagglutinating activity [<xref ref-type="bibr" rid="CR117">117</xref>]<italic toggle="yes">.</italic></p><p id="Par139">Ooi VEC et al. screened 10 purified herbal compounds from 30 herbal extracts and perform antiviral potential studies. From the 10 herbal compounds, three proteins PYM2 of <italic toggle="yes">Pandanus amaryllifolius</italic>, NTL of <italic toggle="yes">Narcissus tazetta</italic>, and POL of <italic toggle="yes">Polygonatum odoratum</italic> exhibit antiviral infectivity against H1N1, H3N2, H5N1, and influenza B viruses, observed through plaque reduction assay. AntiH5N1 efficacy of PYM2 (IC<sub>50</sub> 26.03&#956;g/mL) and POL (IC<sub>50</sub> 6.23&#956;g/mL) are further investigated by introducing 5 mg/kg of the proteins in mouse macrophages where the upregulation of cytokines IL-1&#946;, IL-12, IFN-&#947;, and TNF-&#945; was observed [<xref ref-type="bibr" rid="CR110">110</xref>].</p><p id="Par140"><italic toggle="yes">Narcissus tazetta</italic> lectin is a mannose-binding Lectin protein. Linda S M Ooi et al. describe NTL viral inhibition activity by using an extracellular virus yield reduction assay. NTL inhibits H1N1, H3N2, and influenza B viruses (A(H1N1)/HongKong/CUHK-13003/2002, A(H3N2)/HongKong/CUHK22910/2004, A(H5N1)/HongKong/483/1997, and B/HongKong/CUHK-24964/2004) in a dose-dependent manner (EC<sub>50</sub> values ranging from 0.02 &#956;g/mL to 1.33 &#956;g/mL) but with moderate inhibition on H5N1. The study also shows evidence of NTL inhibiting the H1N1&#8217;s early phase of replication by interacting with surface glycoproteins, thereby avoid the virus for adherence and fusion [<xref ref-type="bibr" rid="CR111">111</xref>].</p><p id="Par141">NTP is a fetuin-binding non-specific lipid transfer protein (nsLTPs) of <italic toggle="yes">Narcissus tazetta</italic> that blocks the neuraminidase of H1N1 (EC<sub>50</sub> of 4.47 mg/mL) thereby inhibiting the replication which is revealed from a MTT assay [<xref ref-type="bibr" rid="CR112">112</xref>].
<list list-type="simple"><list-item><label>iii.</label><p id="Par142">Carbohydrates: Carbohydrates are the major constituents of the plant which are produced by the photosynthetic process [<xref ref-type="bibr" rid="CR153">153</xref>]. They are produced in larger amounts and are classified into four types as Monosaccharides, Disaccharides, Oligosaccharides, and Polysaccharides.</p></list-item></list></p><p id="Par143">Monosaccharides are the simplest carbohydrates that have polyhydroxy aldehyde or ketone groups [<xref ref-type="bibr" rid="CR154">154</xref>]. Hayashi et al. demonstrate direct influenza H1N1 inhibitory activity of the <italic toggle="yes">Houttuynia cordata</italic> steam distillate without any cytotoxic effect against HeLa and MDCK cells. Aldehyde such as lauryl aldehyde and capryl aldehyde and ketone including methyl-nonyl ketone were the components of distillate which inactivate the influenza virus. The virus inactivation assay reveals either the distillate or its components exert virucidal activity by interfering with the function of the viral envelope [<xref ref-type="bibr" rid="CR102">102</xref>].</p><p id="Par144">Hayashi et al. isolated trans cinnamaldehyde (CA) from the cortex of <italic toggle="yes">Cinnamomum cassia</italic> and analyze its anti-influenza efficiency against H1N1 (A/PR/8/34, A/USSR/92/77), H3N2 (A/Aichi/2/68), and B (B /Lee/40). The in vitro study reveals dose-dependent inhibition of CA where 40&#956;M reduces 29.7% virus yield at 3 h p.i. and 200 &#956;M treatment does not show the virus growth.CA affects protein synthesis at post-transcriptional level but not degrade the preexisting or synthesized proteins. To the mouse lung-adapted PR8 virus&#8211;infected mice, CA administered through inhalation and nasal inoculation which shows 100% and 70% increasing survival rate on 8 days without remarkable weight loss. Notably, CA inhalator mouse bronchoalveolar lavage fluid (BALF) shows a decrease in virus yield by 1 log [<xref ref-type="bibr" rid="CR89">89</xref>].</p><p id="Par145">Polysaccharides are complex monosaccharides that play an essential role in the pharmaceutical industry for their effective inhibitory response against viruses like Influenza, HIV, Coxsackie virus B3 [CVB3], herpes simplex virus, hepatitis virus, and cytomeglalovirus [<xref ref-type="bibr" rid="CR155">155</xref>]. Various polysaccharides isolated from the herbs like <italic toggle="yes">Bupleurum chinense</italic> [BCPS], <italic toggle="yes">Houttuynia cordata</italic> [HCP], <italic toggle="yes">Isatis indigotica</italic> root [IRPS], <italic toggle="yes">Panax ginseng</italic> [GP], and <italic toggle="yes">Astragalus</italic> polysaccharide (APS) proved to be boosting up various immunological activities and prevent the effect of influenza infection.</p><p id="Par146"><italic toggle="yes">Bupleurum chinense</italic> polysaccharides [BCPS] act as an immunostimulating agent which enhances anti-influenza virus antibody. This was well demonstrated by Zhang and Chen&#8217;s studies, by injecting 100 mg/kg of BCPS in normal and influenza-infected mice. The results show increased lymphocyte transformation and enhanced NK cell function [<xref ref-type="bibr" rid="CR78">78</xref>].</p><p id="Par147"><italic toggle="yes">Houttuynia cordata</italic> polysaccharide [HCP] lessens the severity of organ injury due to influenza virus infection. Zhu et al. discovered its role by administered orally by gavages to H1N1 (A/FM/1/47)-infected mice and observed an increase in survival rate through inhibition of the release of pulmonary inflammatory cytokine and expression of TLR4-NF-&#954;B. Restoring and improvement of damaged tissue also noted [<xref ref-type="bibr" rid="CR103">103</xref>]<italic toggle="yes">.</italic></p><p id="Par148"><italic toggle="yes">Isatis indigotica</italic> root polysaccharide (IRPS) show a low cytotoxic effect and promote proliferation (1.25 mg/mL concentration) in MDCK cells infected with swine influenza virus (SIV) H3N2 of the strain (A/swine/Henan/2010). Through MTT assay, the preventive, inhibitory, and direct effect of IRPS against SIV was observed. IRPS (312.5&#8211;1250 &#956;g/mL) increases the percentage of prevention from 12.64 to 74.00% which shows the MDCK cell protection with enhanced antiviral ability. In addition to that, the cell membrane was stabilized by IRPS, which provides the potential to inhibit adsorption, penetration, and infection of SIV. A dose-dependent increase of IRPS (156.25&#8211;1250 &#956;g/mL) increased the percentage of inhibition from 31.92% to 84.95% suggested; IRPS may play a potent role in inhibiting viral RNA and protein synthesis. Surprisingly, IRPS direct effect was found to be weak in SIV-adapted MDCK cells. By in vivo study, the mice were orally administered with varying doses of IRPS chosen as 75 mg/kg/day, 50 mg/kg/day, and 25 mg/kg/day before the infection. The mice at 3 dpi show significant clinical signs, while at high dosage applied, 5 dpi regained the weight. The IRPS reduced pathological changes, with improved lesions and normal alveolar structure. Host immunity signaling molecule NO (Nitric oxide) was increased at 2 and 5 dpi; similarly, the antibody IgG in blood serum is increased significantly at 9 dpi. IRPS induces cytokine production and reduces pulmonary inflammation, which was evident from the detection of cytokine in lung homogenate [<xref ref-type="bibr" rid="CR105">105</xref>].</p><p id="Par149"><italic toggle="yes">Panax ginseng</italic> polysaccharide [GP] increases the survival rate of H1N1 (A/PR/8/34)-, (A/California/04/2009)-, and H3N2 (A/Philippines/82)-infected mice by providing intranasal 25 mg/kg or intravenous 10 mg/kg doses. The GP-treated H1N1 infect mice exhibit a lower level of viral titer along with reduced inflammatory cytokine (IL-6). It is noted that a higher dosage does not increase the survival rate. GP provides protection effect even before the influenza infection, and regular consumption protects against heterosubtypic lethal challenges [<xref ref-type="bibr" rid="CR114">114</xref>].</p><p id="Par150">In this study, Kallon et al. use <italic toggle="yes">Astragalus</italic> polysaccharide (APS) against H9N2-infected chick embryo fibroblasts (CEF) culture. APS of 321.25 &#956;g/mL concentrations is determined as optimal for the stimulation of CEF Proliferation. Appropriate dosage of APS administered during pre-addition (321.25 &#956;g/mL), post-addition, and simultaneous addition shows a significant reduction of viruses. APS upregulated IL-4, IL-10, LITAF, and IL-12 cytokine expression but IFN-&#947;, LITAF, IL-6, and IL-12 were downregulated. APS inoculation decreased MHC I and MHC II expression but increased after H9N2 infection. Peripheral blood lymphocytes expressing CD3+, CD4+, and CD8+ T cell surface markers were increased after APS immunization. Post-immunization of APS (5mg/kg) enhanced the antibody titer at 7 and 14 days [<xref ref-type="bibr" rid="CR76">76</xref>].
<list list-type="simple"><list-item><label>iv.</label><p id="Par151">Ester: Ester has ideal characteristics with chemical stability. Its unique characters attract to create prodrug [<xref ref-type="bibr" rid="CR156">156</xref>]. Several ester compounds show promising anti-influenza features.</p></list-item></list></p><p id="Par152">Zhang et al. isolated 13 compounds from the dried fruit powders of <italic toggle="yes">Chaenomeles speciosa</italic> and identify 3, 4-dihydroxybenzoic acid (Benzoic acid derivative), quercetin (flavonol), and methyl 3-hydroxybutanedioic ester (Ester) showed remarkable anti-influenza activity<italic toggle="yes">.</italic> The compounds 3, 4-dihydroxybenzoic acid (IC<sub>50</sub> 1.02 &#956;g/mL), and quercetin (IC<sub>50</sub> 3.82 &#956;g/mL) displayed significant dose-dependent DPPH radical scavenging activity<italic toggle="yes">.</italic> 5&#956;g/mL of 3, 4-dihydroxybenzoic acid, quercetin, and methyl 3-hydroxybutanedioic ester inhibit TNF-&#945; <italic toggle="yes">by</italic> 22.73%, 33.14%, and 37.19% and NO production inhibition. High IL-6 production inhibition (39.79%) was observed in methyl 3-hydroxybutanedioic ester. The compounds 3, 4-dihydroxybenzoic acid (IC<sub>50</sub> 1.27 &#956;g/mL) and methyl 3-hydroxybutanedioic ester (IC<sub>50</sub> 1.90 &#956;g/mL) featured H1N1 (A/PR/8/34) NA inhibition activity <italic toggle="yes">i</italic>n a dose-dependent manner [<xref ref-type="bibr" rid="CR88">88</xref>].</p><p id="Par153">The study of Ibrahim et al. informed that a new diglyceride ester along with asebotin (a dihydrochalcone) from <italic toggle="yes">Thallasodendron ciliatum</italic> exerted anti-AIV activity against A/chicken/Egypt/1055/2010 (H5N1) in MDCK cells. This compound inhibited the virus with a concentration of 1 ng mL<sup>&#8722;1</sup> by a percentage of 67.26 and 53.81. Its efficacy was similar to zanamivir which showed a higher concentration of inhibition of 10 ng mL<sup>&#8722;</sup> 1[<xref ref-type="bibr" rid="CR146">146</xref>].</p><p id="Par154">Cai et al. validated Withaferin A of <italic toggle="yes">Withania somnifera</italic> as a potent source for H1N1 NA inhibition through docking studies. In the study, Withaferin A shows a high binding affinity towards NA [<xref ref-type="bibr" rid="CR149">149</xref>].
<list list-type="simple"><list-item><label>xxii.</label><p id="Par155">Shikimic acid: Shikimic acid is an important biochemical metabolite and its pathway is essential for the synthesis of plant amino acid [<xref ref-type="bibr" rid="CR157">157</xref>]. Antiviral drug Tamiflu&#174; is prepared by using shikimic acid as base material [<xref ref-type="bibr" rid="CR158">158</xref>]. Several plants and their parts like fruits of <italic toggle="yes">Illicium religiosum</italic> and <italic toggle="yes">Illicium verum</italic>, barks of <italic toggle="yes">Illicium anisatum</italic>, <italic toggle="yes">Pinus thunbergii</italic>, and <italic toggle="yes">Pinus densiflora</italic>, stems and leaves of <italic toggle="yes">Saxifraga stolonifera</italic>, and <italic toggle="yes">Houttuynia cordata</italic> exhibits high shikimic acid content [<xref ref-type="bibr" rid="CR159">159</xref>].</p></list-item></list></p><p id="Par156">Recently shikimic acid has been noted in <italic toggle="yes">Taxodium distichum</italic> extract and it is a carbocyclic sialic acid analog. Hence, the authors Hsieh et al. [<xref ref-type="bibr" rid="CR145">145</xref>] suggest that it may also exert the function as a neuraminidase inhibitor.</p></sec><sec id="Sec11"><title>Secondary metabolism</title><p id="Par157">Secondary metabolism comprises metabolic pathways which are not essential for the functioning or survival of the plant. Both primary and secondary metabolism, along with their regulatory pathways facilitates the plant to survive under stressful conditions [<xref ref-type="bibr" rid="CR160">160</xref>]. Interestingly the secondary metabolites are derived from the primary metabolites and their various pathways [<xref ref-type="bibr" rid="CR161">161</xref>]. Indeed, plants produce a wide array of secondary metabolites, but there is no precontrived and commonly agreed system of classification [<xref ref-type="bibr" rid="CR162">162</xref>]. However, based on their chemical structure and biosynthetic origin, they are classified into three major classes as terpenes, alkaloids, and phenolics [<xref ref-type="bibr" rid="CR163">163</xref>]. In addition to this, some special categories like terpenoids, glycosides, diaryl heptanoids, and isothiocyanates are included under secondary metabolites. Figure <xref rid="Fig3" ref-type="fig">3</xref> categorizes the various classes of secondary metabolites.
<fig id="Fig3" position="float" orientation="portrait"><label>Fig. 3</label><caption><p>Classes of secondary metabolites</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO3" position="float" orientation="portrait" xlink:href="43094_2021_269_Fig3_HTML.jpg"/></fig></p><sec id="Sec12"><title>Terpenes</title><p id="Par158">Terpenes are a large class of secondary metabolites and they are classified based on the isoprene unit. monoterpenes, sesquiterpene, triterpene, and meroterpene are the various classes of terpenes [<xref ref-type="bibr" rid="CR164">164</xref>, <xref ref-type="bibr" rid="CR165">165</xref>].</p></sec><sec id="Sec13"><title>Monoterpenes</title><p id="Par159">Gangopadhyay et al. used Hex 5.1 Docking software and dock 13 herbal and lead inhibitors with wild-type and mutant haemagglutinins of H5N1. The study reveals that the monoterpenes menthol and eucalyptol show strong interactions by binding to glutamate 11 site of haemagglutinin thereby inhibiting viral fusion with the host cell [<xref ref-type="bibr" rid="CR151">151</xref>].</p></sec><sec id="Sec14"><title>Sesquiterpene</title><p id="Par160">Patchouli alcohol (PA) is a sesquiterpene extracted from <italic toggle="yes">Pogostemon cablin</italic>. Yu et al. investigated both in vitro and in vivo anti-influenza activity of PA against H1N1 (A/Puerto Rico/8/34, A/NWS/33, and A/Virginia/ATCC1/2009). The in vitro time-of-addition assay (TOA) indicates the reduction of viral multiplication is observed before and after infection. The anti-viral mechanisms of action were studied, by using neuraminidase inhibition assay (NI), hemagglutination inhibition (HI) assay, and western blot assay. This study explores PA neither inhibits NA nor HA of the influenza viruses, but it targets virus particles and cellular PI3K/Akt and ERK/MAPK signaling pathways thereby arresting the viral infection. Reduction of a viral nucleoprotein by PA was noticed by western blot assay. The in vivo study is carried by intranasal administration of PA to the IAV-infected mouse pneumonia model. This study explores the increased survival, decreased pneumonia symptoms comparable to the effects of Oseltamivir [<xref ref-type="bibr" rid="CR121">121</xref>].</p><p id="Par161">Li et al. perform in vivo anti-influenza studies by oral administration of Patchouli alcohol (PA) (20 mg/kg to 80 mg/kg) into the influenza A virus (A/FM/1/47)-infected mice. This study noticed the improved survival rate of the infected mice. The humoral immune response is detected by using an enzyme-linked immunosorbent assay (ELISA) which detects the elevation of IgA, IgM, and IgG antibodies. The flow cytometric analysis is used to detect cell-mediated immune response which results in the increased CD3+ and CD4+ T cell levels. An increase in the production of anti-inflammatory cytokines IL-10 and IFN-&#947; reveals the reduction of lung inflammation due to infection [<xref ref-type="bibr" rid="CR122">122</xref>].</p><p id="Par162">Wu et al. [<xref ref-type="bibr" rid="CR123">123</xref>] investigate in vitro, in vivo, and in silico studies on Patchouli alcohol (PA) against influenza A virus (A/Leningrad/134/17/1957, H2N2). In vivo, MTT assay reveals PA at IC50 of 4.03 &#177; 0.23 &#956;M inhibits the viral penetration. Through in vivo, PA at a dose of 5 mg/kg/day protects the infected mice, comparable with Oseltamivir. In silico docking and molecular dynamic simulations exhibit PA binding in the Asp151, Arg152, Glu119, Glu276, and Tyr406 active site regions of H2N2 NA with interaction energy of &#8211; 40.38 kcal mol<sup>&#8211;1</sup>.</p></sec><sec id="Sec15"><title>Triterpene</title><p id="Par163">The study of Hong et al. investigates triterpene compounds, Betulinic acid (BeA), of <italic toggle="yes">Zizyphus jujuba</italic> have antiviral activity against influenza A/PR/8&#8211;infected A549 cell line and C57BL/6 mice. In in vivo study, the SRB method assesses proliferation inhibition in a dose-dependent manner (0.4&#8211;50 &#956;M) in A549 cells without major cytotoxicity. Intraperitoneally administering BeA (10 mg/kg/dose) into the infected mice reveals the attenuation of increased necrosis, inflammatory cells, and pulmonary edema. ELISA study marks the decreased level of inflammatory cytokine IFN-&#947; level in BeA-treated infected mouse lung [<xref ref-type="bibr" rid="CR150">150</xref>].</p></sec><sec id="Sec16"><title>Meroterpene</title><p id="Par164">Bakuchiol is a meroterpene compound derived from <italic toggle="yes">Psoralea carylifolia</italic>. Shoji et al. investigate naturally occurring (+)-(S)-bakuchiol and synthetic enantiomer (&#8722;)-(R)-bakuchiol against influenza A viral strains A/PR/8/34, A/CA/7/09 (H1N1), and A/Aichi/2/68 (H3N2) and observed (+)-(S)-bakuchiol inhibited the H1N1 strains but not the H3N2 strain by inhibiting viral growth, decreased viral mRNAs and protein expression in MDCK cells. Naturally occurring (+)-(S)-bakuchiol shows greater anti-influenza activity than enantiomer (&#8722;)-(R)-bakuchiol. Bakuchiol induced Nrf2 activation and upregulated <italic toggle="yes">NQO1</italic>, p53, and <italic toggle="yes">GSTA3</italic> mRNA levels in MDCK cells thereby inhibiting viral growth [<xref ref-type="bibr" rid="CR125">125</xref>].</p></sec><sec id="Sec17"><title>Terpenoids</title><p id="Par165">Terpenoids are a modified class of terpenes with various cyclizations and rearrangement of the carbon skeleton [<xref ref-type="bibr" rid="CR165">165</xref>, <xref ref-type="bibr" rid="CR166">166</xref>]. Sesquiterpenoids, diterpenoids, and triterpenoids are the various types of terpenoids. Terpenoid-derived drugs gained significant attention towards the treatment of human infectious diseases [<xref ref-type="bibr" rid="CR167">167</xref>].</p></sec><sec id="Sec18"><title>Sesquiterpenoids</title><p id="Par166">Sesquiterpenoids are derived from sesquiterpenes showing diverse hydrocarbon backbone [<xref ref-type="bibr" rid="CR168">168</xref>].</p><p id="Par167">The Sesquiterpenoid Germacrone is one of the active components found in the rhizome of <italic toggle="yes">Curcuma longa</italic>. Liao et al. explain the antiviral activity of Germacrone against influenza A viruses (A/PuertoRico/8/34, A/human/Hubei/1/2009, A/human/WSN/33 (H1N1), A/human/Hubei/3/2005 (H3N2), and influenza B viruses (B/human/Hubei/1/2007) in MDCK and A549 cells by the dose-dependent manner with EC<sub>50</sub> of 6.03 &#956;M. The neuraminidase assay in A549 cells and plaque reduction assay show reduced NA and plaque numbers. Through indirect immunofluorescence assay, reduction of viral protein expression, RNA synthesis, and the progeny viruses observed both in MDCK and A549 cells. In a time-of-addition study, the early stage of viral inhibitory activities was observed. Germacrone administered at 100 mg/kg provides effective protection. Moreover, the studies suggested Germacrone in combination with oseltamivir produces a significant effect [<xref ref-type="bibr" rid="CR92">92</xref>].</p></sec><sec id="Sec19"><title>Diterpenoid</title><p id="Par168">Diterpenoid compounds belong to the Terpenoid class [<xref ref-type="bibr" rid="CR169">169</xref>] that is produced by diterpene synthases (diTPSs) and other enzymes resulting in a wide structural diversity [<xref ref-type="bibr" rid="CR170">170</xref>]. Generally, these compounds are odorless with strong flavors.</p><p id="Par169">Andrographolide is a Diterpenoid obtained from <italic toggle="yes">Andrographis paniculata.</italic> Recent studies show Andrographolide derivatives have potent activity opposing influenza infection. 14-a-lipoyl andrographolide (AL-1) is the synthesized Andrographolide derivative studied by Chen et al. against influenza A viruses (A/Chicken/Guangdong/96 (H9N2), A/Duck/Guangdong/99 (H5N1), and A/PR/8/34 (H1N1)) in MDCK cells. The in vivo plaque reduction assay using EC<sub>50</sub> of 7.2 to 15.2 mM exhibited the most effective antiviral activities in MDCK cells. Hemagglutination assays show a minimum inhibitory concentration range of 5.3&#8211;16.8 mM indicate that AL-1 directly inhibits hemagglutinin and prevents virus adsorption. In vivo render positive information like prolonged survival, decreased lung consolidation of infected mice by oral gavages of AL-1 ranged from 100 to 200 mg/kg/days. The best result was obtained by administered twice daily for 7 days beginning 24 h before viral exposure [<xref ref-type="bibr" rid="CR72">72</xref>].</p><p id="Par170">Another Andrographolide derivatives compound, 14-deoxy-11,12-dehydroandrographolide (DAP), has potency against influenza A viruses (A/chicken/Hubei/327/2004, A/duck/Hubei/XN/2007 (H5N1), A/PR/8/34, A/NanChang/08/2010 (H1N1), and A/HuNan/01/2014 (H3N2)) in vitro, with CC<sub>50</sub> values of 77 and 243 lg/mL in both A549 and MDCK cells. CCK-8 assay detects DAP exerts no cytotoxic effect on the cells and the morphology of the cells remains unaffected. But it shows a pronounced inhibitory effect on viral progeny. Further analysis of DAP is continued with H5N1 virus (A/chicken/Hubei/327/2004) where viral nucleoprotein (NP) mRNA, NP, and NS1proteins were significantly inhibited but it does not show any effect on the absorption from A549 cells. Immunostaining assay explores Dap effective control in inhibiting nuclear export of viral ribonucleoprotein (vRNP) complexes. The qRT-PCR reduction of proinflammatory cytokines (TNF-a, IL-6, IL-8, IFN-a, IL-1b, and IFN-b) and chemokines (CXCL-10 and CCL-2) by DAP was observed [<xref ref-type="bibr" rid="CR73">73</xref>].</p></sec><sec id="Sec20"><title>Triterpenoids</title><p id="Par171">Triterpenoids are the oxygen derivatives of triterpenes [<xref ref-type="bibr" rid="CR171">171</xref>]. Triterpenoids 3<italic toggle="yes">&#945;</italic>-hydroxylup-20(29)-ene-23,28-dioic acid and 3-<italic toggle="yes">epi</italic>-betulinic acid 3-<italic toggle="yes">O</italic>-sulfate isolated from <italic toggle="yes">Schefflera heptaphylla</italic> profoundly active against influenza A (H1N1) virus with IC<sub>50</sub> values of 25 and 31.3 &#956;g/mL [<xref ref-type="bibr" rid="CR131">131</xref>].</p></sec><sec id="Sec200"><title>Alkaloids</title><p id="Par172">Alkaloids are nitrogen-containing secondary metabolites. Most of the alkaloids are pharmacologically active compounds [<xref ref-type="bibr" rid="CR172">172</xref>]. Some of the noted alkaloids like dendrobine of <italic toggle="yes">Dendrobium nobile</italic>, Indirubin of <italic toggle="yes">Isatis indigotica and Strobilanthes cusia</italic>, Lycorine and Hemanthamine of <italic toggle="yes">Lycoris radiate</italic>, Quinalizidine alkaloids of <italic toggle="yes">Sophora</italic> species, ormosinine appraise for their efficacy against influenza viruses.</p><p id="Par173">The plant <italic toggle="yes">Dendrobium nobile</italic> stem is enriched with alkaloids namely Dendrobine. Li et al. expose dendrobine anti-influenza activity against H1N1 (A/FM-1/1/47, A/Puerto Rico/8/34 H274Y) and H3N2 (A/Aichi/2/68) with IC<sub>50</sub> values of 3.39 &#177; 0.32, 2.16 &#177; 0.91, 5.32 &#177; 1.68 &#956;g/mL, respectively. dendrobine inhibited the production of viral HA mRNA, HA, and NP proteins in both MDCK and A549 cells in a dose-dependent manner. It inhibited the early stage of viral replication by binding with the viral NP (Affinity constant K<sub>D</sub> value: 1.19 &#215; 10&#8722;2 &#956;g/mL) thereby suppress its export resulting in the deactivation of the vRNP complex. In support of these findings, a docking study performed using AutoDock software revealed the binding of dendrobine in the highly conserved region of viral NP [<xref ref-type="bibr" rid="CR95">95</xref>].</p><p id="Par174">Herbs like <italic toggle="yes">Isatis indigotica and Strobilanthes cusia</italic> are enriched with Indirubin pigment used to treat respiratory viral infection. Mak et al. displayed the anti-influenza virus activity by inhibition of RANTES in influenza A (A/NWS/33)-infected H292 cells. It interrupts virus-induced NF-&#954;B translocation and p38 MAP kinase activation [<xref ref-type="bibr" rid="CR106">106</xref>].</p><p id="Par175"><italic toggle="yes">Lycoris radiate</italic> bulbs have been used as traditional Chinese medicine. He et al. isolated and identified 15 alkaloids from it using spectroscopic analysis. Among these, four alkaloids lycorine, hippeastrine, hemanthamine, and 11-hydroxyvittatine exhibited antiviral activities against H5N1 (A/Chicken/Guangdong/178/2004) in MDCK cells with EC<sub>90</sub> values of 0.52, 82.07, 4.15, and 13.45 &#956;m. From these Lycorine and Hemanthamine were further analyzed which block vRNP nuclear export [<xref ref-type="bibr" rid="CR108">108</xref>].</p><p id="Par176">In another study, Lycorine and Hemanthamine were further investigated by He et al. These compounds exert antiviral activity against H5N1 (A/CK/GD/178/04, A/DK/GD/212/04), H3N2 (A/Swine/GD/166/06), H1N1 (A/CK/HN/170/03, A/PuertoRico/8/34), H9N2 (A/CK/GD/400/07, A/CK/GD/228/04) in MDCK cells after the viral entry. These drugs display cytostatic effects by resisting pro-apoptotic stimuli. The virus-infected cell growth slowed down by arresting the cell cycle at the G1/S phase and its cytoskeleton arrangement changed. This showed the target of the viruses is the cytoskeleton in particular the monomer Actin. The compound-treated infected cells displayed a decrease in the S phase of the cell cycle and protect against cytoskeleton disruption [<xref ref-type="bibr" rid="CR109">109</xref>].</p><p id="Par177"><italic toggle="yes">Sophora</italic> species of Leguminosae family endowed with quinolizidine alkaloids exhibit anti-influenza activity. This is evident from the study of Dang et al. against H1N1 (A/Puerto Rico/8/34) virus and H3N2 Oseltamivir-sensitive virus (VR1679) which shows dihydroaloperine potent inhibitory activity with EC<sub>50</sub> of 11.2 &#956;M targeting NP. Interestingly, chemical modifications on the N12 and C16 positions of the aloperine scaffold improve the efficacy approximately about 5-fold [<xref ref-type="bibr" rid="CR140">140</xref>].</p><p id="Par178">On more quinolizidine alkaloids, Matrine of <italic toggle="yes">Sophora flavescens</italic> has been proposed to be a target for the development of anti-influenza drugs. Yang et al. made the first attempt to utilize the molecular imprinted polymer technique, a non-biological method to identify the active components against the influenza virus. In this study, chloroform extracts of chlorogenic acid, phillyrin, matrine, oxymatrine, sophoridine, oxysophoridine, and aspirin were used as test compounds. Synthesized Oseltamivir molecularly imprinted polymer (OSMIP) was applied to liquid chromatography (LC) which exposed the retention time of 140 min used as template (OSMIP-LC column) for the selection of test compounds. The compound polarity was detected by OSMIP-LC column online and by electrospray ionization (ESI) MS offline shows Matrine with m/z 249 shows similar correlation like Oseltamivir. Further, in vitro study revealed matrine efficacy against H9N2 (A/Goose/Dalian/3/2001) in reducing cytotoxic effect and HI inhibition similar to Oseltamivir. Stereostructural resemblance consent matrine with Oseltamivir [<xref ref-type="bibr" rid="CR141">141</xref>].</p><p id="Par179">In silico studies of Gangopadhyay et al. [<xref ref-type="bibr" rid="CR151">151</xref>] explain the alkaloid ormosinine might be a potential inhibitor of wild-type and mutant haemagglutinins of H5N1 virus.</p></sec><sec id="Sec21"><title>Phenolic compounds</title><p id="Par180">Phenolic compounds are the major secondary metabolite classified into several types as Phenylpropanoid, Tannin, Catechol, and Anthraquinone [<xref ref-type="bibr" rid="CR173">173</xref>].</p></sec><sec id="Sec22"><title>Phenylpropanoid</title><p id="Par181">Phenylpropanoids comprise a wide diverse group of secondary metabolites which are synthesized from the primary metabolites, phenylalanine or tyrosine amino acids, either through the shikimate or the phenylpropanoid pathway. Phenylpropanoids can be categorized into five different groups as Flavonoids, Lignans, Phenolic acids, Stilbenes, and Coumarins [<xref ref-type="bibr" rid="CR174">174</xref>].</p></sec><sec id="Sec23"><title>Flavonoid</title><p id="Par182">Flavonoids are the major group of Phenylpropanoids which comprise 8000 and more compounds [<xref ref-type="bibr" rid="CR175">175</xref>]. The basic skeleton structure of flavonoids is C6-C3-C6 having a fused benzene ring designated as ring A and the pyran as ring c, along with a phenyl group as ring B [<xref ref-type="bibr" rid="CR176">176</xref>]. Flavonoids classified into three different classes as Flavonoids have 2-phenylbenzopyrans, Isoflavonoids with 3-benzopyrans, and neoflavonoids with 4-benzopyrans [<xref ref-type="bibr" rid="CR177">177</xref>]. Besides these, Biflavonoid [<xref ref-type="bibr" rid="CR178">178</xref>] and prenylflavonoid [<xref ref-type="bibr" rid="CR179">179</xref>] are the other classes included under flavonoid.</p></sec><sec id="Sec24"><title>Flavonoid (2-phenylbenzopyrans)</title><p id="Par183">Flavonoids are the natural compounds widely found in fruits, vegetables, flowers, seeds, nuts, spices, stems, chocolate, tea, and wine [<xref ref-type="bibr" rid="CR180">180</xref>]. They have become an indispensable component in drug discovery research and have been ascribed promising resources for combating several viral diseases including influenza [<xref ref-type="bibr" rid="CR181">181</xref>]. They are subdivided into different subgroups as flavones, flavanones, flavonols, flavanonol, flavan-3-ol, anthocyanin, and chalcones [<xref ref-type="bibr" rid="CR182">182</xref>].</p></sec><sec id="Sec25"><title>Flavones</title><p id="Par184">Flavones are widely distributed in plants in various forms. Medicinal plants like <italic toggle="yes">Scutellaria baicalensis</italic> are reported to have the flavones Baicalin, 5, 7, 4&#8242;-trihydroxy-8-methoxyflavone (F36), isoscutellarein (5,7,8,4&#8242;-tetrahydroxyflavone), wogonin, apigenin, baicalein, and chrysin shows anti-influenza activity. Apigenin and luteolin of <italic toggle="yes">Elsholtzia rugulosa</italic>, luteolin of <italic toggle="yes">Perilla frutescens</italic>, quercetin 3-rhamnoside (Q3R) of <italic toggle="yes">Houttuynia cordata</italic>, newly identified flavones of <italic toggle="yes">Sambucus nigra</italic>, and myricetin of <italic toggle="yes">Aronia melanocarpa</italic> are noted for their anti-influenza activities.</p><p id="Par185">The herb <italic toggle="yes">Scutellaria baicalensis</italic> is enriched with flavones like baicalin. Ding et al. proved the efficacy of baicalin against influenza H1N1 (A/FM1/1/47) and H3N2 (A/Beijing/32/92) viruses by both in vitro and in vivo studies. The in vitro study provide EC<sub>50</sub> values 43.3 lg/mL and 104.9 lg/mL and the NI assay shows IC<sub>50</sub> values 52.3 lg/mL and 85.8 lg/mL for the H1N1 and H3N2 viruses, respectively. These results explain baicalin as an effective neuraminidase inhibitor. Baicalin affected the virus budding in MDCK cells inoculated with the virus. Intravenous baicalin injection proved an increased survival rate with improved lung parameters in influenza virus&#8211;infected mice [<xref ref-type="bibr" rid="CR132">132</xref>].</p><p id="Par186">Neuraminidase enzyme also called sialidase cleaves the sialic acid link, between the virions and the host cell surface thereby maintaining the cycle of infection [<xref ref-type="bibr" rid="CR183">183</xref>]. Nagai et al. checked the Sialidase inhibitory activity of flavonoids about 103 species using sodium p-nitrophenyl-N-acetyl-z-<sc>d</sc>-neuraminate as substrate and found 5, 7, 4&#8242;-trihydroxy-8-methoxyflavone (F36) from the roots of <italic toggle="yes">Scutellaria baicalensis</italic> as potent inhibitor (IC<sub>50</sub> &#956;M). Besides that, it blocked the infection and replication of the A/PR/8/34 influenza virus [<xref ref-type="bibr" rid="CR133">133</xref>].</p><p id="Par187">The authors showed the sialidase inhibitory effect of isoscutellarein (5,7,8,4&#8242;-tetrahydroxyflavone) isolated from the leaf of <italic toggle="yes">Scutellaria baicalensis</italic> (Ki 41 &#956;M) and observed replication inhibition in A/WSN/33 and A/PR/ 8/34 viral strains in MDBK cells (IC<sub>50</sub> 20 pM) and allantoic sac of an embryonated egg. The authors observed Isoscutellarein produce a similar effect as F36 and administered both into the mouse-adapted A/PR/8/34. Intranasal administration disclosed F36 (0.5 mg/kg) complete prevention of virus proliferation, intraperitoneal administration showed F36 (4 mg/kg) reduced lung virus titers to 10<sup>&lt;2</sup>, and oral administration explicit isoscutellarein (400 and 40 mg/kg) significantly reduced lung virus titers [<xref ref-type="bibr" rid="CR134">134</xref>].</p><p id="Par188">The author continues further study by isolating 5, 7, 4&#8242;-trihydroxy-8-methoxyflavone (F36) from the roots of <italic toggle="yes">Scutellaria baicalensis</italic> and noted its effect in the reduction of H3N2 (A/Guizhou/54/89) and B (B/Ibaraki/2/85) viruses in MDCK after 4 hours of incubation. It reduces the virus yield by 50% at 20 &#956;m and 90% at 40 &#956;m in a dose-dependent manner. Fusion assay reported F36 was the inhibitor of virus fusion with the endosome/lysosome of the host cell. Intranasal 7 times (3.5 mg/kg) administration of F36 completely prevented the proliferation but did not inhibit proliferation of mouse-adapted with virus inoculation from 18h before to 54 h after [<xref ref-type="bibr" rid="CR135">135</xref>]. The investigators perform the same mode of research work by applying F36 (50&#956;m) on mouse-adapted influenza virus A/PR/8/34 (A/PR8) and obtain a similar result like progeny inhibition and endosome/lysosome membrane fusion inhibition [<xref ref-type="bibr" rid="CR136">136</xref>].</p><p id="Par189">Seong et al. investigated the antiviral role of wogonin isolated from <italic toggle="yes">Scutellaria baicalensis</italic> against influenza H1N1 (A/Puerto-Rico/8/34); seasonal H1N1 and H3N2; and B of Yamagata lineage (clinical influenza strains) and observed replication suppression in virus-adapted MDCK and A549 cell lines. Wogonin (10 &#956;g/mL)-treated influenza A virus&#8211;infected cells had significantly increased transcript levels of IFN-&#946; and IFN-&#955; along with IFN downstream molecules MxA (myxovirus resistance gene A) and OAS (2-5&#8242; oligoadenylate synthetase). Furthermore, wogonin inhibited influenza virus&#8211;induced AMPK (5&#8242; adenosine monophosphate&#8211;activated protein kinase) phosphorylation [<xref ref-type="bibr" rid="CR137">137</xref>].</p><p id="Par190">Hour et al. carried out in vitro and in silico studies using MeOH, EtOAc, and chloroform extracts of <italic toggle="yes">Scutellaria baicalensis</italic> against pandemic 2009 H1N1 (A/Taiwan/CMUH/2009), seasonal H1N1 (A/Taiwan/CMUH/2007, seasonal strains), seasonal H3N2 (Seasonal strains), and H1N1 (influenza A/Puerto Rico/8/34). EtOAc (IC<sub>50</sub>23.7 to 27.4 &#956;g/mL). The chloroform extracts (IC<sub>50</sub> 14.16 to 41.49 &#956;g/mL) considerably decreased the virus proliferation than MeOH extract. The EtOAc (IC<sub>50</sub>73.16 to 487.40 &#956;g/mL) extract was remarkably noted for NA inhibition. HPLC analysis reported the flavone baicalin highly prevailed in the MeOH extract, high presence of apigenin in EtOAc, whereas in the EtOAc, and chloroform extracts were enriched with the flavones baicalein and chrysin. Further, in vitro and in silico studies are carried by using the flavones baicalin, apigenin, baicalein, and chrysin. In silico molecular simulation studies of these flavones against NA reveal baicalein potent interaction with NA1 active sites. In vitro plaque reduction assays also suggest baicalein effectively inhibit replication of pandemic 2009 H1N1 (IC<sub>50</sub> = 0.02 &#956;M) and seasonal 2007 H1N1 (IC<sub>50</sub> = 0.018 &#956;M) [<xref ref-type="bibr" rid="CR138">138</xref>].</p><p id="Par191">Liu et al. isolated five flavonoids, namely apigenin (1), luteolin (2), apiin (3), galuteolin (4), and luteolin-3&#8242;-glucuronyl acid methyl ester (5) from the EtOAc extract of <italic toggle="yes">Elsholtzia rugulosa</italic>. The maximal non-cytotoxic concentration (MNCC) of the EtOAc extract with IC<sub>50</sub> 55.56 &#956;g/mL and its constituents showed inhibition of H1N1 (A/PR/8/34), H3N2 (A/Jinan/15/90), and B (B/Jiangsu/10/2003). Among them, apigenin (IC<sub>50</sub> 1.43 &#956;g/mL) and luteolin (IC<sub>50</sub> 2.06 &#956;g/mL) exhibited the highest activities against H3N2 [<xref ref-type="bibr" rid="CR96">96</xref>].</p><p id="Par192"><italic toggle="yes">Perilla frutescens</italic> seeds contain four main polyphenolic compounds namely, rosmarinic acid-3-<italic toggle="yes">O</italic>-glucoside, rosmarinic acid, luteolin, and apigenin which were tested for the antiviral potential against recombinant virus H1N1 neuraminidase (rvH1N1 NA E.C. 3.2.1.18). Of these, the flavones luteolin (IC<sub>50</sub> 8.4 &#956;M) and the rosmarinic acid (Phenolic acid with IC<sub>50</sub> of 46.7 &#956;M) showed potent NA activity and proved as noncompetitive inhibitors [<xref ref-type="bibr" rid="CR118">118</xref>].</p><p id="Par193">Choi et al. investigated the antiviral effects of the flavone quercetin 3-rhamnoside (Q3R) from <italic toggle="yes">Houttuynia cordata</italic> against H1N1 strain A/WS/33 and observed the reduction of cytopathic effect in virus-infected MDCK cells. Pre-exposure of virus or Pre-inoculation of MDCK cells with Q3R did not alter its infectivity but Q3R role is appreciable only added at 1, 2, and 4 h after virus inoculation with the reduction in viral mRNA synthesis. This made the investigators conclude Q3R inhibits the initial stage of viral replication [<xref ref-type="bibr" rid="CR104">104</xref>].</p><p id="Par194">In vitro studies of Roschek B Jr et al. reveals the inhibitory efficiency of <italic toggle="yes">Sambucus nigra</italic> extract (IC<sub>50</sub> 252 &#177; 34 &#956;g/mL) against H1N1(A/PR/8/34) and identified two flavonoid compounds 5,7,3&#8242;,4&#8242;-tetra-O-methylquercetin (1) and 5,7-dihydroxy-4-oxo-2-(3,4,5-trihydroxyphenyl) chroman-3-yl-3,4,5-trihydroxycyclohexanecarboxylate (2) through direct binding assay and DART TOF-MS analysis. The authors urged these compounds were primarily responsible for anti-influenza activity by synthesizing flavanonol compound 1 and a flavanonol compound dihydromyricetin (corresponding 3-hydroxyflavonone of 2) and observed H1N1 inhibition with IC<sub>50</sub> value of 0.13&#956;g/mL and 2.8&#956;g/mL. These compounds directly bind to the virus particles and prevent host cell entry and/or recognition similar to the antiviral drugs Oseltamivir and Amantadine [<xref ref-type="bibr" rid="CR130">130</xref>].</p><p id="Par195"><italic toggle="yes">Aronia melanocarpa</italic> fruits are rich in polyphenolic compounds which displayed wide antiviral activity against H1N1, H3N2, recombinant H1/PR8 expressing green fluorescent protein (rPR8-GFP), and influenza B virus. The <italic toggle="yes">Aronia</italic> mode of virucidal action is targeting the HA protein of H1N1 (A/Korea/01/2009) which is evident from the HI assay. Its flavone myricetin and the phenolic acid compound ellagic acid successfully inhibited the replication and did not show any cytotoxic effect against MDCK cells. The in vivo study exhibited myricetin and ellagic acid increase the survival rate by 50% and 37.5% of rPR8-GFP virus&#8211;infected mice [<xref ref-type="bibr" rid="CR75">75</xref>].</p></sec><sec id="Sec26"><title>Flavonols</title><p id="Par196">Flavonols exist as Hyperoside in <italic toggle="yes">Azadirachta indica</italic>, Gossypetin and Kaempferol in <italic toggle="yes">Rhodiola rosea</italic>, and quercetin of <italic toggle="yes">Chaenomeles speciosa</italic> endowed as a promising agent for suppressing viral activities.</p><p id="Par197">Ahmad et al. perform in silico docking studies by selecting <italic toggle="yes">Azadirachta indica</italic> active compounds nimbaflavone, rutin, and hyperoside along with drugs OMS, CBX, LGH, naproxen, BMS-883559, and BMS-885838 as ligands and the nucleoprotein structure [PDB ID:3RO5] as a receptor. All these ligands displayed perfect binding by interacting in the conserved residue (ASP302, TYR52, SER50, GLY288, SER376, and ARG99) of the receptor. But the best interaction was obtained from hyperosides along with the drugs LGH, naproxen, BMS-885838, and BMS-883559 [<xref ref-type="bibr" rid="CR77">77</xref>].</p><p id="Par198"><italic toggle="yes">Rhodiola rosea</italic> is a herbaceous plant used for food and medicine which contains constituents like flavonoids, phenylpropanoid and phenyl ethanol derivatives, and aliphatic glycosides. In this study, Jeong et al. isolated five flavonols (3, 5, and 9&#8211;11), and their structure-activity relationship (SAR) is compared with available flavonoids (1, 2, 4, 6&#8211;8, and 12&#8211;14). All these compounds unveiled NI activity against <italic toggle="yes">Clostridium perfringens</italic> (IC<sub>50</sub> 0.8 to56.9 &#956;M) and rvH1N1 (IC<sub>50</sub> 2.2 to 56.5 &#956;M). The antiviral activities of the compounds 1&#8211;6, 8&#8211;12, and14 had EC<sub>50</sub> values of 30.2&#8211;99.1 &#956;M against H1N1 (A/PR/8/34) and 18.5&#8211;103.1 &#956;M against H9N2 (A/Chicken/Korea/MS96/96) in MDCK cells. Of these compounds, gossypetin (6) exhibited the most potent NI inhibitory activity (IC<sub>50</sub> values of 0.8 and 2.6 &#956;M) and kaempferol (3) exhibited the highest anti-influenza activity against H1N1 and H9N2 (EC<sub>50</sub> values of 30.2 and 18.5 &#956;M). The kinetic studies exposed all isolated flavonols act as non-competitive inhibitors [<xref ref-type="bibr" rid="CR127">127</xref>].</p><p id="Par199">The flavonol quercetin of <italic toggle="yes">Chaenomeles speciosa</italic> exhibited significant dose-dependent DPPH radical scavenging activity with IC<sub>50</sub> 3.82 &#956;g/mL. Quercetin of 5&#956;g/mL inhibits TNF-&#945; by 33.14% and NO production [<xref ref-type="bibr" rid="CR88">88</xref>].</p></sec><sec id="Sec27"><title>Flavanonols</title><p id="Par200">Flavanonol dihydromyricetin isolated from <italic toggle="yes">Sambucus nigra</italic> activated and induced the immune system to combat the influenza virus H1N1 (A/PR/8/34) through binding with virions and blocking entry and recognition of the host cell [<xref ref-type="bibr" rid="CR130">130</xref>].</p></sec><sec id="Sec28"><title>Flavan-3-ol</title><p id="Par201">Flavan-3-ol compounds catechin, epicatechin (EC), epigallocatechin (EGC), epicatechin-3-gallate (ECG), epigallocatechin-3-gallate (EGCG), (&#8722;) epigallocatechin gallate (EGCg), and theaflavin digallate (TF3) have been reported in <italic toggle="yes">Camellia sinensis</italic>, (+)-catechin of <italic toggle="yes">Ephedrae herba</italic>, catechin-3-O-gallate of <italic toggle="yes">Polygonum cuspidatum</italic>, and gallocatechin-7-gallate (J10688) of <italic toggle="yes">Pithecellobium clypearia</italic> contribute significantly against influenza viruses.</p><p id="Par202">Tea is produced from the leaves of <italic toggle="yes">Camellia sinensis</italic> and classified into three types as non-fermented green tea, semi-fermented oolong tea, and fermented black and red tea [<xref ref-type="bibr" rid="CR184">184</xref>]. The green tea is enriched with flavonol catechin. There are four main types of catechin predominantly found in green tea, namely epicatechin (EC), epigallocatechin (EGC), epicatechin-3-gallate (ECG), and epigallocatechin-3-gallate (EGCG) [<xref ref-type="bibr" rid="CR185">185</xref>]. Differing from that, the black tea contains the polymerized catechins, namely theaflavins and thearugins [<xref ref-type="bibr" rid="CR184">184</xref>]. Worldwide Green tea consumption is increasing due to the awareness of its health benefits [<xref ref-type="bibr" rid="CR186">186</xref>]. Park et al. conducted a population-based study of school children in Kikugawa City, Japan, using the anonymous questionnaire survey and concluded the work that consumption of 1&#8211;5 cups/day of green tea might prevent influenza infection among schoolchildren in a tea plantation area [<xref ref-type="bibr" rid="CR187">187</xref>]. Matsumoto et al.&#8217;s studies explored green tea catechin prevents influenza among 197 health care workers [<xref ref-type="bibr" rid="CR81">81</xref>].</p><p id="Par203">Imanishi et al. studied the additional inhibitory effect of green tea extract (GTE) in MDCK cells infected with H1N1 (A/PR/8/34), H3N2 (A/Aichi/2/68), and B (B/Singapore/222 (Sing) viruses and observed acidification of ELS (endosome and lysosome) inhibition through vital fluorescence microscopic studies. GTE exerts its effect within 5&#8211;15 min after infection and the authors observed the same inhibitory effects in GTE active catechin component (-) epigallocatechin (EGC) [<xref ref-type="bibr" rid="CR82">82</xref>].</p><p id="Par204">Green tea catechin compounds (&#8722;)-epigallocatechin gallate (EGCG), (&#8722;)-epicatechin gallate (ECG), and (&#8722;)-epigallocatechin (EGC) were analyzed for their anti-influenza activities against HIN1 (Influenza A/Chile/1/83, H3N2 (A/Sydney/5/97) and B (B/Yamagata/16/88) viruses. EGCG (EC<sub>50</sub>22&#8211;28 &#956;M) and ECG (EC<sub>50</sub>22&#8211;40 &#956;M) showed more potent inhibition against the viruses than EGC (EC<sub>50</sub> 309&#8211;318 &#956;M), and also, more effective HI and NI activity and suppression of viral RNA synthesis in MDCK cells were noted in EGCG and ECG than in EGC [<xref ref-type="bibr" rid="CR83">83</xref>].</p><p id="Par205">The catechin (&#8211;)-epigallocatechin-3-O-gallate(EGCG) and EGCG-C-16 showed broad-spectrum anti-influenza activity against H1N1 (A/PuertoRico/8/34, A/Beijing/262/95, Yokohama/77/2008, Yokohama/63/2007, A/Yokohama/91/2008), H3N2 (A/Panama/2007/99), H5N2 (A/Duck/HongKong/342/78), and B (B/Yamanashi/166/98/) viruses. EGCG-C-16 EC<sub>50</sub> values range between 10 and 61 nM which were 7.1- to 44-fold lower than EGCG and CC<sub>50</sub> value was 82 &#956;M which was 3.1-fold lower than EGCG. Hence, EGCG-16 proved as a potent inhibitor with an SI value 2.2- to 14-fold greater than EGCG [<xref ref-type="bibr" rid="CR84">84</xref>].</p><p id="Par206">Nakayama et al. purified (&#8722;) epigallocatechin gallate (EGCg) and theaflavin digallate (TF3) from green and black tea and performed an inhibitory activity in opposition to H1N1 (A/Yamagata/120/86) and B (B/USSR/100/83) virus&#8211;infected MDCK cells. Virus agglutination was observed when it was mixed with EGCg and TF3 even at a low concentration of 1.5 &#956;M and prevents its adsorption to MDCK cells. EGCg and TF3 at the concentration of 1&#8211;16 &#956;M bind to HA, thereby preventing haemagglutination and obstructing its infectivity. However, EGCg (&gt; 200 &#956;M) and TF3 (&gt; 100 &#956;M) were toxic to MDCK cells [<xref ref-type="bibr" rid="CR85">85</xref>]. In support of the above findings, Sahoo et al. perform in silico docking studies and concluded theaflavin as a potent natural inhibitor bind with the lowest energy (&#8211;5.21 kcal/mol) to H1N1 neuraminidase [<xref ref-type="bibr" rid="CR86">86</xref>].</p><p id="Par207">Mantani et al. observation reveal (+)-catechin(1.0-10.0 mM) in the extract of <italic toggle="yes">Ephedra</italic> herba(EHext) inhibits acidification of ELS of H1N1(APR/8/34) at 1 h. Effective inhibition of virus growth was observed when (+)-catechin (1.25&#8211;10.0 mM) treated within 10 min p.i. Surprisingly, 1h or later, treatment exerted little and reversible inhibitory effect [<xref ref-type="bibr" rid="CR97">97</xref>].</p><p id="Par208">Chen et al. isolated and identified seven compounds 2-methoxystypandrone (1), emodin (2), resveratrol(3), polydatin (4), emodin-8-O-beta-<sc>d</sc>-glucopyranoside (5), (E)-3, 5, 12-trihydroxystilbene-3-O-beta-<sc>d</sc>-glucopyranoside-2&#8242;-(3&#8243;, 4&#8243;, 5&#8243;-trihydroxybenzoate) (6), and catechin-3-O-gallate (7) from the ethyl extract of <italic toggle="yes">Polygonum cuspidatum</italic>. These compounds were treated with H1N1-affected MDCK cells and revealed compounds 6 (EC<sub>50</sub> 5.9&#956;M) and 7 (EC<sub>50</sub> 0.9&#956;M) as potent inhibitors exhibiting low cytotoxicity to the host cells. The NI assay identified compounds 3, 6, and 7 with IC<sub>50</sub> values of 129.8, 44.8, and 21.3 as active NA inhibitors [<xref ref-type="bibr" rid="CR124">124</xref>].</p><p id="Par209"><italic toggle="yes">Pithecellobium clypearia</italic> is rich in flavonoid compounds. Kang et al. isolated and identified the flavan-3-ol compounds (2R,3R)-7-O-galloylplumbocatechin A (1), three known flavonoids (&#8722;)-5,3&#8242;,4&#8242;,5&#8242;-tetrahydroxyflavan-7-gallate (2), (+)-3,5,3&#8242;,4&#8242;,5&#8242;-penta-hydroxyflavan-7-gallate (3), and (&#8722;)-7,4&#8242;-di-O-galloyltricetiflavan (4) from the leaves and twigs. These compounds were examined for NA assay, against H1N1 (A/PR/8/34), H3N2 (A/Sydney/5/97), and B (B/Jiangsu/10/2003) viruses. The result indicated compounds 1 (IC<sub>50</sub> 29.77 &#177; 6.12 &#956;g/mL) and 2 (IC<sub>50</sub> 36.91 &#177; 3.80 &#956;g/mL) exhibited moderate activity against H1N1. All the compounds inhibited the expression of proinflammatory cytokines IL-6 or MCP-1 induced in H1N1 virus&#8211;adapted A549 cells. The structural verification of the compounds was performed using spectroscopic analysis [<xref ref-type="bibr" rid="CR119">119</xref>].</p><p id="Par210">From the leaves and twigs of <italic toggle="yes">Pithecellobium clypearia</italic>, Li et al. isolated flavan-3-ol gallocatechin-7-gallate (J10688) which acts as a novel CLK1 inhibitor with potent anti-influenza activity. In vivo studies performed by using intravenous administration of J10688 (30 mg/kg/day) in H1N1-infected ICR mice which showed inhibition of pro-inflammatory cytokines IFN-&#947;, IL-6, TNF-&#945;, and IL-1&#946;, thereby preventing the viral infection and lung injury, and increased survival rate (91.67%). In addition to this, dose-dependent treatment of J10688 stimulated lymphocyte proliferation, thereby cellular and humoral immune responsees were improved. In vivo cytotoxic studies performed by using J10688 against the strains H1N1 (A/PR/8/34), H3N2 (A/Sydney/5/97), and B (B/Jiangsu/10/2003) showed EC<sub>50</sub> values 1.69, 2.28, and 23.18 &#956;M, respectively. Hence, further anti-influenza studies were conducted by using H1N1-infected A549 cells where J10688 dose-dependently (3, 10, 30, &#956;mol/L) decrease viral NP, M2, and RNA synthesis. Alternative splicing of the influenza virus M2 gene depends on the host cdc2-like kinase 1 (CLK1). J10688 was an effective CLK1 inhibitor, by downregulating SC35 and SF2/ASF excessive phosphorylation and thereby controlling M2 mRNA alternative splicing [<xref ref-type="bibr" rid="CR120">120</xref>].</p></sec><sec id="Sec29"><title>Anthocyanin</title><p id="Par211">Anthocyanin compounds from <italic toggle="yes">Ribes nigrum</italic> and red-fleshed potato impart inhibitory activity against influenza viruses.</p><p id="Par212">A study performed by Li et al. showed that using <italic toggle="yes">Ribes nigrum</italic> crude extracts with a pH 7.2 inhibit H1N1 (A/PR/8/34) and B (B/Gifu/2/73) plaque formation by 50% of IC<sub>50</sub> 3.2&#956;g/mL and directly inactivated 99% of the virus by 10&#956;g/mL with a pH 2.8. Post-exposure treatment of the extracts presented complete inhibition suppression in H1N1 (10&#8211;100&#956;g/mL) which indicates the extract suppresses the late stage of virus growth. After 8&#8211;9 h of infection (both IVA and IVB) showing MDCK cells are treated with the extract of 100 &#956;g/mL for 1 h, and the virus titers in culture fluids show complete inhibition indicates extract inhibits the virus release [<xref ref-type="bibr" rid="CR128">128</xref>].</p><p id="Par213">The same authors and other investigators further investigated the crude extract and found anthocyanins as major constituents responsible for anti-influenza activity. Using TLC, the extract was fractionated into A to D and Anthocyanin D fraction was further fractionated into A&#8242; to G&#8242;. The fractions D&#8242; to G&#8242; produced potent anti-influenza activity against A and B viruses. E&#8242; and F&#8242; exposed additive antiviral effects and identified as 3-O-alpha-L-rhamnopyranosyl-beta-<sc>d</sc>-glucopyranosyl-cyanidin and 3-O-beta-<sc>d</sc>-glucopyranosyl-cyanidin, and 3-O-alpha-L-rhamnopyranosyl-beta-<sc>d</sc>-glucopyranosyl-delphinidin and 3-O-beta-<sc>d</sc>-glucopyranosyl-delphinidin using HPLC. F&#8242; inhibits virus adsorption, release but not directly inactivate it [<xref ref-type="bibr" rid="CR129">129</xref>].</p><p id="Par214">Hayashi et al. bred anthocyanin-rich tetraploid potatoes cultivars of <italic toggle="yes">Solanum tuberosum ssp. tuberosum</italic> and <italic toggle="yes">S. tuberosum ssp. Andigena</italic> and red-fleshed potato (Inca Red) were selected. The purified anthocyanin powder along with the pigments pelanin (3-<italic toggle="yes">O</italic>-[6-<italic toggle="yes">O</italic>-(4-<italic toggle="yes">O</italic>-p-coumaroyl-&#945;-L-rhamnopyrano-syl)-&#946;-<sc>d</sc>-glucopyranosyl]-5-<italic toggle="yes">O</italic>-&#946;-<sc>d</sc>-glucopyranosyl-pelargoni-din), pelargonidin, pelargonidin 3-p-coumaroylglucose with 5-glucose, and pelargonidin 3-p-coumaroylglucose with 5-malonylglucose were tested for anti-influenza activity against H1N1(A/PR/8/34) and B(B/Gifu/2/73). The result revealed that anthocyanin powder showed the best inhibitory activity against H1N1 (IC<sub>50</sub> 48&#956;g/mL) and B (IC<sub>50</sub> 54 &#956;g/mL) than other pigments. The authors suggested that the antiviral activity of the potato anthocyanin is due to its additive or synergistic effect on other constituents including anthocyanin [<xref ref-type="bibr" rid="CR139">139</xref>].</p></sec><sec id="Sec30"><title>Chalcones</title><p id="Par215">Chalcones bestowed with therapeutical properties have been noted for their anti-influenza activities. Recently chalcones isolated from <italic toggle="yes">Glycyrrhiza uralensis</italic>, <italic toggle="yes">Glycyrrhiza inflata</italic>, <italic toggle="yes">Thalassodendrin ciliatum</italic>, and <italic toggle="yes">Caesalpinia sappan</italic> showed strong anti-influenza activities.</p><p id="Par216">Ryu et al. isolated 18 polyphenol compounds consisted of four chalcones, nine flavonoids, four coumarins and one phenylbenzofuran from the roots of <italic toggle="yes">Glycyrrhiza uralensis</italic> and evaluate their NA inhibitory activity. Of these the chalcone isoliquiritigenin (IC<sub>50</sub> 9.0&#956;M) and coumarin glycyrol (IC<sub>50</sub> 3.1&#956;M) showed strong inhibition on rvH1N1 NA (A/Ber-vig_Mission/1/18) and these are proved to be non competitive inhibitors [<xref ref-type="bibr" rid="CR100">100</xref>].</p><p id="Par217">From the acetone extract of <italic toggle="yes">Glycyrrhiza inflata</italic>, 8 chalcones were isolated, and their NA (H1N1, H9N2, H1N1 (WT), and H1N1 (H274Y)) inhibitory activities were accessed. Of these, compounds 3 (echinantin) and 6 (isoliquiritigenin) without the prenyl group exhibit strong inhibitory activity in viruses-infected 293T cells. Compound 3 (echinantin) and oseltamivir proved synergistic effects against NA of H274Y virus [<xref ref-type="bibr" rid="CR99">99</xref>].</p><p id="Par218">From the EtOAc extract of <italic toggle="yes">Thalassodendron ciliatum</italic>, Thalassodendrone (dihydrochalcone diglycoside), and 5 known phenolic compounds, namely asebotin, quercetin 3,7 diglucoside, protocatechuic acid, ferulic acid, and p-hydroxybenzoic acid were isolated and identified. These compounds were evaluated for anti-influenza activity against H1N1 (influenza A virus /WSN/33) and revealed asebotin (IC<sub>50</sub> 2.00&#956;g/mL, CC<sub>50</sub> 3.36 &#956;g/mL) inhibition and cytotoxic concentration were more than those of thalassodendrone (IC<sub>50</sub> 1.96 &#956;g/mL, CC<sub>50</sub> 3.14 &#956;g/mL) [<xref ref-type="bibr" rid="CR147">147</xref>].</p><p id="Par219">Liu et al. isolated six NA inhibitor compounds that are brazilein, brazilin, protosappanin A, 3-deoxysappanchalcone, sappanchalcone, and rhamnetin from <italic toggle="yes">Caesalpinia sappan</italic> and evaluated their anti-influenza activity against A/PR/8/34 (H1N1), A/Guangdong/243/72 (H3N2), and B/Jiangsu/10/2003 viruses. The results disclosed that the chalcone compounds 3-deoxysappanchalcone (IC<sub>50</sub> 1.06) and sappanchalcone (IC<sub>50</sub> 2.06 &#956;g/mL) explained the highest inhibition activity against H3N2-infected MDCK cells [<xref ref-type="bibr" rid="CR79">79</xref>].</p></sec><sec id="Sec31"><title>Isoflavonoid (3-benzopyrans)</title><p id="Par220">Isoflavonoid compounds build great attention in health-protecting and health-promoting effects preferable to use in human medicine [<xref ref-type="bibr" rid="CR188">188</xref>]. This class includes pterocarpans [<xref ref-type="bibr" rid="CR189">189</xref>] and homoisoflavonoids [<xref ref-type="bibr" rid="CR190">190</xref>].</p></sec><sec id="Sec32"><title>Pterocarpans</title><p id="Par221">From the methanol extract of <italic toggle="yes">Sophora flavescens</italic>, three pterocarpans and six flavanones were isolated and their NA inhibitory activity disclosed all the isolated compounds excluded the compound 3, showing inhibitory effects between 12 and 20 &#956;M. Among these, pterocarpan 1 with IC<sub>50</sub> 1.4 &#956;M displayed the best inhibition activity. Moreover, molecular docking studies of pterocarpan 1 with the receptor neuraminidase (PDB 1L7F) show the binding region nearer to the active site of the receptor [<xref ref-type="bibr" rid="CR142">142</xref>].</p></sec><sec id="Sec33"><title>Homoisoflavonoid</title><p id="Par222">Homoisoflavonoids are a rare class of flavonoids present in few plant families like Fabaceae, Asparagaceae, Portulacaceae, Cucurbitaceae, and Polygonaceae [<xref ref-type="bibr" rid="CR191">191</xref>]. Recently, it is reported in <italic toggle="yes">Caesalpinia sappan</italic> of the Fabaceae family disclosing potential anti-influenza activities.</p><p id="Par223">Jeong et al. isolated 12 homoisoflavonoid compounds from the dried heartwood of <italic toggle="yes">Caesalpinia sappan</italic> and their antiviral efficacy against H1N1 (A/PR/8/34), H3N2 (A/Hong Kong/8/68), and H9N2 (A/Chicken/Korea/MS96/96) describe the compounds are reversible non-competitive inhibitors. Homoisoflavonoids with an unsaturated group like sappanone A (2) and brazilin (12) unveiled higher NA activity than saturated sappanone B (3). Hence, the investigators conclude that the &#945;, &#946;-unsaturated carbonyl group in the A-ring is the main factor needed for NA inhibition [<xref ref-type="bibr" rid="CR80">80</xref>].</p></sec><sec id="Sec34"><title>Biflavonoid</title><p id="Par224">Biflavonoids like Ginkgetin obtained from <italic toggle="yes">Ginkgo biloba</italic> inhibit the influenza virus sialidase. Miki et al. analyze the anti-influenza sialidase activity of ginkgetin, synthesized ginkgetin-sialic acid conjugates (6R, 6S, 7R, 7S, 8R, 8S, 9R, 9S), and 5, 7, 4&#8242;-trihydroxy-8-methoxyflavone (F36) against H1N1 (A/PR/8/34), H3N2 (A/Guizhou/54/89) and B (B/Ibaraki/2/85) viruses. Ginkgetin inhibited sialidase of H1N1 and H3N2 with IC<sub>50</sub> values of 55.00 and 9.78 &#956;g/mL whereas the conjugate 8R (IC <sub>50</sub> 5.50 lg/mL and 0.82 lg/mL) showed considerable inhibitory power. Ginkgetin acts as a sialidase inhibitor but it exerts a cytotoxic effect in MDCK cells, while the conjugates 8R and 8S are empowered with low cytotoxic effect and high sialidase inhibition. The intranasal application of 8R and 8S to the H1N1-infected mice reflected an increased survival rate of 75&#8211;78% at day 10 and 62.5&#8211;56% at day 21 [<xref ref-type="bibr" rid="CR98">98</xref>].</p></sec><sec id="Sec35"><title>Prenylflavonoid</title><p id="Par225">In the study by Chiou et al., prenylflavonoid 8-prenylkaempferol (8-PK) was isolated from the roots of <italic toggle="yes">Sophora flavescens</italic> and added into MDCK cells infected with H1N1 (A/PR/8/34) which significantly reduced RANTES accumulation along with nuclear factor-&#954;B (NF-&#954;B) and interferon regulatory factor 3 (IRF-3) nuclear translocation in a dose-dependent manner. The investigators revealed the fact that both NF-&#954;B and IRF-3 were essential for H1N1 RANTES production. The influenza virus&#8211;activated PI3K pathway and Akt phosphorylation were also attenuated along with the prevention of I&#954;B degradation by 8-PK. This PI3K-Akt pathway was essential for NF-&#954;B- and IRF-3-mediated RANTES production [<xref ref-type="bibr" rid="CR143">143</xref>].</p></sec><sec id="Sec36"><title>Prenylflavanones</title><p id="Par226">Ma et al. unveil that the six prenylflavanones, namely sophoraflavanones M(1) and N (2) glabranin (3) (2S)-7-hydroxy-5-methoxy-8-prenylflavanone(4), (2S)-8-[2-(3-hydroxyisopropyl)-5-methyl-4-hexenyl]-2&#8242;-methoxy-5,7,4&#8242;-trihydroxyflavanone (5), and leachianone B (6) from the roots of <italic toggle="yes">Sophora flavescens</italic> showed inhibition against H1N1 (A/WSN/33/2009) except compound 5 (EC<sub>50</sub> 43.9 &#956;M) which produced moderate inhibitory activity [<xref ref-type="bibr" rid="CR144">144</xref>].</p></sec><sec id="Sec37"><title>Lignans</title><p id="Par227">Lignans are the polymers of lignin comprising a large number of compounds. Compounds include arctiin, arctigenin in <italic toggle="yes">Arctium lappa</italic>, clemastanin B, and lariciresinol-4-O-&#946;-<sc>d</sc>-glucopyranoside from <italic toggle="yes">Isatis indigotica</italic> which played a predominant role to restrict influenza viral infections.</p><p id="Par228">Hayashi et al. explored two lignan components, arctiin and arctigenin, isolated from the fruits of <italic toggle="yes">Arctium lappa</italic> which exerted strong inhibitory effects on the replication of the H1N1 (A/NWS/33) virus. Further ongoing investigation reveals that arctigenin exhibited a 6- to 8-fold lower IC<sub>50</sub> value (IC<sub>50</sub> 3.8&#8211;2.9 &#956;M) with minimum cytotoxic effect (CC<sub>50</sub> 45 &#956;M) than arctin (IC<sub>50</sub> 24&#8211;22 &#956;M, CC<sub>50</sub> 290 &#956;M) in virus-infected MDCK cells. Thus, it will be interesting to investigate and characterize arctigenin through the time of addition assay and progeny release assay. Surprisingly, arctigenin&#8217;s best inhibitory effect was noted within immediate addition of virus-infected MDCK cells suggesting that it interacted with the early stage of viral replication but did not inhibit its cellular penetration. The addition of arctigenin, even after 8 h p.i. gives a scope that it inhibits viral progeny and release. The investigator&#8217;s in vivo study explicitly explains that the oral administration of arctiin was converted into arctigenin in virus-infected mice along with more production of antibodies against the influenza virus. The authors observed the synergistic effect of arctiin and oseltamivir decreased the virus yield in both bronchoalveolar lavage fluids and lungs of infected mice [<xref ref-type="bibr" rid="CR74">74</xref>].</p><p id="Par229">Yang et al. isolated the lignan clemastanin from the root of <italic toggle="yes">Isatis indigotica</italic> and evaluated its antiviral inhibition efficiency against influenza viruses, respiratory syncytial virus (RSV), adenovirus 3 (ADV3), parainfluenza virus 3 (PIV3), enterovirus 71 (EV71), and human rhinovirus (HRV). The authors observed the compound inefficiency against all the viruses except influenza viruses (H1N1, H3N2, H6N2, H7N3, H9N2, and influenza B) with IC<sub>50</sub> 0.087&#8211;0.72 mg/mL. A distinct reduction of virus titer was observed only when the compound was added after viral incubation in the MDCK cell. The time course assay was performed using H1N1 (A/PR/8/34) and prominent inhibition was observed when clemastanin B treated 0&#8211;2 h after virus adsorption in the cell line, which suggested the compound target was at the early stage of replication. Moreover, this cell line unveiled the presence of viral RNP in their nucleus, which implies clemastanin B interferes with RNP export. Through a multi-passage experiment, the authors identified clemastanin B did not create drug resistance by the virus [<xref ref-type="bibr" rid="CR107">107</xref>].</p></sec><sec id="Sec38"><title>Phenolic acid</title><p id="Par230">Phenolic acids are derivatives of benzoic acid and cinnamic acids. Benzoic acid derivatives include <italic toggle="yes">p-</italic>hydroxybenzoic acid, gallic acid, and ellagic acid, whereas cinnamic acid derivatives include rosmarinic acid [<xref ref-type="bibr" rid="CR192">192</xref>].</p><p id="Par231">The benzoic acid derivative compound 3, 4-dihydroxybenzoic acid of <italic toggle="yes">Chaenomeles speciosa</italic> shows significant dose-dependent DPPH radical scavenging and NA inhibition activities against H1N1. It also significantly inhibits <italic toggle="yes">TNF-&#945;</italic> and NO production [<xref ref-type="bibr" rid="CR88">88</xref>].</p><p id="Par232">The water-soluble polyphenol tannin is found in various plants and brings antiviral activity. Theisen et al. demonstrate anti-influenza activity of ethanol extract of <italic toggle="yes">Hamamelis virginiana</italic> bark against various strains of influenza A virus (H1N1 A/Puerto Rico/8/34, pandemic H1N1 A/Luxembourg/46/2009, seasonal H3N2 A/Luxembourg/01/2005, H7N9 A/Anhui/01/2013) and found that gallic acid (phenolic acid), hamamelitannin (gallic acid derivative), tannic acid, and pentagalloylglucose (tannin) are the active part. The bark extract fractionated by ultrafiltration (UF) segregates low- and high-molecular-weight compounds. The low-molecular-weight compounds of less than 500 g/mol are gallic acid, epigallocatechin gallate, or hamamelitannin which exhibit neuraminidase inhibition but not hemagglutination, whereas high-molecular-weight tannin-containing extracts and tannic acid (1702 g/mol) show inhibition of viral binding and neuraminidase [<xref ref-type="bibr" rid="CR101">101</xref>].</p><p id="Par233">Ellagic acid of <italic toggle="yes">Aronia melanocarpa</italic> inhibits replication without cytotoxic effect in HIN1 (A/Korea/01/2009)-adapted MDCK cells and increased the 37.5% survival rate of rPR8-GFP virus-infected mice [<xref ref-type="bibr" rid="CR75">75</xref>].</p><p id="Par234"><italic toggle="yes">Perilla frutescens</italic> seeds contain rosmarinic acid, a cinnamic acid derivative, which shows potent NA activity with IC<sub>50</sub> of 46.7 &#956;M and proved as noncompetitive inhibitors [<xref ref-type="bibr" rid="CR118">118</xref>].</p></sec><sec id="Sec39"><title>Stilbenes</title><p id="Par235">Resveratrol, a low-molecular-weight stilbene compound isolated from the ethyl extract of <italic toggle="yes">Polygonum cuspidatum</italic> act as NA inhibitors with IC<sub>50</sub> values of 129.8 [<xref ref-type="bibr" rid="CR124">124</xref>].</p></sec><sec id="Sec40"><title>Coumarins</title><p id="Par236">Kurokawa et al. selected six antipyretic compounds, 7-hydroxycoumarin (coumarin), 4-allylanisole, cinnamic acid ethylester, acetic acid cinnamylester, 2X-hydroxyacetophenone, and 2-hydroxycinnamic acid (cinnamyl derivatives) from the organic solvent-extractable fractions of <italic toggle="yes">Cinnamomum cassia</italic> and examined their antipyretic effects in H1N1 (A/PR/8/34)-infected mice that showed a remarkable reduction in rectal temperature. Further, four compounds, 7-hydroxycoumarin, 4-allylanisole, cinnamic acid ethylester, and acetic acid cinnamylester, suppressed the rise of interleukin-1&#945; production to the basal level and reduced its circulation in the serum. The presence of the ester bond is the main determiner for both antipyretic and interleukin-1&#945; suppression [<xref ref-type="bibr" rid="CR90">90</xref>].</p><p id="Par237">The above study brings out the fact that the coumarin compound, 7-hydroxycoumarin (7HC), reduced the pro-inflammatory cytokines along with antipyretic and interleukin suppression activities. The author Kurokawa and other investigators investigate 7HC in detail and explore 30 mg/kg oral administration of 7HC significantly reduces weight loss and virus production in the lung bronchoalveolar lavage fluid (BALF) of influenza-adapted mice. The author identified the suppression of pro-inflammatory and Th1 cytokine (IL-12 and interferon-gamma) results in the reduction of virus titer [<xref ref-type="bibr" rid="CR91">91</xref>].</p><p id="Par238">The coumarin glycyrol of <italic toggle="yes">Glycyrrhiza uralensis</italic> with IC<sub>50</sub> 3.1 &#956;M showed strong inhibition on rvH1N1 NA and proved to be a non-competitive inhibitor [<xref ref-type="bibr" rid="CR100">100</xref>].</p></sec><sec id="Sec41"><title>Tannin</title><p id="Par239">The hydrolyzable tannins strictinin found in <italic toggle="yes">Camellia sinensis</italic> comprised about 0&#8211;1.0% dry weight. The study of Saha et al. revealed that strictinin inhibits influenza A and B virus replication in a dose-dependent way by using MDCK cells. The influenza strains used for the study are A/PuertoRico/8/34 (H1N1), A/Memphis/1/71 (H3N2), A/Aichi/2/68(H3N2), A/duck/HK/313/4/78 (H5N3), A/swine/Hokkaido/10/85(H3N2), A/WSN/33 (H1N1), and B/Lee/40. These studies bring the fact that strictinin acts directly with the viral particles and inhibit the early stage of viral entry and virus-induced hemifusion [<xref ref-type="bibr" rid="CR87">87</xref>].</p><p id="Par240">Haidari et al. studied pomegranate polyphenol extract (PPE) against H1N1 (A/USSR/90/77), H3N2 (A/Hong Kong/2/68, A/HK (H3N2)), and B (B/Harbin/07/94) viruses, which shows drastic proliferation inhibition without cytotoxicity in virus-adapted MDCK cells. H3N2-induced agglutination of chicken is inhibited by PPE suggesting the target was viral attachment. PPE showed direct inhibitory and virucidal effects on the H3N2 virus which are observed through the RT-PCR technique. The single-cycle and multiple-cycle growth conditions indicated PPE affects viral replication but did not alter vRNP entry and translocation in the host cell. To identify active potential components from the extract, four polyphenol compounds, ellagic acid, caffeic acid, luteolin, and punicalagin, were selected and examined. Surprisingly, the tannin compound punicalagin plays similar activities, like PPE, and mimics the same effect. In addition to that, PPE produces a synergic effect when combined with oseltamivir [<xref ref-type="bibr" rid="CR126">126</xref>]..</p><p id="Par241">The tannin-rich components tannic acid and pentagalloylglucose of <italic toggle="yes">Hamamelis virginiana</italic> of 1702 g/mol show inhibition of viral binding and neuraminidase [<xref ref-type="bibr" rid="CR101">101</xref>].</p></sec><sec id="Sec42"><title>Catechol</title><p id="Par242">Hydroxytyrosol (HT) is one of the main phenolic components of <italic toggle="yes">Olea eurolaea</italic> belonging to the class of catechols produced a virucidal effect which was revealed in the study of Yamada et al. Hydroxytyrosol inactivates enveloped viruses including influenza A/Hokkaido/30/2000 (H1N1), A/Hokkaido/52/98 (H3N2), A/chicken/Yamaguchi/7/04 (H5N1), and A/chicken/Yokohama/aq55/01 (H9N2). HT did not show any cytotoxic effect on MDCK cells; it affected H9N2 virus NP protein synthesis and suppressed mRNA synthesis at 24 h.p.i. Electron microscopic analysis detects the structural disruption of the H9N2 virus by HT [<xref ref-type="bibr" rid="CR113">113</xref>].</p></sec><sec id="Sec43"><title>Anthraquinone</title><p id="Par243"><italic toggle="yes">Aloe vera</italic> is a widely used herb of economical importance. In this study, two new anthraquinones, namely aloesaponarin-I (1) and aloesaponarin-II (2), were isolated from the roots. From aloesaponarin-I (1), six derivatives were obtained by the consecutive process like methylation (3), acetylation (4), and O-glycosyl (5, 6). As well as from aloesaponarin-II (2), a new derivative termed Tetra-O-acetyl-&#946;-<sc>d</sc>-glucopyranosyl derivative obtained and these entire compounds experimented against H1N1 (A/Yucat&#225;n/2370/09, A/Mexico/InDRE797/10) infection. All these compounds (CC<sub>50</sub> &gt; 90 &#956;M) did not exert any cytotoxic effect in MDCK cells. Virus replication inhibition analyzed by cytopathic effect reduction assay (CPE) noted compounds 3-(2&#8242;,3&#8242;,4&#8242;,6&#8242;-tetra-O-acetyl-&#946;-<sc>d</sc>-glucopyranosyl-aloesaponarin-I (5) and 3-(2&#8242;,3&#8242;,4&#8242;,6&#8242;-tetra-O-acetyl-&#946;-<sc>d</sc>-glucopyranosyl-aloesaponarin-II (7) against A/Yucat&#225;n/2370/09 (IC<sub>50</sub> of 30.77 and 13.70 &#956;M) and A/Mexico/InDRE797/10 (IC<sub>50</sub> of 62.28 and 19.47 &#956;M) reduction effect. Since other derivatives did not exhibit any antiviral effect, compounds 5 and 7 were taken for further studies. Plaque inhibition test using A/Yucat&#225;n/2370/09 strain noted the dose-dependent addition of compound 5 (50 and 100 &#956;M) had significantly reduced the virus titer more than compound 7. The time-of-addition experiment appraising the efficacy of two compounds yielded a 70% reduction of virus titer at 6&#8211;10 h post-treatment [<xref ref-type="bibr" rid="CR69">69</xref>].</p></sec><sec id="Sec44"><title>Glycosides</title><p id="Par244">Glycosides are active biological compounds reported in <italic toggle="yes">Albizia julibrissin</italic>, <italic toggle="yes">Panax quinquefolium</italic>, and <italic toggle="yes">Panax ginseng</italic> proved effective anti-influenza compounds.</p><p id="Par245">Sun et al. isolated total saponin from the stem bark of <italic toggle="yes">Albizia julibrissin</italic> (AJSt) and fractionated it into AJS30, AJS50, AJS75, and AJS95. These compounds hemolytic activities and their adjuvant effect was reviewed. The compound AJSt, AJS50, AJS75, and AJS95 experienced minor hemolytic effects. The adjuvant effect of the compounds in the mice immunized with ovalbumin (OVA) and recombinant fowlpox virus vector&#8211;based avian influenza vaccine (rFPV) unveiled AJSt, AJS50, and AJS75 potent activities like enhancing concanavalin A (Con A), lipopolysaccharide (LPS), antigen-stimulated splenocyte proliferation, and serum antigen-specific IgG, IgG1, IgG2a, and IgG2b antibody titers. In-depth analysis of adjuvant action revealed AJS75 was the most potent adjuvant by inducing cellular and humoral response through stimulating cytokines and chemokines [<xref ref-type="bibr" rid="CR68">68</xref>].</p><p id="Par246">Dong et al. selected ginseng extracts (GE) and ginsenosides against the 2009 pandemic virus (A/Nanchang/8002/2009 H1N1 (NC2)) and observed the effect in both in vitro and in vivo study. The mice infected with GE-NC2 showed an increased survival rate and minimum weight loss. Similarly, the pretreated ginsenoside- and NC2 (Rb1-NC2)-received mice show a remarkable survival rate. Meanwhile, the mice at 3 d.p.i. show a reduction in viral titer which revealed ginsenoside action against lethal lung damage. Hemagglutination assay confirms the interaction of ginsenoside with the HA, thereby interfering with the virus attachment. The authors explore sugar moieties of ginseng play a crucial role in the interaction with HA of the virus. Oligosaccharide binding assay confirms that ginsenoside prevents virus attachment with &#945; 2&#8211;3&#8242; sialic acid receptors on the host cell surface. Subsequently, it minimizes virus entry and thereof decreases the infection [<xref ref-type="bibr" rid="CR116">116</xref>].</p><p id="Par247">Chan et al. chose special types of ginsenoside (Re, Rg1, and PPT) of <italic toggle="yes">Panax ginseng</italic> and studied the effect of inflammation and apoptosis induced by the H9N2 (A/Quail/Hong Kong/G1/97) virus. Human umbilical vein endothelial cells (HUVECs) were infected with H9N2 produce inflammation by inducing the chemokine IP-10 production. Ginsenoside PPT inhibits IP-10 production by regulating the micro RNA, miR-15b. Post-treatment of ginsenoside Re (50 &#956;M) partially reduced the virus-adapted apoptosis which denotes its cytoprotection and increased cell viability effect [<xref ref-type="bibr" rid="CR115">115</xref>].</p></sec><sec id="Sec45"><title>Diarylheptanoids</title><p id="Par248">Diarylheptanoids are structurally distinctive compounds with diverse biological and pharmacological effects [<xref ref-type="bibr" rid="CR193">193</xref>]. Recently, its anti-influenza effects have been reported in <italic toggle="yes">Alpinia officinarum</italic> and <italic toggle="yes">Curcuma longa</italic>.</p><p id="Par249">From the rhizome of <italic toggle="yes">Alpinia officinarum</italic>, ten diarylheptanoids were isolated and their anti-influenza efficiency against H1N1 (A/PR/8/34) examined which provide the EC<sub>50</sub> value of diarylheptanoids was lower than CC<sub>50</sub> and MNCC (maximum non-cytotoxic concentration). The diarylheptanoids 7-4&#8243;-hydroxy-3&#8243;-methoxyphenyl)-1-phenyl-4E-hepen-3-one (3) and (5S)-5-hydroxy-7-(4&#8243;-hydroxyphenyl)-1-phenyl-3-heptanone (8) show the EC<sub>50</sub> values 2.9 &#177; 0.3 &#956;g/mL and 0.7 &#177; 0.3 &#956;g/mL were lower than the control ribavirin EC<sub>50</sub> 16.7 &#177; 0.4 &#956;g/mL. Hence, the authors suggested diarylheptanoids 3 and 8 as a potent source of anti-influenza activity [<xref ref-type="bibr" rid="CR70">70</xref>].</p><p id="Par250">The authors continued the study by orally administering these two compounds 7-4&#8243;-hydroxy-3&#8243;-methoxyphenyl)-1-phenyl-4E-hepen-3-one (AO-0002) and (5S)-5-hydroxy-7-(4&#8243;-hydroxyphenyl)-1-phenyl-3-heptanone (AO-0011) three times daily to the H1N1 (A/PR/8/34)-infected mice for 6 days after infection. AO-0002 (100 mg/kg) effectively reduced the bodyweight loss and enhanced the survival period of infected mice. AO-0002 (30 mg/kg, 30 and 100 mg/kg) notably reduced the virus titer in the lung BALF of infected mice on days 3 and 6 after infection. AO-0011 did not exhibit the above activities; hence, the author selected AO-0002 for further in vitro analysis. AO-0002 effectively inhibited the infection of H1N1 (A/PR/8/34, oseltamivir-resistant A/PR/8/34, A/Bangkok/93/03), H3N2 (A/Ishikawa/7/82, A/Fukushima/13/43), and B (B/Singapore/222/79, B/Fukushima/15/93) viruses in MDCK cells. Plaque reduction assay revealed AO-0002 was unable to interfere with the adsorption or invasion of the virus but dose-dependently (20&#8211;40 &#956;g/mL) suppressed the expression of viral antigen and mRNA synthesis [<xref ref-type="bibr" rid="CR71">71</xref>].</p><p id="Par251">Chen et al. evaluated the efficiency of curcumin against H1N1 (A/Puerto Rico/8/34) and H6N1 (A/chicken/Taiwan/NCHU0507/99) which revealed no cytotoxic effect in virus-infected MDCK cells. Dose-dependent addition of curcumin reduced viral replication. Specifically, 30 &#956;M of curcumin lessened 90% of virus yield. Time-of-addition experiments verified the direct inhibitory effect of curcumin. The mechanism was revealed by plaque reduction assay, which showed the early stage of inhibitory activity includes attachment prevention but not penetration. HA assay demonstrated curcumin possesses HA inhibition activity by interacting and interrupting the link between viruses HA and host cell receptors but not with the host RBC cell. In comparison with amantadine, curcumin did not evoke viral resistance [<xref ref-type="bibr" rid="CR93">93</xref>].</p><p id="Par252"><italic toggle="yes">Curcuma longa</italic> empowers a broad spectrum of antiviral activities. This creates interest for the investigators to investigate the presence of the substance in the herb. Recently, Dao et al. isolated 3 new (1&#8211;3) and 10 known (4&#8211;13) curcuminoids from the rhizome of <italic toggle="yes">Curcuma longa</italic> and performed neuraminidase inhibition assays against H1N1 (A/California/08/2009, A/Sw/Kor/CAH1/04, H274Y mutant) and H9N2 (A/Chicken/Korea/O1310/2001). From the study, all compounds are proven as non-competitive inhibitors with significant NA activity, of which compounds 4, 5, and 13 showed the best potent ability [<xref ref-type="bibr" rid="CR94">94</xref>].</p></sec><sec id="Sec46"><title>Isothiocyanate</title><p id="Par253">Isothiocyanate is one of the active ingredients of <italic toggle="yes">Wasabi japonica</italic> which shows a significant virucidal effect against the influenza virus when treated with the composition of O.1SmL isothiocyanate in addition to 0.05 mL virus. The content of isothiocyanate differs in different parts of the plant where the rhizome (0.80 mol&#183;mL<sup>&#8722;1</sup>) had a high amount compared with the fibrous root and petiole [<xref ref-type="bibr" rid="CR148">148</xref>].</p></sec></sec></sec><sec id="Sec47"><title>Conclusion</title><p id="Par254">Influenza remains a global threat. Even though it is under control, handling the pandemic situation remains a great challenge. Vaccine development and drug resistance coupled together to create a massive crisis in the difficult condition. To combat the problem, new drugs are necessary to practice. Keeping this view, alternative and traditional medicines provide new insights into the arrival of new drugs. This paper emphasizes an overview of the active ingredients of plants and their promising scientifically validated activity of the anti-influenza characteristics. Therefore, shortly, these active ingredients can be promoted for use as a new safe drug. A successful attempt can be claimed only when the clinical trial is appreciable.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>ADV3</term><def><p id="Par4">Adenovirus 3</p></def></def-item><def-item><term>AL-1</term><def><p id="Par5">14-a-Lipoyl andrographolide</p></def></def-item><def-item><term>AMPK</term><def><p id="Par6">5&#8242; adenosine monophosphate-activated protein kinase</p></def></def-item><def-item><term>APS</term><def><p id="Par7"><italic toggle="yes">Astragalus</italic> polysaccharide</p></def></def-item><def-item><term>AJSt</term><def><p id="Par8">Total saponin from the stem bark of <italic toggle="yes">Albizia julibrissin</italic></p></def></def-item><def-item><term>BALF</term><def><p id="Par9">Bronchoalveolar lavage fluid</p></def></def-item><def-item><term>BCPS</term><def><p id="Par10"><italic toggle="yes">Bupleurum chinense</italic> polysaccharides</p></def></def-item><def-item><term>BeA</term><def><p id="Par11">Betulinic acid</p></def></def-item><def-item><term>CC<sub>50</sub></term><def><p id="Par12">Half maximal cytotoxic concentration</p></def></def-item><def-item><term>CDC</term><def><p id="Par13">Centers for Disease Control and Prevention</p></def></def-item><def-item><term>CEF</term><def><p id="Par14">Chick embryo fibroblasts</p></def></def-item><def-item><term>CLK1</term><def><p id="Par15">cdc2-like kinase 1</p></def></def-item><def-item><term>Con A</term><def><p id="Par16">Concanavalin A</p></def></def-item><def-item><term>CPE</term><def><p id="Par17">Cytopathic effect reduction assay</p></def></def-item><def-item><term>CVB3</term><def><p id="Par18">Coxsackie virus B3</p></def></def-item><def-item><term>DAP</term><def><p id="Par19">14-deoxy-11,12-dehydroandrographolide</p></def></def-item><def-item><term>DART TOF-MS</term><def><p id="Par20">Direct analysis in real time mass spectrometry</p></def></def-item><def-item><term>diTPSs</term><def><p id="Par21">Diterpene synthases</p></def></def-item><def-item><term>EC<sub>50</sub></term><def><p id="Par22">Half maximal effective concentration</p></def></def-item><def-item><term>EC</term><def><p id="Par23">Epicatechin</p></def></def-item><def-item><term>ECG</term><def><p id="Par24">Epicatechin-3-gallate</p></def></def-item><def-item><term>EGC</term><def><p id="Par25">Epigallocatechin</p></def></def-item><def-item><term>EGCg</term><def><p id="Par26">(&#8722;) Epigallocatechin gallate</p></def></def-item><def-item><term>EGCG</term><def><p id="Par27">Epigallocatechin-3-gallate</p></def></def-item><def-item><term>EHext</term><def><p id="Par28">Extract of <italic toggle="yes">Ephedra herba</italic></p></def></def-item><def-item><term>ELS</term><def><p id="Par29">Endosome and lysosome</p></def></def-item><def-item><term>ELISA</term><def><p id="Par30">Enzyme-linked immunosorbent assay</p></def></def-item><def-item><term>ESI</term><def><p id="Par31">Electrospray ionization</p></def></def-item><def-item><term>EtOAc</term><def><p id="Par32">Ethyl acetate</p></def></def-item><def-item><term>EV71</term><def><p id="Par33">Enterovirus 71</p></def></def-item><def-item><term>FDA</term><def><p id="Par34">Food and Drug Administration</p></def></def-item><def-item><term>GE</term><def><p id="Par35">Ginseng extract</p></def></def-item><def-item><term>GP</term><def><p id="Par36"><italic toggle="yes">Panax ginseng</italic> polysaccharides</p></def></def-item><def-item><term>GTE</term><def><p id="Par37">Green tea extract</p></def></def-item><def-item><term>HA</term><def><p id="Par38">Hemagglutinin</p></def></def-item><def-item><term>7HC</term><def><p id="Par39">7-Hydroxycoumarin</p></def></def-item><def-item><term>HCP</term><def><p id="Par40"><italic toggle="yes">Houttuynia cordata</italic> polysaccharides</p></def></def-item><def-item><term>HEF</term><def><p id="Par41">Hemagglutinin esterase fusion</p></def></def-item><def-item><term>HeLa</term><def><p id="Par42">Human epithelioid cervical carcinoma</p></def></def-item><def-item><term>HI</term><def><p id="Par43">Hemagglutination inhibition assay</p></def></def-item><def-item><term>HIV</term><def><p id="Par44">Human immunodeficiency virus</p></def></def-item><def-item><term>HPLC</term><def><p id="Par45">High-performance liquid chromatography</p></def></def-item><def-item><term>HRV</term><def><p id="Par46">Human rhinovirus</p></def></def-item><def-item><term>HT</term><def><p id="Par47">Hydroxytyrosol</p></def></def-item><def-item><term>HUVECs</term><def><p id="Par48">Human umbilical vein endothelial cells</p></def></def-item><def-item><term>IAV</term><def><p id="Par49">Influenza A virus</p></def></def-item><def-item><term>IBV</term><def><p id="Par50">Influenza B virus</p></def></def-item><def-item><term>IC</term><def><p id="Par51">Inhibitory concentration</p></def></def-item><def-item><term>IC<sub>50</sub></term><def><p id="Par52">Half maximal inhibitory concentration</p></def></def-item><def-item><term>ICV</term><def><p id="Par53">Influenza C virus</p></def></def-item><def-item><term>IDV</term><def><p id="Par54">Influenza D virus</p></def></def-item><def-item><term>IFN</term><def><p id="Par55">Interferon</p></def></def-item><def-item><term>IIV</term><def><p id="Par56">Inactivated influenza vaccines</p></def></def-item><def-item><term>IRF-3</term><def><p id="Par57">Interferon regulatory factor 3</p></def></def-item><def-item><term>IRPS</term><def><p id="Par58"><italic toggle="yes">Isatis indigotica</italic> root polysaccharides</p></def></def-item><def-item><term>LAIV</term><def><p id="Par59">Live attenuated influenza vaccines</p></def></def-item><def-item><term>LC</term><def><p id="Par60">Liquid chromatography</p></def></def-item><def-item><term>LPS</term><def><p id="Par61">Lipopolysaccharide</p></def></def-item><def-item><term>M1</term><def><p id="Par62">Matrix protein</p></def></def-item><def-item><term>MDBK</term><def><p id="Par63">Madin-Darby bovine kidney cells</p></def></def-item><def-item><term>MDCK</term><def><p id="Par64">Madin-Darby bovine canine kidney cells</p></def></def-item><def-item><term>MeOH</term><def><p id="Par65">Methanol</p></def></def-item><def-item><term>MNCC</term><def><p id="Par66">Maximal non-cytotoxic concentration</p></def></def-item><def-item><term>MxA</term><def><p id="Par67">Myxovirus resistance gene A</p></def></def-item><def-item><term>MS</term><def><p id="Par68">Mass spectroscopy</p></def></def-item><def-item><term>MTT assay</term><def><p id="Par69">3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, a tetrazole) assay</p></def></def-item><def-item><term>NA</term><def><p id="Par70">Neuraminidase</p></def></def-item><def-item><term>NEML</term><def><p id="Par71">National essential medicines list</p></def></def-item><def-item><term>NF-&#954;B</term><def><p id="Par72">Nuclear factor-&#954;B</p></def></def-item><def-item><term>NI</term><def><p id="Par73">Neuraminidase inhibition assay</p></def></def-item><def-item><term>NIC</term><def><p id="Par74">National Influenza Centers</p></def></def-item><def-item><term>NO</term><def><p id="Par75">Nitric oxide</p></def></def-item><def-item><term>NP</term><def><p id="Par76">Nucleoprotein or nucleocapsid protein</p></def></def-item><def-item><term>nsLTPs</term><def><p id="Par77">Fetuin-binding non-specific lipid transfer protein</p></def></def-item><def-item><term>NTL</term><def><p id="Par78"><italic toggle="yes">Narcissus tazetta</italic> lectin</p></def></def-item><def-item><term>OAS</term><def><p id="Par79">2-5&#8242; oligoadenylate synthetase</p></def></def-item><def-item><term>OSMIP</term><def><p id="Par80">Oseltamivir molecularly imprinted polymer</p></def></def-item><def-item><term>OVA</term><def><p id="Par81">Ovalbumin</p></def></def-item><def-item><term>8-PK</term><def><p id="Par82">8-Prenylkaempferol</p></def></def-item><def-item><term>PA</term><def><p id="Par83">Patchouli alcohol</p></def></def-item><def-item><term>PDB</term><def><p id="Par84">Protein Data Bank</p></def></def-item><def-item><term>p.i.</term><def><p id="Par85">Post-infection</p></def></def-item><def-item><term>PIV3</term><def><p id="Par86">Parainfluenza virus 3</p></def></def-item><def-item><term>PPE</term><def><p id="Par87">Pomegranate polyphenol extract</p></def></def-item><def-item><term>Q3R</term><def><p id="Par88">Quercetin 3-rhamnoside</p></def></def-item><def-item><term>QIV</term><def><p id="Par89">Quadrivalent inactivated vaccine</p></def></def-item><def-item><term>qRT-PCR</term><def><p id="Par90">Real-time quantitative reverse transcription PCR</p></def></def-item><def-item><term>RANTES</term><def><p id="Par91">Regulated upon Activation, Normal T cell Expressed and Secreted</p></def></def-item><def-item><term>rFPV</term><def><p id="Par92">Recombinant fowlpox virus vector&#8211;based avian influenza vaccine</p></def></def-item><def-item><term>RSV</term><def><p id="Par93">Respiratory syncytial virus</p></def></def-item><def-item><term>SAR</term><def><p id="Par94">Structure-activity relationship</p></def></def-item><def-item><term>SIV</term><def><p id="Par95">Swine influenza virus</p></def></def-item><def-item><term>SRB method</term><def><p id="Par96">Sulforhodamine B assay (SRB)</p></def></def-item><def-item><term>T&amp;CM</term><def><p id="Par97">Traditional and Complementary medicine</p></def></def-item><def-item><term>TF3</term><def><p id="Par98">Theaflavin digallate</p></def></def-item><def-item><term>TIV</term><def><p id="Par99">Trivalent inactivated vaccine</p></def></def-item><def-item><term>TLC</term><def><p id="Par100">Thin-layer chromatography</p></def></def-item><def-item><term>TOA</term><def><p id="Par101">Time-of-addition assay</p></def></def-item><def-item><term>UF</term><def><p id="Par102">Ultrafiltration</p></def></def-item><def-item><term>vRNP</term><def><p id="Par103">Nuclear export of viral ribonucleoprotein</p></def></def-item><def-item><term>vRNP complex</term><def><p id="Par104">Viral ribonucleoprotein complex</p></def></def-item><def-item><term>WHO</term><def><p id="Par105">World Health Organization</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher&#8217;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>Not applicable.</p></ack><notes notes-type="author-contribution"><title>Authors&#8217; contributions</title><p>BDA collected and analyzed the data and wrote the manuscript. SR gave proper suggestions and approved the submission. Both authors contributed significantly to bring out this review and they have read and approved the manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>All information provided in the manuscript is obtained from the references.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par255">Not applicable.</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par256">Not applicable.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interests</title><p id="Par257">The authors declare that they have no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dacso</surname><given-names>CC</given-names></name><name name-style="western"><surname>Couch</surname><given-names>RB</given-names></name><name name-style="western"><surname>Six</surname><given-names>HR</given-names></name><name name-style="western"><surname>Young</surname><given-names>JF</given-names></name><name name-style="western"><surname>Quarles</surname><given-names>JM</given-names></name><name name-style="western"><surname>Kasel</surname><given-names>JA</given-names></name></person-group><article-title>Sporadic occurrence of zoonotic swine influenza virus infections</article-title><source>J Clin Microbiol</source><year>1984</year><volume>20</volume><issue>4</issue><fpage>833</fpage><lpage>835</lpage><pub-id pub-id-type="doi">10.1128/JCM.20.4.833-835.1984</pub-id><pub-id pub-id-type="pmid">6092435</pub-id><pub-id pub-id-type="pmcid">PMC271447</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Simonsen</surname><given-names>L</given-names></name></person-group><article-title>The global impact of influenza on morbidity and mortality</article-title><source>Vaccine</source><year>1999</year><volume>17</volume><fpage>S3</fpage><lpage>S10</lpage><pub-id pub-id-type="doi">10.1016/s0264-410x(99)00099-7</pub-id><pub-id pub-id-type="pmid">10471173</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>McCauley</surname><given-names>JW</given-names></name><name name-style="western"><surname>Hongo</surname><given-names>S</given-names></name><name name-style="western"><surname>Kaverin</surname><given-names>NV</given-names></name><name name-style="western"><surname>Kochs</surname><given-names>G</given-names></name><name name-style="western"><surname>Lamb</surname><given-names>RA</given-names></name><name name-style="western"><surname>Matrosovich</surname><given-names>MN</given-names></name><name name-style="western"><surname>Perez</surname><given-names>DR</given-names></name><name name-style="western"><surname>Palese</surname><given-names>P</given-names></name><name name-style="western"><surname>Presti</surname><given-names>RM</given-names></name><name name-style="western"><surname>Rimstad</surname><given-names>E</given-names></name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>King</surname><given-names>AMQ</given-names></name><name name-style="western"><surname>Adams</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Carstens</surname><given-names>EB</given-names></name><name name-style="western"><surname>Lefkowitz</surname><given-names>E</given-names></name></person-group><article-title>Orthomyxoviridae</article-title><source>Virus taxonomy, classification and nomenclature of viruses: ninth report of the International Committee on Taxonomy of Viruses</source><year>2012</year><publisher-loc>New York</publisher-loc><publisher-name>Elsevier</publisher-name><fpage>749</fpage><lpage>761</lpage></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ortiz-Baez</surname><given-names>AS</given-names></name><name name-style="western"><surname>Eden</surname><given-names>JS</given-names></name><name name-style="western"><surname>Moritz</surname><given-names>C</given-names></name><name name-style="western"><surname>Holmes</surname><given-names>EC</given-names></name></person-group><article-title>A divergent Articulavirus in an Australian gecko identified using meta-transcriptomics and protein structure comparisons</article-title><source>Viruses</source><year>2020</year><volume>12</volume><issue>6</issue><fpage>613</fpage><pub-id pub-id-type="doi">10.3390/v12060613</pub-id><pub-id pub-id-type="pmcid">PMC7354609</pub-id><pub-id pub-id-type="pmid">32512909</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Bresee</surname><given-names>JS</given-names></name><name name-style="western"><surname>Fry</surname><given-names>AM</given-names></name><name name-style="western"><surname>Sambhara</surname><given-names>S</given-names></name><name name-style="western"><surname>Cox</surname><given-names>NJ</given-names></name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Plotkin</surname><given-names>SA</given-names></name><name name-style="western"><surname>Orenstein</surname><given-names>WA</given-names></name><name name-style="western"><surname>Offit</surname><given-names>PA</given-names></name><name name-style="western"><surname>Edwards</surname><given-names>KM</given-names></name></person-group><article-title>Inactivated influenza vaccines</article-title><source>Plotkin&#8217;s Vaccines,7th edn</source><year>2018</year><publisher-name>Elsevier</publisher-name><fpage>456</fpage><lpage>488</lpage></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>B</given-names></name><name name-style="western"><surname>Loeb</surname><given-names>M</given-names></name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Poland</surname><given-names>GA</given-names></name></person-group><article-title>Influenza Vaccines&#8212;Are They Efficacious or Not?</article-title><source>Vaccinations</source><year>2019</year><publisher-name>Elsevier</publisher-name><fpage>89</fpage><lpage>103</lpage></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Long</surname><given-names>JS</given-names></name><name name-style="western"><surname>Mistry</surname><given-names>B</given-names></name><name name-style="western"><surname>Haslam</surname><given-names>SM</given-names></name><name name-style="western"><surname>Barclay</surname><given-names>WS</given-names></name></person-group><article-title>Host and viral determinants of influenza A virus species specificity.Nat</article-title><source>Rev Microbiol</source><year>2019</year><volume>17</volume><issue>2</issue><fpage>67</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1038/s41579-018-0115-z</pub-id><pub-id pub-id-type="pmid">30487536</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Pellett</surname><given-names>PE</given-names></name><name name-style="western"><surname>Mitra</surname><given-names>S</given-names></name><name name-style="western"><surname>Holland</surname><given-names>TC</given-names></name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Tselis</surname><given-names>AC</given-names></name><name name-style="western"><surname>Booss</surname><given-names>J</given-names></name></person-group><article-title>Basics of virology</article-title><source>Handbook of clinical neurology</source><year>2014</year><publisher-name>Elsevier</publisher-name><fpage>45</fpage><lpage>66</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/B978-0-444-53488-0.00002-X</pub-id><pub-id pub-id-type="pmcid">PMC7152233</pub-id><pub-id pub-id-type="pmid">25015480</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhai</surname><given-names>SL</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><name name-style="western"><surname>Chen</surname><given-names>SN</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>X</given-names></name><name name-style="western"><surname>Lin</surname><given-names>T</given-names></name><name name-style="western"><surname>Liu</surname><given-names>R</given-names></name><name name-style="western"><surname>Lv</surname><given-names>DH</given-names></name><name name-style="western"><surname>Wen</surname><given-names>XH</given-names></name><name name-style="western"><surname>Wei</surname><given-names>WK</given-names></name><name name-style="western"><surname>Wang</surname><given-names>D</given-names></name><name name-style="western"><surname>Li</surname><given-names>F</given-names></name></person-group><article-title>Influenza D virus in animal species in Guangdong Province, southern China</article-title><source>Emerg Infect Dis</source><year>2017</year><volume>23</volume><issue>8</issue><fpage>1392</fpage><lpage>1396</lpage><pub-id pub-id-type="doi">10.3201/eid2308.170059</pub-id><pub-id pub-id-type="pmid">28726609</pub-id><pub-id pub-id-type="pmcid">PMC5547803</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>White</surname><given-names>SK</given-names></name><name name-style="western"><surname>Ma</surname><given-names>W</given-names></name><name name-style="western"><surname>McDaniel</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Gray</surname><given-names>GC</given-names></name><name name-style="western"><surname>Lednicky</surname><given-names>JA</given-names></name></person-group><article-title>Serologic evidence of exposure to influenza D virus among persons with occupational contact with cattle</article-title><source>J Clin Virol</source><year>2016</year><volume>81</volume><fpage>31</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1016/j.jcv.2016.05.017</pub-id><pub-id pub-id-type="pmid">27294672</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Asha</surname><given-names>K</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>B</given-names></name></person-group><article-title>Emerging influenza D virus threat: what we know so far</article-title><source>J Clin Med</source><year>2019</year><volume>8</volume><issue>2</issue><fpage>192</fpage><pub-id pub-id-type="doi">10.3390/jcm8020192</pub-id><pub-id pub-id-type="pmcid">PMC6406440</pub-id><pub-id pub-id-type="pmid">30764577</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stohr</surname><given-names>K</given-names></name></person-group><article-title>Overview of the WHO Global Influenza Programme</article-title><source>Dev Biol (Basel)</source><year>2003</year><volume>115</volume><fpage>3</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">15088769</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jester</surname><given-names>B</given-names></name><name name-style="western"><surname>Schwerzmann</surname><given-names>J</given-names></name><name name-style="western"><surname>Mustaquim</surname><given-names>D</given-names></name><name name-style="western"><surname>Aden</surname><given-names>T</given-names></name><name name-style="western"><surname>Brammer</surname><given-names>L</given-names></name><name name-style="western"><surname>Humes</surname><given-names>R</given-names></name><name name-style="western"><surname>Shult</surname><given-names>P</given-names></name><name name-style="western"><surname>Shahangian</surname><given-names>S</given-names></name><name name-style="western"><surname>Gubareva</surname><given-names>L</given-names></name><name name-style="western"><surname>Xu</surname><given-names>X</given-names></name><name name-style="western"><surname>Miller</surname><given-names>J</given-names></name></person-group><article-title>Mapping of the US domestic influenza virologic surveillance landscape</article-title><source>Emerg Infect Dis</source><year>2018</year><volume>24</volume><issue>7</issue><fpage>1300</fpage><lpage>1306</lpage><pub-id pub-id-type="doi">10.3201/eid2407.180028</pub-id><pub-id pub-id-type="pmcid">PMC6038762</pub-id><pub-id pub-id-type="pmid">29715078</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="other">World Health Organization (2019) WHO Global Report on Traditional and Complementary Medicine. Available at: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.who.int/publications-detail/who-global-report-on-traditional-and-complementary-medicine-2019">https://www.who.int/publications-detail/who-global-report-on-traditional-and-complementary-medicine-2019</ext-link>. Accessed May 3, 2020.</mixed-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pan</surname><given-names>SY</given-names></name><name name-style="western"><surname>Litscher</surname><given-names>G</given-names></name><name name-style="western"><surname>Chan</surname><given-names>K</given-names></name><name name-style="western"><surname>Yu</surname><given-names>ZL</given-names></name><name name-style="western"><surname>Chen</surname><given-names>HQ</given-names></name><name name-style="western"><surname>Ko</surname><given-names>KM</given-names></name></person-group><article-title>Traditional medicines in the world: where to go next?</article-title><source>Evid Based Complement Alternat Med</source><year>2014</year><volume>2014</volume><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1155/2014/739895</pub-id><pub-id pub-id-type="pmcid">PMC4295149</pub-id><pub-id pub-id-type="pmid">25610481</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bouvier</surname><given-names>NM</given-names></name><name name-style="western"><surname>Palese</surname><given-names>P</given-names></name></person-group><article-title>The biology of influenza viruses</article-title><source>Vaccine</source><year>2008</year><volume>26</volume><fpage>D49</fpage><lpage>D53</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2008.07.039</pub-id><pub-id pub-id-type="pmid">19230160</pub-id><pub-id pub-id-type="pmcid">PMC3074182</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yi Tsang</surname><given-names>N</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>LH</given-names></name><name name-style="western"><surname>Wai Tsang</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>HJ</given-names></name></person-group><article-title>Antiviral Activity and Molecular Targets of Plant Natural Products Against Avian Influenza Virus</article-title><source>Curr Org Chem</source><year>2017</year><volume>21</volume><fpage>1777</fpage><lpage>1804</lpage><pub-id pub-id-type="doi">10.2174/1385272821666170227120138</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Laver</surname><given-names>WG</given-names></name><name name-style="western"><surname>Webster</surname><given-names>RG</given-names></name></person-group><article-title>Preparation and immunogenicity of a purified influenza virus haemagglutinin and neuraminidase subunit vaccine</article-title><source>Postgrad Med J</source><year>1976</year><volume>52</volume><issue>608</issue><fpage>373</fpage><lpage>378</lpage><pub-id pub-id-type="doi">10.1136/pgmj.52.608.373</pub-id><pub-id pub-id-type="pmid">785428</pub-id><pub-id pub-id-type="pmcid">PMC2496313</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Francis</surname><given-names>ME</given-names></name><name name-style="western"><surname>King</surname><given-names>ML</given-names></name><name name-style="western"><surname>Kelvin</surname><given-names>AA</given-names></name></person-group><article-title>Back to the Future for Influenza Preimmunity-Looking Back at Influenza Virus History to Infer the Outcome of Future Infections</article-title><source>Viruses</source><year>2019</year><volume>11</volume><issue>2</issue><fpage>E122</fpage><pub-id pub-id-type="doi">10.3390/v11020122</pub-id><pub-id pub-id-type="pmid">30704019</pub-id><pub-id pub-id-type="pmcid">PMC6410066</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gao</surname><given-names>Q</given-names></name><name name-style="western"><surname>Brydon</surname><given-names>EW</given-names></name><name name-style="western"><surname>Palese</surname><given-names>P</given-names></name></person-group><article-title>A seven-segmented influenza A virus expressing the influenza C virus glycoprotein HEF</article-title><source>J Virol</source><year>2008</year><volume>82</volume><fpage>6419</fpage><lpage>6426</lpage><pub-id pub-id-type="doi">10.1128/JVI.00514-08</pub-id><pub-id pub-id-type="pmid">18448539</pub-id><pub-id pub-id-type="pmcid">PMC2447078</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stewart</surname><given-names>SM</given-names></name><name name-style="western"><surname>Pekosz</surname><given-names>A</given-names></name></person-group><article-title>The influenza C virus CM2 protein can alter intracellular pH, and its transmembrane domain can substitute for that of the influenza A virus M2 protein and support infectious virus production</article-title><source>J Virol</source><year>2012</year><volume>86</volume><fpage>1277</fpage><lpage>1281</lpage><pub-id pub-id-type="doi">10.1128/JVI.05681-11</pub-id><pub-id pub-id-type="pmid">21917958</pub-id><pub-id pub-id-type="pmcid">PMC3255851</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matsuzaki</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sugawara</surname><given-names>K</given-names></name><name name-style="western"><surname>Furuse</surname><given-names>Y</given-names></name><name name-style="western"><surname>Shimotai</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hongo</surname><given-names>S</given-names></name><name name-style="western"><surname>Oshitani</surname><given-names>H</given-names></name><name name-style="western"><surname>Mizuta</surname><given-names>K</given-names></name><name name-style="western"><surname>Nishimura</surname><given-names>H</given-names></name></person-group><article-title>Genetic lineage and reassortment of influenza C viruses circulating between 1947 and 2014</article-title><source>J Virol</source><year>2016</year><volume>90</volume><fpage>8251</fpage><lpage>8265</lpage><pub-id pub-id-type="doi">10.1128/JVI.00969-16</pub-id><pub-id pub-id-type="pmid">27384661</pub-id><pub-id pub-id-type="pmcid">PMC5008092</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakatsu</surname><given-names>S</given-names></name><name name-style="western"><surname>Murakami</surname><given-names>S</given-names></name><name name-style="western"><surname>Shindo</surname><given-names>K</given-names></name><name name-style="western"><surname>Horimoto</surname><given-names>T</given-names></name><name name-style="western"><surname>Sagara</surname><given-names>H</given-names></name><name name-style="western"><surname>Noda</surname><given-names>T</given-names></name><name name-style="western"><surname>Kawaoka</surname><given-names>Y</given-names></name></person-group><article-title>Influenza C and D viruses package eight organized ribonucleoprotein complexes</article-title><source>J Virol</source><year>2018</year><volume>92</volume><fpage>e02084</fpage><lpage>e02017</lpage><pub-id pub-id-type="doi">10.1128/JVI.02084-17</pub-id><pub-id pub-id-type="pmid">29321324</pub-id><pub-id pub-id-type="pmcid">PMC5827381</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Su</surname><given-names>S</given-names></name><name name-style="western"><surname>Fu</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>G</given-names></name><name name-style="western"><surname>Kerlin</surname><given-names>F</given-names></name><name name-style="western"><surname>Veit</surname><given-names>M</given-names></name></person-group><article-title>Novel influenza D virus: epidemiology, pathology, evolution and biological characteristics</article-title><source>Virulence</source><year>2017</year><volume>8</volume><fpage>1580</fpage><lpage>1591</lpage><pub-id pub-id-type="doi">10.1080/21505594.2017.1365216</pub-id><pub-id pub-id-type="pmid">28812422</pub-id><pub-id pub-id-type="pmcid">PMC5810478</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hilleman</surname><given-names>MR</given-names></name></person-group><article-title>Antigenic variation of influenza viruses</article-title><source>Annu Rev Microbiol</source><year>1954</year><volume>8</volume><fpage>311</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.1146/annurev.mi.08.100154.001523</pub-id><pub-id pub-id-type="pmid">13198110</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Hill</surname><given-names>KL</given-names></name><name name-style="western"><surname>Donelson</surname><given-names>JE</given-names></name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Brenner</surname><given-names>S</given-names></name><name name-style="western"><surname>Miller</surname><given-names>JH</given-names></name></person-group><article-title>Antigenic Variation</article-title><source>Encyclopedia of Genetics</source><year>2001</year><publisher-name>Academic Press</publisher-name><fpage>79</fpage><lpage>81</lpage></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Lamb</surname><given-names>A</given-names></name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Mahy</surname><given-names>BWJ</given-names></name><name name-style="western"><surname>Van Regenmortel</surname><given-names>MHV</given-names></name></person-group><article-title>Influenza</article-title><source>Encyclopedia of Virology, 3rd Edition</source><year>2008</year><publisher-name>Academic Press</publisher-name><fpage>95</fpage><lpage>104</lpage></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Ditmar</surname><given-names>MF</given-names></name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Polin</surname><given-names>RA</given-names></name><name name-style="western"><surname>Ditmar</surname><given-names>MF</given-names></name></person-group><article-title>Infectious Diseases</article-title><source>Pediatric Secrets, 5th Edition</source><year>2011</year><publisher-name>Mosby</publisher-name><fpage>354</fpage><lpage>422</lpage></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gerth</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Bauer</surname><given-names>KH</given-names></name><name name-style="western"><surname>Steinitz</surname><given-names>H</given-names></name></person-group><article-title>Is there evidence for antigenic drift of influenza C virus?</article-title><source>Zentralbl Bakteriol Parasitenkd Infekt Hyg</source><year>1975</year><volume>231</volume><fpage>47</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">1154916</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Treanor</surname><given-names>J</given-names></name></person-group><article-title>Influenza vaccine&#8212;outmaneuvering antigenic shift and drift</article-title><source>N Engl J Med</source><year>2004</year><volume>350</volume><fpage>218</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1056/NEJMp038238</pub-id><pub-id pub-id-type="pmid">14724300</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><mixed-citation publication-type="other">Centers for Disease Control and Prevention (2018) Immunization: The Basics definition of terms. Available at: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.cdc.gov/vaccines/vac-gen/imz-basics.htm">https://www.cdc.gov/vaccines/vac-gen/imz-basics.htm</ext-link>. Accessed May 16, 2018</mixed-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ulmer</surname><given-names>J</given-names></name><name name-style="western"><surname>Valley</surname><given-names>U</given-names></name><name name-style="western"><surname>Rappuoli</surname><given-names>R</given-names></name></person-group><article-title>Vaccine manufacturing: challenges and solutions</article-title><source>Nat Biotechnol</source><year>2006</year><volume>24</volume><fpage>1377</fpage><lpage>1383</lpage><pub-id pub-id-type="doi">10.1038/nbt1261</pub-id><pub-id pub-id-type="pmid">17093488</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Palese</surname><given-names>P</given-names></name></person-group><article-title>Making better influenza virus vaccines?</article-title><source>Emerg Infect Dis</source><year>2006</year><volume>12</volume><issue>1</issue><fpage>61</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.3201/eid1201.051043</pub-id><pub-id pub-id-type="pmid">16494719</pub-id><pub-id pub-id-type="pmcid">PMC3291403</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krammer</surname><given-names>F</given-names></name><name name-style="western"><surname>Palese</surname><given-names>P</given-names></name></person-group><article-title>Advances in the development of influenza virus vaccines</article-title><source>Nat Rev Drug Discov</source><year>2015</year><volume>14</volume><fpage>167</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1038/nrd4529</pub-id><pub-id pub-id-type="pmid">25722244</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moa</surname><given-names>AM</given-names></name><name name-style="western"><surname>Muscatello</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Turner</surname><given-names>RM</given-names></name><name name-style="western"><surname>MacIntyre</surname><given-names>CR</given-names></name></person-group><article-title>Epidemiology of influenza B in Australia: 2001-2014 influenza seasons</article-title><source>Influenza Other Respir Viruses</source><year>2017</year><volume>11</volume><issue>2</issue><fpage>102</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1111/irv.12432</pub-id><pub-id pub-id-type="pmid">27650482</pub-id><pub-id pub-id-type="pmcid">PMC5304570</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Halasa</surname><given-names>NB</given-names></name><name name-style="western"><surname>Gerber</surname><given-names>MA</given-names></name><name name-style="western"><surname>Berry</surname><given-names>AA</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>EL</given-names></name><name name-style="western"><surname>Winokur</surname><given-names>P</given-names></name><name name-style="western"><surname>Keyserling</surname><given-names>H</given-names></name><name name-style="western"><surname>Eckard</surname><given-names>AR</given-names></name><name name-style="western"><surname>Hill</surname><given-names>H</given-names></name><name name-style="western"><surname>Wolff</surname><given-names>MC</given-names></name><name name-style="western"><surname>McNeal</surname><given-names>MM</given-names></name><name name-style="western"><surname>Edwards</surname><given-names>KM</given-names></name><name name-style="western"><surname>Bernstein</surname><given-names>DI</given-names></name></person-group><article-title>Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of Age</article-title><source>J Pediatric Infect Dis Soc</source><year>2015</year><volume>4</volume><issue>3</issue><fpage>214</fpage><lpage>224</lpage><pub-id pub-id-type="doi">10.1093/jpids/piu061</pub-id><pub-id pub-id-type="pmid">26334249</pub-id><pub-id pub-id-type="pmcid">PMC4554205</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>K</given-names></name><name name-style="western"><surname>Wu</surname><given-names>X</given-names></name><name name-style="western"><surname>Shi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Gou</surname><given-names>X</given-names></name><name name-style="western"><surname>Huang</surname><given-names>J</given-names></name></person-group><article-title>Immunogenicity of H5N1 influenza vaccines in elderly adults: a systematic review and meta-analysis</article-title><source>Hum Vaccin Immunother</source><year>2021</year><volume>17</volume><issue>2</issue><fpage>475</fpage><lpage>484</lpage><pub-id pub-id-type="doi">10.1080/21645515.2020.1777822</pub-id><pub-id pub-id-type="pmid">32692606</pub-id><pub-id pub-id-type="pmcid">PMC7899698</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><mixed-citation publication-type="other">Centers for Disease Control and Prevention (2018). Seasonal Flu Shot. Available at: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.cdc.gov/flu/prevent/flushot.htm">https://www.cdc.gov/flu/prevent/flushot.htm</ext-link>. Accessed May 16, 2018.</mixed-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wong</surname><given-names>SS</given-names></name><name name-style="western"><surname>Webby</surname><given-names>RJ</given-names></name></person-group><article-title>Traditional and new influenza vaccines</article-title><source>Clin Microbiol Rev</source><year>2013</year><volume>26</volume><issue>3</issue><fpage>476</fpage><lpage>492</lpage><pub-id pub-id-type="doi">10.1128/CMR.00097-12</pub-id><pub-id pub-id-type="pmid">23824369</pub-id><pub-id pub-id-type="pmcid">PMC3719499</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Robertson</surname><given-names>CA</given-names></name><name name-style="western"><surname>DiazGranados</surname><given-names>CA</given-names></name><name name-style="western"><surname>Decker</surname><given-names>MD</given-names></name><name name-style="western"><surname>Chit</surname><given-names>A</given-names></name><name name-style="western"><surname>Mercer</surname><given-names>M</given-names></name><name name-style="western"><surname>Greenberg</surname><given-names>DP</given-names></name></person-group><article-title>Fluzone&#174; High-Dose Influenza Vaccine</article-title><source>Expert Rev Vaccines</source><year>2016</year><volume>15</volume><issue>12</issue><fpage>1495</fpage><lpage>1505</lpage><pub-id pub-id-type="doi">10.1080/14760584.2016.1254044</pub-id><pub-id pub-id-type="pmid">27813430</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sullivan</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Jacobson</surname><given-names>R</given-names></name><name name-style="western"><surname>Poland</surname><given-names>GA</given-names></name></person-group><article-title>Advances in the vaccination of the elderly against influenza: role of a high-dose vaccine</article-title><source>Expert Rev Vaccines</source><year>2010</year><volume>9</volume><issue>10</issue><fpage>1127</fpage><lpage>1133</lpage><pub-id pub-id-type="doi">10.1586/erv.10.117</pub-id><pub-id pub-id-type="pmid">20923264</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Overton</surname><given-names>ET</given-names></name></person-group><article-title>Sometimes, more is better</article-title><source>J. Infect. Dis.</source><year>2012</year><volume>205</volume><fpage>697</fpage><lpage>699</lpage><pub-id pub-id-type="doi">10.1093/infdis/jir838</pub-id><pub-id pub-id-type="pmid">22275400</pub-id><pub-id pub-id-type="pmcid">PMC3274372</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tregoning</surname><given-names>JS</given-names></name><name name-style="western"><surname>Russell</surname><given-names>RF</given-names></name><name name-style="western"><surname>Kinnear</surname><given-names>E</given-names></name></person-group><article-title>Adjuvanted influenza vaccines</article-title><source>Hum Vaccin Immunother</source><year>2018</year><volume>14</volume><issue>3</issue><fpage>550</fpage><lpage>564</lpage><pub-id pub-id-type="doi">10.1080/21645515.2017.1415684</pub-id><pub-id pub-id-type="pmid">29232151</pub-id><pub-id pub-id-type="pmcid">PMC5861793</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><mixed-citation publication-type="other">Centers for Disease Control and Prevention (2021). Live Attenuated Influenza Vaccine [LAIV] (The Nasal Spray Flu Vaccine) Available at:<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.cdc.gov/flu/prevent/nasalspray.htm">https://www.cdc.gov/flu/prevent/nasalspray.htm</ext-link>. Accessed January 25, 2021</mixed-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clancy</surname><given-names>S</given-names></name></person-group><article-title>Genetics of the influenza virus</article-title><source>Nature Education</source><year>2008</year><volume>1</volume><issue>1</issue><fpage>83</fpage></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Madsen</surname><given-names>A</given-names></name><name name-style="western"><surname>Cox</surname><given-names>RJ</given-names></name></person-group><article-title>Prospects and challenges in the development of universal influenza vaccines</article-title><source>Vaccines</source><year>2020</year><volume>8</volume><issue>3</issue><fpage>361</fpage><pub-id pub-id-type="doi">10.3390/vaccines8030361</pub-id><pub-id pub-id-type="pmcid">PMC7563311</pub-id><pub-id pub-id-type="pmid">32640619</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pica</surname><given-names>N</given-names></name><name name-style="western"><surname>Palese</surname><given-names>P</given-names></name></person-group><article-title>Toward a universal influenza virus vaccine: prospects and challenges</article-title><source>Annu Rev Med</source><year>2013</year><volume>64</volume><fpage>189</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.1146/annurev-med-120611-145115</pub-id><pub-id pub-id-type="pmid">23327522</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wei</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Crank</surname><given-names>MC</given-names></name><name name-style="western"><surname>Shiver</surname><given-names>J</given-names></name><name name-style="western"><surname>Graham</surname><given-names>BS</given-names></name><name name-style="western"><surname>Mascola</surname><given-names>JR</given-names></name><name name-style="western"><surname>Nabel</surname><given-names>GJ</given-names></name></person-group><article-title>Next-generation influenza vaccines: opportunities and challenges</article-title><source>Nat Rev Drug Discov</source><year>2020</year><volume>19</volume><fpage>239</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.1038/s41573-019-0056-x</pub-id><pub-id pub-id-type="pmid">32060419</pub-id><pub-id pub-id-type="pmcid">PMC7223957</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Houser</surname><given-names>K</given-names></name><name name-style="western"><surname>Subbarao</surname><given-names>K</given-names></name></person-group><article-title>Influenza vaccines: challenges and solutions</article-title><source>Cell Host Microbe.</source><year>2015</year><volume>17</volume><issue>3</issue><fpage>295</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2016.08.019</pub-id><pub-id pub-id-type="pmid">25766291</pub-id><pub-id pub-id-type="pmcid">PMC4362519</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><mixed-citation publication-type="other">Science.gov (2021) Oak Ridge, TN, US. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.science.gov/topicpages/v/vaccine+manufacturing+capacity">https://www.science.gov/topicpages/v/vaccine+manufacturing+capacity</ext-link></mixed-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McLean</surname><given-names>KA</given-names></name><name name-style="western"><surname>Goldin</surname><given-names>S</given-names></name><name name-style="western"><surname>Nannei</surname><given-names>C</given-names></name><name name-style="western"><surname>Sparrow</surname><given-names>E</given-names></name><name name-style="western"><surname>Torelli</surname><given-names>G</given-names></name></person-group><article-title>The 2015 global production capacity of seasonal and pandemic influenza vaccine</article-title><source>Vaccine</source><year>2016</year><volume>34</volume><issue>45</issue><fpage>5410</fpage><lpage>5413</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2016.08.019</pub-id><pub-id pub-id-type="pmid">27531411</pub-id><pub-id pub-id-type="pmcid">PMC5357707</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Plans</surname><given-names>P</given-names></name></person-group><article-title>Recommendations for the prevention and treatment of influenza using antiviral drugs based on cost-effectiveness</article-title><source>Expert Rev Pharmacoecon Outcomes Res</source><year>2008</year><volume>8</volume><fpage>563</fpage><lpage>573</lpage><pub-id pub-id-type="doi">10.1586/14737167.8.6.563</pub-id><pub-id pub-id-type="pmid">20528367</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shie</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Fang</surname><given-names>JM</given-names></name></person-group><article-title>Development of effective anti-influenza drugs: congeners and conjugates - a review</article-title><source>J Biomed Sci</source><year>2019</year><volume>26</volume><fpage>84</fpage><pub-id pub-id-type="doi">10.1186/s12929-019-0567-0</pub-id><pub-id pub-id-type="pmid">31640786</pub-id><pub-id pub-id-type="pmcid">PMC6806523</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><mixed-citation publication-type="other">Influenza (flu) antiviral drugs and related information (2020) US Food and Drug Administration, Rockville. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.fda.gov/drugs/information-drug-class/influenza-flu-antiviral-drugs-and-related-information#ApprovedDrugs">https://www.fda.gov/drugs/information-drug-class/influenza-flu-antiviral-drugs-and-related-information#ApprovedDrugs</ext-link>. Accessed October 26,2020</mixed-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kohno</surname><given-names>S</given-names></name><name name-style="western"><surname>Kida</surname><given-names>H</given-names></name><name name-style="western"><surname>Mizuguchi</surname><given-names>M</given-names></name><name name-style="western"><surname>Hirotsu</surname><given-names>N</given-names></name><name name-style="western"><surname>Ishida</surname><given-names>T</given-names></name><name name-style="western"><surname>Kadota</surname><given-names>J</given-names></name><name name-style="western"><surname>Shimada</surname><given-names>J</given-names></name></person-group><article-title>Intravenous peramivir for treatment of influenza A and B virus infection in high-risk patients</article-title><source>Antimicrob Agents Chemother</source><year>2011</year><volume>55</volume><issue>6</issue><fpage>2803</fpage><lpage>2812</lpage><pub-id pub-id-type="doi">10.1128/AAC.01718-10</pub-id><pub-id pub-id-type="pmid">21464252</pub-id><pub-id pub-id-type="pmcid">PMC3101422</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Allen</surname><given-names>UD</given-names></name><name name-style="western"><surname>Aoki</surname><given-names>FY</given-names></name><name name-style="western"><surname>Stiver</surname><given-names>HG</given-names></name></person-group><article-title>The use of antiviral drugs for influenza: recommended guidelines for practitioners</article-title><source>Can J Infect Dis Med Microbiol</source><year>2006</year><volume>17</volume><fpage>273</fpage><lpage>284</lpage><pub-id pub-id-type="doi">10.1155/2006/165940</pub-id><pub-id pub-id-type="pmid">18382639</pub-id><pub-id pub-id-type="pmcid">PMC2095091</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hayden</surname><given-names>FG</given-names></name><name name-style="western"><surname>Sugaya</surname><given-names>N</given-names></name><name name-style="western"><surname>Hirotsu</surname><given-names>N</given-names></name><name name-style="western"><surname>Lee</surname><given-names>N</given-names></name><name name-style="western"><surname>de Jong</surname><given-names>MD</given-names></name><name name-style="western"><surname>Hurt</surname><given-names>AC</given-names></name><name name-style="western"><surname>Ishida</surname><given-names>T</given-names></name><name name-style="western"><surname>Sekino</surname><given-names>H</given-names></name><name name-style="western"><surname>Yamada</surname><given-names>K</given-names></name><name name-style="western"><surname>Portsmouth</surname><given-names>S</given-names></name><name name-style="western"><surname>Kawaguchi</surname><given-names>K</given-names></name><name name-style="western"><surname>Shishido</surname><given-names>T</given-names></name><name name-style="western"><surname>Arai</surname><given-names>M</given-names></name><name name-style="western"><surname>Tsuchiya</surname><given-names>K</given-names></name><name name-style="western"><surname>Uehara</surname><given-names>T</given-names></name><name name-style="western"><surname>Watanabe</surname><given-names>A</given-names></name><name name-style="western"><surname>Baloxavir Marboxil Investigators</surname><given-names>G</given-names></name></person-group><article-title>Baloxavir marboxil for uncomplicated influenza in adults and adolescents</article-title><source>N Engl J Med</source><year>2018</year><volume>379</volume><fpage>913</fpage><lpage>923</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1716197</pub-id><pub-id pub-id-type="pmid">30184455</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mishin</surname><given-names>VP</given-names></name><name name-style="western"><surname>Patel</surname><given-names>MC</given-names></name><name name-style="western"><surname>Chesnokov</surname><given-names>A</given-names></name><name name-style="western"><surname>De La Cruz</surname><given-names>J</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>HT</given-names></name><name name-style="western"><surname>Lollis</surname><given-names>L</given-names></name><name name-style="western"><surname>Hodges</surname><given-names>E</given-names></name><name name-style="western"><surname>Jang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Barnes</surname><given-names>J</given-names></name><name name-style="western"><surname>Uyeki</surname><given-names>T</given-names></name><name name-style="western"><surname>Davis</surname><given-names>CT</given-names></name><name name-style="western"><surname>Wentworth</surname><given-names>DE</given-names></name><name name-style="western"><surname>Gubareva</surname><given-names>LV</given-names></name></person-group><article-title>Susceptibility of influenza A, B, C, and D viruses to baloxavir (1)</article-title><source>Emerg Infect Dis</source><year>2019</year><volume>25</volume><issue>10</issue><fpage>1969</fpage><lpage>1972</lpage><pub-id pub-id-type="doi">10.3201/eid2510.190607</pub-id><pub-id pub-id-type="pmid">31287050</pub-id><pub-id pub-id-type="pmcid">PMC6759234</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Amarelle</surname><given-names>L</given-names></name><name name-style="western"><surname>Lecuona</surname><given-names>E</given-names></name><name name-style="western"><surname>Sznajder</surname><given-names>JI</given-names></name></person-group><article-title>Anti-influenza treatment: drugs currently used and under development</article-title><source>Arch Bronconeumol</source><year>2017</year><volume>53</volume><fpage>19</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1016/j.arbres.2016.07.004</pub-id><pub-id pub-id-type="pmid">27519544</pub-id><pub-id pub-id-type="pmcid">PMC6889083</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Clercq</surname><given-names>E</given-names></name></person-group><article-title>Antiviral agents active against influenza A viruses</article-title><source>Nat Rev Drug Discov.</source><year>2006</year><volume>5</volume><fpage>1015</fpage><lpage>1025</lpage><pub-id pub-id-type="doi">10.1038/nrd2175</pub-id><pub-id pub-id-type="pmid">17139286</pub-id><pub-id pub-id-type="pmcid">PMC7097821</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><mixed-citation publication-type="other">World Health Organization (2010) Pandemic (H1N1) 2009: antiviral drug resistance. Available at: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.who.int/csr/disease/swineflu/frequently_asked_questions/%20antivirals/resistance/en/">https://www.who.int/csr/disease/swineflu/frequently_asked_questions/ antivirals/resistance/en/</ext-link>. Accessed 29 Dec 2010.</mixed-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Norberg</surname><given-names>P</given-names></name><name name-style="western"><surname>Lindh</surname><given-names>M</given-names></name><name name-style="western"><surname>Olofsson</surname><given-names>S</given-names></name></person-group><article-title>Published sequences do not support transfer of oseltamivir resistance mutations from avian to human influenza A virus strains</article-title><source>BMC Infect Dis</source><year>2015</year><volume>15</volume><issue>1</issue><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1186/s12879-015-0860-9</pub-id><pub-id pub-id-type="pmid">25887656</pub-id><pub-id pub-id-type="pmcid">PMC4387679</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pal</surname><given-names>SK</given-names></name><name name-style="western"><surname>Shukla</surname><given-names>Y</given-names></name></person-group><article-title>Herbal medicine: current status and the future</article-title><source>Asian Pac J Cancer Prev.</source><year>2003</year><volume>4</volume><fpage>281</fpage><lpage>288</lpage><pub-id pub-id-type="pmid">14728584</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ganjhu</surname><given-names>RK</given-names></name><name name-style="western"><surname>Mudgal</surname><given-names>PP</given-names></name><name name-style="western"><surname>Maity</surname><given-names>H</given-names></name><name name-style="western"><surname>Dowarha</surname><given-names>D</given-names></name><name name-style="western"><surname>Devadiga</surname><given-names>S</given-names></name><name name-style="western"><surname>Nag</surname><given-names>S</given-names></name><name name-style="western"><surname>Arunkumar</surname><given-names>G</given-names></name></person-group><article-title>Herbal plants and plant preparations as remedial approach for viral diseases</article-title><source>VirusDis</source><year>2015</year><volume>26</volume><issue>4</issue><fpage>225</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1007/s13337-015-0276-6</pub-id><pub-id pub-id-type="pmcid">PMC4663710</pub-id><pub-id pub-id-type="pmid">26645032</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mousa</surname><given-names>HA</given-names></name></person-group><article-title>Prevention and treatment of influenza, influenza-like illness, and common cold by herbal, complementary, and natural therapies</article-title><source>J Evid Based Complementary Altern Med.</source><year>2017</year><volume>22</volume><issue>1</issue><fpage>166</fpage><lpage>174</lpage><pub-id pub-id-type="doi">10.1177/2156587216641831</pub-id><pub-id pub-id-type="pmid">27055821</pub-id><pub-id pub-id-type="pmcid">PMC5871211</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kamboj</surname><given-names>VP</given-names></name></person-group><article-title>Herbal medicine</article-title><source>Curr Sci</source><year>2000</year><volume>78</volume><fpage>35</fpage><lpage>51</lpage></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arora</surname><given-names>R</given-names></name><name name-style="western"><surname>Chawla</surname><given-names>R</given-names></name><name name-style="western"><surname>Marwah</surname><given-names>R</given-names></name><name name-style="western"><surname>Arora</surname><given-names>P</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>R</given-names></name><name name-style="western"><surname>Kaushik</surname><given-names>V</given-names></name><name name-style="western"><surname>Goel</surname><given-names>R</given-names></name><name name-style="western"><surname>Kaur</surname><given-names>A</given-names></name><name name-style="western"><surname>Silambarasan</surname><given-names>M</given-names></name><name name-style="western"><surname>Tripathi</surname><given-names>R</given-names></name></person-group><article-title>Potential of complementary and alternative medicine in preventive management of novel H1N1 flu (Swine flu) pandemic: thwarting potential disasters in the bud</article-title><source>Evid Based Complement Altern Med</source><year>2011</year><volume>2011</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1155/2011/586506</pub-id><pub-id pub-id-type="pmcid">PMC2957173</pub-id><pub-id pub-id-type="pmid">20976081</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>H</given-names></name><name name-style="western"><surname>He</surname><given-names>S</given-names></name><name name-style="western"><surname>Shi</surname><given-names>M</given-names></name></person-group><article-title>Adjuvant-active fraction from <italic toggle="yes">Albizia julibrissin</italic> saponins improves immune responses by inducing cytokine and chemokine at the site of injection</article-title><source>Int Immunopharmacol</source><year>2014</year><volume>22</volume><issue>2</issue><fpage>346</fpage><lpage>355</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2014.07.021</pub-id><pub-id pub-id-type="pmid">25075718</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Borges-Arg&#225;ez</surname><given-names>R</given-names></name><name name-style="western"><surname>Chan-Balan</surname><given-names>R</given-names></name><name name-style="western"><surname>Cetina-Montejo</surname><given-names>L</given-names></name><name name-style="western"><surname>Ayora-Talavera</surname><given-names>G</given-names></name><name name-style="western"><surname>Sansores-Peraza</surname><given-names>P</given-names></name><name name-style="western"><surname>G&#243;mez-Carballo</surname><given-names>J</given-names></name><name name-style="western"><surname>C&#225;ceres-Farf&#225;n</surname><given-names>M</given-names></name></person-group><article-title>In vitro evaluation of anthraquinones from <italic toggle="yes">Aloe vera</italic> (<italic toggle="yes">Aloe barbadensis</italic> Miller) roots and several derivatives against strains of influenza virus</article-title><source>Ind Crops Prod</source><year>2019</year><volume>132</volume><fpage>468</fpage><lpage>475</lpage><pub-id pub-id-type="doi">10.1016/j.indcrop.2019.02.056</pub-id><pub-id pub-id-type="pmid">32288269</pub-id><pub-id pub-id-type="pmcid">PMC7138392</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sawamura</surname><given-names>R</given-names></name><name name-style="western"><surname>Sun</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yasukawa</surname><given-names>K</given-names></name><name name-style="western"><surname>Shimizu</surname><given-names>T</given-names></name><name name-style="western"><surname>Watanabe</surname><given-names>W</given-names></name><name name-style="western"><surname>Kurokawa</surname><given-names>M</given-names></name></person-group><article-title>Antiviral activities of diarylheptanoids against influenza virus in vitro</article-title><source>J Nat Med</source><year>2010</year><volume>64</volume><issue>1</issue><fpage>117</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1007/s11418-009-0372-2</pub-id><pub-id pub-id-type="pmid">20091245</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sawamura</surname><given-names>R</given-names></name><name name-style="western"><surname>Shimizu</surname><given-names>T</given-names></name><name name-style="western"><surname>Sun</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yasukawa</surname><given-names>K</given-names></name><name name-style="western"><surname>Miura</surname><given-names>M</given-names></name><name name-style="western"><surname>Toriyama</surname><given-names>M</given-names></name><name name-style="western"><surname>Motohashi</surname><given-names>S</given-names></name><name name-style="western"><surname>Watanabe</surname><given-names>W</given-names></name><name name-style="western"><surname>Konno</surname><given-names>K</given-names></name><name name-style="western"><surname>Kurokawa</surname><given-names>M</given-names></name></person-group><article-title><italic toggle="yes">In vitro</italic> and <italic toggle="yes">in vivo</italic> anti-influenza virus activity of diarylheptanoids isolated from <italic toggle="yes">Alpinia officinarum</italic></article-title><source>Antivir Chem Chemother</source><year>2010</year><volume>21</volume><issue>1</issue><fpage>33</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.3851/IMP1676</pub-id><pub-id pub-id-type="pmid">21045258</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>JX</given-names></name><name name-style="western"><surname>Xue</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Ye</surname><given-names>WC</given-names></name><name name-style="western"><surname>Fang</surname><given-names>BH</given-names></name><name name-style="western"><surname>Liu</surname><given-names>YH</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>SH</given-names></name><name name-style="western"><surname>Yu</surname><given-names>P</given-names></name><name name-style="western"><surname>Wang</surname><given-names>YQ</given-names></name></person-group><article-title>Activity of andrographolide and its derivatives against influenza virus in vivo and in vitro</article-title><source>Biol Pharm Bull</source><year>2009</year><volume>32</volume><issue>8</issue><fpage>1385</fpage><lpage>1391</lpage><pub-id pub-id-type="doi">10.1248/BPB.32.1385</pub-id><pub-id pub-id-type="pmid">19652378</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cai</surname><given-names>W</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chen</surname><given-names>S</given-names></name><name name-style="western"><surname>Wang</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>A</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>H</given-names></name><name name-style="western"><surname>Chen</surname><given-names>H</given-names></name><name name-style="western"><surname>Jin</surname><given-names>M</given-names></name></person-group><article-title>14-Deoxy-11, 12-dehydroandrographolide exerts anti-influenza A virus activity and inhibits replication of H5N1 virus by restraining nuclear export of viral ribonucleoprotein complexes</article-title><source>Antiviral Res</source><year>2015</year><volume>118</volume><fpage>82</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2015.03.008</pub-id><pub-id pub-id-type="pmid">25800824</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hayashi</surname><given-names>K</given-names></name><name name-style="western"><surname>Narutaki</surname><given-names>K</given-names></name><name name-style="western"><surname>Nagaoka</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hayashi</surname><given-names>T</given-names></name><name name-style="western"><surname>Uesato</surname><given-names>S</given-names></name></person-group><article-title>Therapeutic effect of arctiin and arctigenin in immunocompetent and immunocompromised mice infected with influenza A virus</article-title><source>Biolo Pharm Bull</source><year>2010</year><volume>33</volume><issue>7</issue><fpage>1199</fpage><lpage>1205</lpage><pub-id pub-id-type="doi">10.1248/bpb.33.1199</pub-id><pub-id pub-id-type="pmid">20606313</pub-id></element-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>S</given-names></name><name name-style="western"><surname>Kim</surname><given-names>JI</given-names></name><name name-style="western"><surname>Lee</surname><given-names>I</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S</given-names></name><name name-style="western"><surname>Hwang</surname><given-names>MW</given-names></name><name name-style="western"><surname>Bae</surname><given-names>JY</given-names></name><name name-style="western"><surname>Heo</surname><given-names>J</given-names></name><name name-style="western"><surname>Kim</surname><given-names>D</given-names></name><name name-style="western"><surname>Han</surname><given-names>SZ</given-names></name><name name-style="western"><surname>Park</surname><given-names>MS</given-names></name></person-group><article-title><italic toggle="yes">Aronia melanocarpa</italic> and its components demonstrate antiviral activity against influenza viruses</article-title><source>Biochem Biophys Res Commun</source><year>2013</year><volume>440</volume><issue>1</issue><fpage>14</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2013.08.090</pub-id><pub-id pub-id-type="pmid">24012672</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kallon</surname><given-names>S</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Ji</surname><given-names>J</given-names></name><name name-style="western"><surname>Chen</surname><given-names>C</given-names></name><name name-style="western"><surname>Xi</surname><given-names>Q</given-names></name><name name-style="western"><surname>Chang</surname><given-names>S</given-names></name><name name-style="western"><surname>Xue</surname><given-names>C</given-names></name><name name-style="western"><surname>Ma</surname><given-names>J</given-names></name><name name-style="western"><surname>Xie</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name></person-group><article-title><italic toggle="yes">Astragalus</italic> polysaccharide enhances immunity and inhibits H9N2 avian influenza virus in vitro and in vivo</article-title><source>J Animal Sci Biotechnol</source><year>2013</year><volume>4</volume><issue>1</issue><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1186/2049-1891-4-22</pub-id><pub-id pub-id-type="pmcid">PMC3729712</pub-id><pub-id pub-id-type="pmid">23786718</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahmad</surname><given-names>A</given-names></name><name name-style="western"><surname>Javed</surname><given-names>MR</given-names></name><name name-style="western"><surname>Rao</surname><given-names>AQ</given-names></name><name name-style="western"><surname>Husnain</surname><given-names>T</given-names></name></person-group><article-title>Designing and screening of universal drug from neem (<italic toggle="yes">Azadirachta indica</italic>) and standard drug chemicals against influenza virus nucleoprotein</article-title><source>BMC complement Altern Med</source><year>2016</year><volume>16</volume><issue>1</issue><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1186/s12906-016-1469-2</pub-id><pub-id pub-id-type="pmid">27986088</pub-id><pub-id pub-id-type="pmcid">PMC5162082</pub-id></element-citation></ref><ref id="CR78"><label>78.</label><mixed-citation publication-type="other">Zhang XQ, Chen HS (1989) Immuno-pharmacological effects of Bupleurum chinense polysaccharide. Chinese J Pharmacol Toxicol&#160;3(1):30&#8211;33</mixed-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>AL</given-names></name><name name-style="western"><surname>Shu</surname><given-names>SH</given-names></name><name name-style="western"><surname>Qin</surname><given-names>HL</given-names></name><name name-style="western"><surname>Lee</surname><given-names>SM</given-names></name><name name-style="western"><surname>Wang</surname><given-names>YT</given-names></name><name name-style="western"><surname>Du</surname><given-names>GH</given-names></name></person-group><article-title>In vitro anti-influenza viral activities of constituents from <italic toggle="yes">Caesalpinia sappan</italic></article-title><source>Planta Med</source><year>2009</year><volume>75</volume><fpage>337</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1055/s-0028-1112208</pub-id><pub-id pub-id-type="pmid">19148862</pub-id></element-citation></ref><ref id="CR80"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jeong</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Kim</surname><given-names>YM</given-names></name><name name-style="western"><surname>Kim</surname><given-names>JH</given-names></name><name name-style="western"><surname>Kim</surname><given-names>JY</given-names></name><name name-style="western"><surname>Park</surname><given-names>JY</given-names></name><name name-style="western"><surname>Park</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Ryu</surname><given-names>YB</given-names></name><name name-style="western"><surname>Lee</surname><given-names>WS</given-names></name></person-group><article-title>Homoisoflavonoids from <italic toggle="yes">Caesalpinia sappan</italic> displaying viral neuraminidases inhibition</article-title><source>Biol Pharm Bull</source><year>2012</year><volume>35</volume><issue>5</issue><fpage>786</fpage><lpage>790</lpage><pub-id pub-id-type="doi">10.1248/bpb.35.786</pub-id><pub-id pub-id-type="pmid">22687418</pub-id></element-citation></ref><ref id="CR81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matsumoto</surname><given-names>K</given-names></name><name name-style="western"><surname>Yamada</surname><given-names>H</given-names></name><name name-style="western"><surname>Takuma</surname><given-names>N</given-names></name><name name-style="western"><surname>Niino</surname><given-names>H</given-names></name><name name-style="western"><surname>Sagesaka</surname><given-names>YM</given-names></name></person-group><article-title>Effects of green tea catechins and theanine on preventing influenza infection among healthcare workers: a randomized controlled trial</article-title><source>BMC Complement Altern Med</source><year>2011</year><volume>11</volume><issue>1</issue><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1186/1472-6882-11-15</pub-id><pub-id pub-id-type="pmid">21338496</pub-id><pub-id pub-id-type="pmcid">PMC3049752</pub-id></element-citation></ref><ref id="CR82"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Imanishi</surname><given-names>N</given-names></name><name name-style="western"><surname>Tuji</surname><given-names>Y</given-names></name><name name-style="western"><surname>Katada</surname><given-names>Y</given-names></name><name name-style="western"><surname>Maruhashi</surname><given-names>M</given-names></name><name name-style="western"><surname>Konosu</surname><given-names>S</given-names></name><name name-style="western"><surname>Mantani</surname><given-names>N</given-names></name><name name-style="western"><surname>Terasawa</surname><given-names>K</given-names></name><name name-style="western"><surname>Ochiai</surname><given-names>H</given-names></name></person-group><article-title>Additional inhibitory effect of tea extract on the growth of influenza A and B viruses in MDCK cells</article-title><source>Microbiol Immunol</source><year>2002</year><volume>46</volume><issue>7</issue><fpage>491</fpage><lpage>494</lpage><pub-id pub-id-type="doi">10.1111/j.1348-0421.2002.tb02724.x</pub-id><pub-id pub-id-type="pmid">12222936</pub-id></element-citation></ref><ref id="CR83"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Song</surname><given-names>JM</given-names></name><name name-style="western"><surname>Lee</surname><given-names>KH</given-names></name><name name-style="western"><surname>Seong</surname><given-names>BL</given-names></name></person-group><article-title>Antiviral effect of catechins in green tea on influenza virus</article-title><source>Antiviral Res</source><year>2005</year><volume>68</volume><issue>2</issue><fpage>66</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2005.06.010</pub-id><pub-id pub-id-type="pmid">16137775</pub-id></element-citation></ref><ref id="CR84"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaihatsu</surname><given-names>K</given-names></name><name name-style="western"><surname>Mori</surname><given-names>S</given-names></name><name name-style="western"><surname>Matsumura</surname><given-names>H</given-names></name><name name-style="western"><surname>Daidoji</surname><given-names>T</given-names></name><name name-style="western"><surname>Kawakami</surname><given-names>C</given-names></name><name name-style="western"><surname>Kurata</surname><given-names>H</given-names></name><name name-style="western"><surname>Nakaya</surname><given-names>T</given-names></name><name name-style="western"><surname>Kato</surname><given-names>N</given-names></name></person-group><article-title>Broad and potent anti-influenza virus spectrum of epigallocatechin-3-O-gallate-monopalmitate</article-title><source>J Mol Genet Med</source><year>2009</year><volume>3</volume><issue>2</issue><fpage>195</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.4172/1747-0862.1000034</pub-id><pub-id pub-id-type="pmid">20076790</pub-id><pub-id pub-id-type="pmcid">PMC2805839</pub-id></element-citation></ref><ref id="CR85"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakayama</surname><given-names>M</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>K</given-names></name><name name-style="western"><surname>Toda</surname><given-names>M</given-names></name><name name-style="western"><surname>Okubo</surname><given-names>S</given-names></name><name name-style="western"><surname>Hara</surname><given-names>Y</given-names></name><name name-style="western"><surname>Shimamura</surname><given-names>T</given-names></name></person-group><article-title>Inhibition of the infectivity of influenza virus by tea polyphenols</article-title><source>Antiviral Res</source><year>1993</year><volume>21</volume><issue>4</issue><fpage>289</fpage><lpage>299</lpage><pub-id pub-id-type="doi">10.1016/0166-3542(93)90008-7</pub-id><pub-id pub-id-type="pmid">8215301</pub-id></element-citation></ref><ref id="CR86"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sahoo</surname><given-names>M</given-names></name><name name-style="western"><surname>Jena</surname><given-names>L</given-names></name><name name-style="western"><surname>Rath</surname><given-names>SN</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>S</given-names></name></person-group><article-title>Identification of suitable natural inhibitor against influenza A (H1N1) neuraminidase protein by molecular docking</article-title><source>Genomics Inform</source><year>2016</year><volume>14</volume><issue>3</issue><fpage>96</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.5808/GI.2016.14.3.96</pub-id><pub-id pub-id-type="pmid">27729839</pub-id><pub-id pub-id-type="pmcid">PMC5056903</pub-id></element-citation></ref><ref id="CR87"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saha</surname><given-names>RK</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>T</given-names></name><name name-style="western"><surname>Kurebayashi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Fukushima</surname><given-names>K</given-names></name><name name-style="western"><surname>Minami</surname><given-names>A</given-names></name><name name-style="western"><surname>Kinbara</surname><given-names>N</given-names></name><name name-style="western"><surname>Ichitani</surname><given-names>M</given-names></name><name name-style="western"><surname>Sagesaka</surname><given-names>YM</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>T</given-names></name></person-group><article-title>Antiviral effect of strictinin on influenza virus replication</article-title><source>Antiviral Res</source><year>2010</year><volume>88</volume><issue>1</issue><fpage>10</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2010.06.008</pub-id><pub-id pub-id-type="pmid">20615432</pub-id></element-citation></ref><ref id="CR88"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>YX</given-names></name><name name-style="western"><surname>Liu</surname><given-names>AL</given-names></name><name name-style="western"><surname>Wang</surname><given-names>HD</given-names></name><name name-style="western"><surname>Wang</surname><given-names>YL</given-names></name><name name-style="western"><surname>Du</surname><given-names>GH</given-names></name></person-group><article-title>Antioxidant, anti-inflammatory and anti-influenza properties of components from <italic toggle="yes">Chaenomeles speciosa</italic></article-title><source>Molecules</source><year>2010</year><volume>15</volume><issue>11</issue><fpage>8507</fpage><lpage>8517</lpage><pub-id pub-id-type="doi">10.3390/molecules15118507</pub-id><pub-id pub-id-type="pmid">21102377</pub-id><pub-id pub-id-type="pmcid">PMC6259204</pub-id></element-citation></ref><ref id="CR89"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hayashi</surname><given-names>K</given-names></name><name name-style="western"><surname>Imanishi</surname><given-names>N</given-names></name><name name-style="western"><surname>Kashiwayama</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kawano</surname><given-names>A</given-names></name><name name-style="western"><surname>Terasawa</surname><given-names>K</given-names></name><name name-style="western"><surname>Shimada</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ochiai</surname><given-names>H</given-names></name></person-group><article-title>Inhibitory effect of cinnamaldehyde, derived from Cinnamomi cortex, on the growth of influenza A/PR/8 virus in vitro and in vivo</article-title><source>Antiviral Res</source><year>2007</year><volume>74</volume><issue>1</issue><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2007.01.003</pub-id><pub-id pub-id-type="pmid">17303260</pub-id></element-citation></ref><ref id="CR90"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kurokawa</surname><given-names>M</given-names></name><name name-style="western"><surname>Kumeda</surname><given-names>CA</given-names></name><name name-style="western"><surname>Yamamura</surname><given-names>JI</given-names></name><name name-style="western"><surname>Kamiyama</surname><given-names>T</given-names></name><name name-style="western"><surname>Shiraki</surname><given-names>K</given-names></name></person-group><article-title>Antipyretic activity of cinnamyl derivatives and related compounds in influenza virus-infected mice</article-title><source>Eur J Pharmacol</source><year>1998</year><volume>348</volume><issue>1</issue><fpage>45</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1016/S0014-2999(98)00121-6</pub-id><pub-id pub-id-type="pmid">9650830</pub-id></element-citation></ref><ref id="CR91"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kurokawa</surname><given-names>M</given-names></name><name name-style="western"><surname>Watanabe</surname><given-names>W</given-names></name><name name-style="western"><surname>Shimizu</surname><given-names>T</given-names></name><name name-style="western"><surname>Sawamura</surname><given-names>R</given-names></name><name name-style="western"><surname>Shiraki</surname><given-names>K</given-names></name></person-group><article-title>Modulation of cytokine production by 7-hydroxycoumarin in vitro and its efficacy against influenza infection in mice</article-title><source>Antiviral Res</source><year>2010</year><volume>85</volume><issue>2</issue><fpage>373</fpage><lpage>380</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2009.11.001</pub-id><pub-id pub-id-type="pmid">19913056</pub-id></element-citation></ref><ref id="CR92"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liao</surname><given-names>Q</given-names></name><name name-style="western"><surname>Qian</surname><given-names>Z</given-names></name><name name-style="western"><surname>Liu</surname><given-names>R</given-names></name><name name-style="western"><surname>An</surname><given-names>L</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name></person-group><article-title>Germacrone inhibits early stages of influenza virus infection</article-title><source>Antiviral Res</source><year>2013</year><volume>100</volume><issue>3</issue><fpage>578</fpage><lpage>588</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2013.09.021</pub-id><pub-id pub-id-type="pmid">24095670</pub-id></element-citation></ref><ref id="CR93"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>DY</given-names></name><name name-style="western"><surname>Shien</surname><given-names>JH</given-names></name><name name-style="western"><surname>Tiley</surname><given-names>L</given-names></name><name name-style="western"><surname>Chiou</surname><given-names>SS</given-names></name><name name-style="western"><surname>Wang</surname><given-names>SY</given-names></name><name name-style="western"><surname>Chang</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Lee</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Chan</surname><given-names>KW</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>WL</given-names></name></person-group><article-title>Curcumin inhibits influenza virus infection and haemagglutination activity</article-title><source>Food Chem</source><year>2010</year><volume>119</volume><issue>4</issue><fpage>1346</fpage><lpage>1351</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2009.09.011</pub-id></element-citation></ref><ref id="CR94"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dao</surname><given-names>TT</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>PH</given-names></name><name name-style="western"><surname>Won</surname><given-names>HK</given-names></name><name name-style="western"><surname>Kim</surname><given-names>EH</given-names></name><name name-style="western"><surname>Park</surname><given-names>J</given-names></name><name name-style="western"><surname>Won</surname><given-names>BY</given-names></name><name name-style="western"><surname>Oh</surname><given-names>WK</given-names></name></person-group><article-title>Curcuminoids from Curcuma longa and their inhibitory activities on influenza A neuraminidases</article-title><source>Food Chem</source><year>2012</year><volume>134</volume><issue>1</issue><fpage>21</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2012.02.015</pub-id></element-citation></ref><ref id="CR95"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>R</given-names></name><name name-style="western"><surname>Liu</surname><given-names>T</given-names></name><name name-style="western"><surname>Liu</surname><given-names>M</given-names></name><name name-style="western"><surname>Chen</surname><given-names>F</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J</given-names></name></person-group><article-title>Anti-influenza A virus activity of dendrobine and its mechanism of action</article-title><source>J Agric Food Chem</source><year>2017</year><volume>65</volume><issue>18</issue><fpage>3665</fpage><lpage>3674</lpage><pub-id pub-id-type="doi">10.1021/acs.jafc.7b00276</pub-id><pub-id pub-id-type="pmid">28417634</pub-id></element-citation></ref><ref id="CR96"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>AL</given-names></name><name name-style="western"><surname>Liu</surname><given-names>B</given-names></name><name name-style="western"><surname>Qin</surname><given-names>HL</given-names></name><name name-style="western"><surname>Lee</surname><given-names>SM</given-names></name><name name-style="western"><surname>Wang</surname><given-names>YT</given-names></name><name name-style="western"><surname>Du</surname><given-names>GH</given-names></name></person-group><article-title>Anti-influenza virus activities of flavonoids from the medicinal plant <italic toggle="yes">Elsholtzia rugulosa</italic></article-title><source>Planta Med</source><year>2008</year><volume>74</volume><issue>8</issue><fpage>847</fpage><lpage>851</lpage><pub-id pub-id-type="doi">10.1055/s-2008-1074558</pub-id><pub-id pub-id-type="pmid">18553272</pub-id></element-citation></ref><ref id="CR97"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mantani</surname><given-names>N</given-names></name><name name-style="western"><surname>Imanishi</surname><given-names>N</given-names></name><name name-style="western"><surname>Kawamata</surname><given-names>H</given-names></name><name name-style="western"><surname>Terasawa</surname><given-names>K</given-names></name><name name-style="western"><surname>Ochiai</surname><given-names>H</given-names></name></person-group><article-title>Inhibitory effect of (+)-catechin on the growth of influenza A/PR/8 virus in MDCK cells</article-title><source>Planta Med</source><year>2001</year><volume>67</volume><issue>03</issue><fpage>240</fpage><lpage>243</lpage><pub-id pub-id-type="doi">10.1055/s-2001-12009</pub-id><pub-id pub-id-type="pmid">11345695</pub-id></element-citation></ref><ref id="CR98"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miki</surname><given-names>K</given-names></name><name name-style="western"><surname>Nagai</surname><given-names>T</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>K</given-names></name><name name-style="western"><surname>Tsujimura</surname><given-names>R</given-names></name><name name-style="western"><surname>Koyama</surname><given-names>K</given-names></name><name name-style="western"><surname>Kinoshita</surname><given-names>K</given-names></name><name name-style="western"><surname>Furuhata</surname><given-names>K</given-names></name><name name-style="western"><surname>Yamada</surname><given-names>H</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>K</given-names></name></person-group><article-title>Anti-influenza virus activity of biflavonoids</article-title><source>Bioorg Med Chem Lett</source><year>2007</year><volume>17</volume><issue>3</issue><fpage>772</fpage><lpage>775</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2006.10.075</pub-id><pub-id pub-id-type="pmid">17110111</pub-id></element-citation></ref><ref id="CR99"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dao</surname><given-names>TT</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>PH</given-names></name><name name-style="western"><surname>Lee</surname><given-names>HS</given-names></name><name name-style="western"><surname>Kim</surname><given-names>E</given-names></name><name name-style="western"><surname>Park</surname><given-names>J</given-names></name><name name-style="western"><surname>Lim</surname><given-names>SI</given-names></name><name name-style="western"><surname>Oh</surname><given-names>WK</given-names></name></person-group><article-title>Chalcones as novel influenza A (H1N1) neuraminidase inhibitors from <italic toggle="yes">Glycyrrhiza inflata</italic></article-title><source>Bioorg Med Chem Lett</source><year>2011</year><volume>21</volume><issue>1</issue><fpage>294</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2010.11.016</pub-id><pub-id pub-id-type="pmid">21123068</pub-id></element-citation></ref><ref id="CR100"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ryu</surname><given-names>YB</given-names></name><name name-style="western"><surname>Kim</surname><given-names>JH</given-names></name><name name-style="western"><surname>Park</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Chang</surname><given-names>JS</given-names></name><name name-style="western"><surname>Rho</surname><given-names>MC</given-names></name><name name-style="western"><surname>Bae</surname><given-names>KH</given-names></name><name name-style="western"><surname>Park</surname><given-names>KH</given-names></name><name name-style="western"><surname>Lee</surname><given-names>WS</given-names></name></person-group><article-title>Inhibition of neuraminidase activity by polyphenol compounds isolated from the roots of <italic toggle="yes">Glycyrrhiza uralensis</italic></article-title><source>Bioorg Med Chem Lett</source><year>2010</year><volume>20</volume><issue>3</issue><fpage>971</fpage><lpage>974</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2009.12.106</pub-id><pub-id pub-id-type="pmid">20064716</pub-id></element-citation></ref><ref id="CR101"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Theisen</surname><given-names>LL</given-names></name><name name-style="western"><surname>Erdelmeier</surname><given-names>CA</given-names></name><name name-style="western"><surname>Spoden</surname><given-names>GA</given-names></name><name name-style="western"><surname>Boukhallouk</surname><given-names>F</given-names></name><name name-style="western"><surname>Sausy</surname><given-names>A</given-names></name><name name-style="western"><surname>Florin</surname><given-names>L</given-names></name><name name-style="western"><surname>Muller</surname><given-names>CP</given-names></name></person-group><article-title>Tannins from <italic toggle="yes">Hamamelis virginiana</italic> bark extract: characterization and improvement of the antiviral efficacy against influenza A virus and human papillomavirus</article-title><source>PLoS one</source><year>2014</year><volume>9</volume><issue>1</issue><fpage>e88062</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0088062</pub-id><pub-id pub-id-type="pmid">24498245</pub-id><pub-id pub-id-type="pmcid">PMC3909258</pub-id></element-citation></ref><ref id="CR102"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hayashi</surname><given-names>K</given-names></name><name name-style="western"><surname>Kamiya</surname><given-names>M</given-names></name><name name-style="western"><surname>Hayashi</surname><given-names>T</given-names></name></person-group><article-title>Virucidal effects of the steam distillate from <italic toggle="yes">Houttuynia cordata</italic> and its components on HSV-1, influenza virus and HIV</article-title><source>Planta Med</source><year>1995</year><volume>61</volume><fpage>237</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1055/s-2006-958063</pub-id><pub-id pub-id-type="pmid">7617766</pub-id></element-citation></ref><ref id="CR103"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>H</given-names></name><name name-style="western"><surname>Lu</surname><given-names>X</given-names></name><name name-style="western"><surname>Ling</surname><given-names>L</given-names></name><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><name name-style="western"><surname>Ou</surname><given-names>Y</given-names></name><name name-style="western"><surname>Shi</surname><given-names>X</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chen</surname><given-names>D</given-names></name></person-group><article-title><italic toggle="yes">Houttuynia cordata</italic> polysaccharides ameliorate pneumonia severity and intestinal injury in mice with influenza virus infection</article-title><source>J Ethnopharmacol</source><year>2018</year><volume>218</volume><fpage>90</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2018.02.016</pub-id><pub-id pub-id-type="pmid">29471085</pub-id></element-citation></ref><ref id="CR104"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Choi</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Song</surname><given-names>JH</given-names></name><name name-style="western"><surname>Park</surname><given-names>KS</given-names></name><name name-style="western"><surname>Kwon</surname><given-names>DH</given-names></name></person-group><article-title>Inhibitory effects of quercetin 3-rhamnoside on influenza A virus replication</article-title><source>Eur J Pharm Sci</source><year>2009</year><volume>37</volume><issue>3-4</issue><fpage>329</fpage><lpage>333</lpage><pub-id pub-id-type="doi">10.1016/j.ejps.2009.03.002</pub-id><pub-id pub-id-type="pmid">19491023</pub-id></element-citation></ref><ref id="CR105"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Xue</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>F</given-names></name><name name-style="western"><surname>Yan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><name name-style="western"><surname>Jin</surname><given-names>Q</given-names></name></person-group><article-title>Effects of <italic toggle="yes">Isatis</italic> root polysaccharide in mice infected with H3N2 swine influenza virus</article-title><source>Res Vet Sci</source><year>2018</year><volume>119</volume><fpage>91</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1016/j.rvsc.2018.04.012</pub-id><pub-id pub-id-type="pmid">29890386</pub-id></element-citation></ref><ref id="CR106"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mak</surname><given-names>NK</given-names></name><name name-style="western"><surname>Leung</surname><given-names>CY</given-names></name><name name-style="western"><surname>Wei</surname><given-names>XY</given-names></name><name name-style="western"><surname>Shen</surname><given-names>XL</given-names></name><name name-style="western"><surname>Wong</surname><given-names>RN</given-names></name><name name-style="western"><surname>Leung</surname><given-names>KN</given-names></name><name name-style="western"><surname>Fung</surname><given-names>MC</given-names></name></person-group><article-title>Inhibition of RANTES expression by indirubin in influenza virus-infected human bronchial epithelial cells</article-title><source>Biochem Pharmacol</source><year>2004</year><volume>67</volume><fpage>167</fpage><lpage>174</lpage><pub-id pub-id-type="doi">10.1016/j.bcp.2003.08.020</pub-id><pub-id pub-id-type="pmid">14667939</pub-id></element-citation></ref><ref id="CR107"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>JI</given-names></name><name name-style="western"><surname>Lin</surname><given-names>Q</given-names></name><name name-style="western"><surname>Li</surname><given-names>C</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>N</given-names></name></person-group><article-title>Antiviral activity of Isatis indigotica root-derived clemastanin B against human and avian influenza A and B viruses in vitro</article-title><source>Int J Mol Med</source><year>2013</year><volume>31</volume><issue>4</issue><fpage>867</fpage><lpage>873</lpage><pub-id pub-id-type="doi">10.3892/ijmm.2013.1274</pub-id><pub-id pub-id-type="pmid">23403777</pub-id></element-citation></ref><ref id="CR108"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>J</given-names></name><name name-style="western"><surname>Qi</surname><given-names>WB</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><name name-style="western"><surname>Tian</surname><given-names>J</given-names></name><name name-style="western"><surname>Jiao</surname><given-names>PR</given-names></name><name name-style="western"><surname>Liu</surname><given-names>GQ</given-names></name><name name-style="western"><surname>Ye</surname><given-names>WC</given-names></name><name name-style="western"><surname>Liao</surname><given-names>M</given-names></name></person-group><article-title>Amaryllidaceae alkaloids inhibit nuclear-to-cytoplasmic export of ribonucleoprotein (RNP) complex of highly pathogenic avian influenza virus H5N1</article-title><source>Influenza Other Respi Viruses</source><year>2013</year><volume>7</volume><issue>6</issue><fpage>922</fpage><lpage>931</lpage><pub-id pub-id-type="doi">10.1111/irv.12035</pub-id><pub-id pub-id-type="pmcid">PMC4634243</pub-id><pub-id pub-id-type="pmid">23136954</pub-id></element-citation></ref><ref id="CR109"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>J</given-names></name><name name-style="western"><surname>Qi</surname><given-names>W</given-names></name><name name-style="western"><surname>Tian</surname><given-names>J</given-names></name><name name-style="western"><surname>Jiao</surname><given-names>P</given-names></name><name name-style="western"><surname>Liu</surname><given-names>G</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>C</given-names></name><name name-style="western"><surname>Liao</surname><given-names>M</given-names></name></person-group><article-title>Amaryllidaceae alkaloids exhibit anti-influenza activity in MDCK cells, an investigation of Amaryllidaceae Alkaloids and MDCK cells insight</article-title><source>J Anim Vet Adv</source><year>2012</year><volume>11</volume><issue>14</issue><fpage>2485</fpage><lpage>2492</lpage><pub-id pub-id-type="doi">10.3923/javaa.2012.2485.2492</pub-id></element-citation></ref><ref id="CR110"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ooi</surname><given-names>VEC</given-names></name><name name-style="western"><surname>Chan</surname><given-names>PKS</given-names></name><name name-style="western"><surname>Chiu</surname><given-names>LCM</given-names></name><name name-style="western"><surname>Sun</surname><given-names>SSM</given-names></name><name name-style="western"><surname>Wong</surname><given-names>HNC</given-names></name></person-group><article-title>Antiviral activity of Chinese medicine - derived phytochemicals against avian influenza A ( H5N1 ) virus</article-title><source>Hong Kong Med J</source><year>2014</year><volume>20</volume><issue>4</issue><fpage>37</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">25224118</pub-id></element-citation></ref><ref id="CR111"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ooi</surname><given-names>LS</given-names></name><name name-style="western"><surname>Ho</surname><given-names>WS</given-names></name><name name-style="western"><surname>Ngai</surname><given-names>KL</given-names></name><name name-style="western"><surname>Tian</surname><given-names>L</given-names></name><name name-style="western"><surname>Chan</surname><given-names>PK</given-names></name><name name-style="western"><surname>Sun</surname><given-names>SS</given-names></name><name name-style="western"><surname>Ooi</surname><given-names>VE</given-names></name></person-group><article-title><italic toggle="yes">Narcissus tazetta</italic> lectin shows strong inhibitory effects against respiratory syncytial virus, influenza A (H1N1, H3N2, H5N1) and B viruses</article-title><source>J Biosci</source><year>2010</year><volume>35</volume><fpage>95</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1007/s12038-010-0012-8</pub-id><pub-id pub-id-type="pmid">20413914</pub-id><pub-id pub-id-type="pmcid">PMC7091448</pub-id></element-citation></ref><ref id="CR112"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ooi</surname><given-names>LSM</given-names></name><name name-style="western"><surname>Tian</surname><given-names>L</given-names></name><name name-style="western"><surname>Su</surname><given-names>M</given-names></name><name name-style="western"><surname>Ho</surname><given-names>WS</given-names></name><name name-style="western"><surname>Sun</surname><given-names>SSM</given-names></name><name name-style="western"><surname>Chung</surname><given-names>HY</given-names></name><name name-style="western"><surname>Wong</surname><given-names>HNC</given-names></name><name name-style="western"><surname>Ooi</surname><given-names>VEC</given-names></name></person-group><article-title>Isolation, characterization, molecular cloning and modeling of a new lipid transfer protein with antiviral and antiproliferative activities from <italic toggle="yes">Narcissus tazetta</italic></article-title><source>Peptides</source><year>2008</year><volume>29</volume><fpage>2101</fpage><lpage>2109</lpage><pub-id pub-id-type="doi">10.1016/j.peptides.2008.08.020</pub-id><pub-id pub-id-type="pmid">18824058</pub-id></element-citation></ref><ref id="CR113"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamada</surname><given-names>K</given-names></name><name name-style="western"><surname>Ogawa</surname><given-names>H</given-names></name><name name-style="western"><surname>Hara</surname><given-names>A</given-names></name><name name-style="western"><surname>Yoshida</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yonezawa</surname><given-names>Y</given-names></name><name name-style="western"><surname>Karibe</surname><given-names>K</given-names></name><name name-style="western"><surname>Nghia</surname><given-names>VB</given-names></name><name name-style="western"><surname>Yoshimura</surname><given-names>H</given-names></name><name name-style="western"><surname>Yamamoto</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yamada</surname><given-names>M</given-names></name><name name-style="western"><surname>Nakamura</surname><given-names>K</given-names></name><name name-style="western"><surname>Imai</surname><given-names>K</given-names></name></person-group><article-title>Mechanism of the antiviral effect of hydroxytyrosol on influenza virus appears to involve morphological change of the virus</article-title><source>Antiviral Res</source><year>2009</year><volume>83</volume><issue>1</issue><fpage>35</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2009.03.002</pub-id><pub-id pub-id-type="pmid">19501255</pub-id></element-citation></ref><ref id="CR114"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoo</surname><given-names>DG</given-names></name><name name-style="western"><surname>Kim</surname><given-names>MC</given-names></name><name name-style="western"><surname>Park</surname><given-names>MK</given-names></name><name name-style="western"><surname>Park</surname><given-names>KM</given-names></name><name name-style="western"><surname>Quan</surname><given-names>FS</given-names></name><name name-style="western"><surname>Song</surname><given-names>JM</given-names></name><name name-style="western"><surname>Wee</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Wang</surname><given-names>BZ</given-names></name><name name-style="western"><surname>Cho</surname><given-names>YK</given-names></name><name name-style="western"><surname>Compans</surname><given-names>RW</given-names></name><name name-style="western"><surname>Kang</surname><given-names>SM</given-names></name></person-group><article-title>Protective effect of ginseng polysaccharides on influenza viral infection</article-title><source>PLoS One</source><year>2012</year><volume>7</volume><issue>3</issue><fpage>e33678</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0033678</pub-id><pub-id pub-id-type="pmid">22442708</pub-id><pub-id pub-id-type="pmcid">PMC3307756</pub-id></element-citation></ref><ref id="CR115"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chan</surname><given-names>LY</given-names></name><name name-style="western"><surname>Kwok</surname><given-names>HH</given-names></name><name name-style="western"><surname>Chan</surname><given-names>RW</given-names></name><name name-style="western"><surname>Peiris</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Mak</surname><given-names>NK</given-names></name><name name-style="western"><surname>Wong</surname><given-names>RN</given-names></name><name name-style="western"><surname>Chan</surname><given-names>MC</given-names></name><name name-style="western"><surname>Yue</surname><given-names>PY</given-names></name></person-group><article-title>Dual functions of ginsenosides in protecting human endothelial cells against influenza H9N2-induced inflammation and apoptosis</article-title><source>J Ethnopharmacol</source><year>2011</year><volume>137</volume><issue>3</issue><fpage>1542</fpage><lpage>1546</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2011.08.022</pub-id><pub-id pub-id-type="pmid">21872652</pub-id></element-citation></ref><ref id="CR116"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dong</surname><given-names>W</given-names></name><name name-style="western"><surname>Farooqui</surname><given-names>A</given-names></name><name name-style="western"><surname>Leon</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Kelvin</surname><given-names>DJ</given-names></name></person-group><article-title>Inhibition of influenza A virus infection by ginsenosides</article-title><source>PLoS One</source><year>2017</year><volume>12</volume><issue>2</issue><fpage>e0171936</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0171936</pub-id><pub-id pub-id-type="pmid">28187149</pub-id><pub-id pub-id-type="pmcid">PMC5302443</pub-id></element-citation></ref><ref id="CR117"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ooi</surname><given-names>LS</given-names></name><name name-style="western"><surname>Sun</surname><given-names>SS</given-names></name><name name-style="western"><surname>Ooi</surname><given-names>VE</given-names></name></person-group><article-title>Purification and characterization of a new antiviral protein from the leaves of <italic toggle="yes">Pandanus amaryllifolius</italic> (Pandanaceae)</article-title><source>Int J Biochem Cell Biol</source><year>2004</year><volume>36</volume><fpage>1440</fpage><lpage>1446</lpage><pub-id pub-id-type="doi">10.1016/j.biocel.2004.01.015</pub-id><pub-id pub-id-type="pmid">15147723</pub-id></element-citation></ref><ref id="CR118"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ha</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Lee</surname><given-names>MH</given-names></name><name name-style="western"><surname>Park</surname><given-names>CH</given-names></name><name name-style="western"><surname>Kim</surname><given-names>JI</given-names></name><name name-style="western"><surname>Oh</surname><given-names>E</given-names></name><name name-style="western"><surname>Pae</surname><given-names>SB</given-names></name><name name-style="western"><surname>Park</surname><given-names>JE</given-names></name><name name-style="western"><surname>Kim</surname><given-names>SU</given-names></name><name name-style="western"><surname>Kwak</surname><given-names>DY</given-names></name></person-group><article-title>rvH1N1 neuraminidase inhibitory activities of phenolics from <italic toggle="yes">Perilla frutescens</italic> (L.) and their contents in cultivars and germplasm</article-title><source>Plant Breed Biotech</source><year>2018</year><volume>6</volume><issue>4</issue><fpage>404</fpage><lpage>412</lpage><pub-id pub-id-type="doi">10.9787/PBB.2018.6.4.404</pub-id></element-citation></ref><ref id="CR119"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kang</surname><given-names>J</given-names></name><name name-style="western"><surname>Liu</surname><given-names>C</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>B</given-names></name><name name-style="western"><surname>Li</surname><given-names>C</given-names></name><name name-style="western"><surname>Chen</surname><given-names>R</given-names></name><name name-style="western"><surname>Liu</surname><given-names>A</given-names></name></person-group><article-title>Studies on the bioactive flavonoids isolated from <italic toggle="yes">Pithecellobium clypearia</italic> Benth</article-title><source>Molecules</source><year>2014</year><volume>19</volume><issue>4</issue><fpage>4479</fpage><lpage>4490</lpage><pub-id pub-id-type="doi">10.3390/molecules19044479</pub-id><pub-id pub-id-type="pmid">24727419</pub-id><pub-id pub-id-type="pmcid">PMC6271231</pub-id></element-citation></ref><ref id="CR120"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>C</given-names></name><name name-style="western"><surname>Xu</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Lian</surname><given-names>WW</given-names></name><name name-style="western"><surname>Pang</surname><given-names>XC</given-names></name><name name-style="western"><surname>Jia</surname><given-names>H</given-names></name><name name-style="western"><surname>Liu</surname><given-names>AL</given-names></name><name name-style="western"><surname>Du</surname><given-names>GH</given-names></name></person-group><article-title>Anti-influenza effect and action mechanisms of the chemical constituent gallocatechin-7-gallate from <italic toggle="yes">Pithecellobium clypearia</italic> Benth</article-title><source>Acta Pharmacol Sin</source><year>2018</year><volume>39</volume><issue>12</issue><fpage>1913</fpage><lpage>1922</lpage><pub-id pub-id-type="doi">10.1038/s41401-018-0030-x</pub-id><pub-id pub-id-type="pmid">29802302</pub-id><pub-id pub-id-type="pmcid">PMC6289332</pub-id></element-citation></ref><ref id="CR121"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name><name name-style="western"><surname>Liu</surname><given-names>W</given-names></name><name name-style="western"><surname>Hao</surname><given-names>C</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W</given-names></name></person-group><article-title>Inhibition effects of patchouli alcohol against influenza a virus through targeting cellular PI3K/Akt and ERK/MAPK signaling pathways</article-title><source>Virol J</source><year>2019</year><volume>16</volume><issue>1</issue><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1186/s12985-019-1266-x</pub-id><pub-id pub-id-type="pmid">31870450</pub-id><pub-id pub-id-type="pmcid">PMC6929483</pub-id></element-citation></ref><ref id="CR122"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>YC</given-names></name><name name-style="western"><surname>Peng</surname><given-names>SZ</given-names></name><name name-style="western"><surname>Chen</surname><given-names>HM</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>FX</given-names></name><name name-style="western"><surname>Xu</surname><given-names>PP</given-names></name><name name-style="western"><surname>Xie</surname><given-names>JH</given-names></name><name name-style="western"><surname>He</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Chen</surname><given-names>JN</given-names></name><name name-style="western"><surname>Lai</surname><given-names>XP</given-names></name><name name-style="western"><surname>Su</surname><given-names>ZR</given-names></name></person-group><article-title>Oral administration of patchouli alcohol isolated from Pogostemonis Herba augments protection against influenza viral infection in mice</article-title><source>Int Immunopharmacol</source><year>2012</year><volume>12</volume><issue>1</issue><fpage>294</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2011.12.007</pub-id><pub-id pub-id-type="pmid">22193241</pub-id></element-citation></ref><ref id="CR123"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>B</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Jin</surname><given-names>M</given-names></name><name name-style="western"><surname>Wang</surname><given-names>G</given-names></name></person-group><article-title>Inhibitory effect and possible mechanism of action of patchouli alcohol against influenza A (H2N2) virus</article-title><source>Molecules</source><year>2011</year><volume>16</volume><issue>8</issue><fpage>6489</fpage><lpage>6501</lpage><pub-id pub-id-type="doi">10.3390/molecules16086489</pub-id><pub-id pub-id-type="pmid">21814161</pub-id><pub-id pub-id-type="pmcid">PMC6264369</pub-id></element-citation></ref><ref id="CR124"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>KT</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>WL</given-names></name><name name-style="western"><surname>Liu</surname><given-names>JW</given-names></name><name name-style="western"><surname>Zu</surname><given-names>M</given-names></name><name name-style="western"><surname>He</surname><given-names>ZN</given-names></name><name name-style="western"><surname>Du</surname><given-names>GH</given-names></name><name name-style="western"><surname>Chen</surname><given-names>WW</given-names></name><name name-style="western"><surname>Liu</surname><given-names>AL</given-names></name></person-group><article-title>Active neuraminidase constituents of Polygonum cuspidatum against influenza A(H1N1) influenza virus</article-title><source>Zhongguo Zhong Yao Za Zhi</source><year>2012</year><volume>37</volume><issue>20</issue><fpage>3068</fpage><lpage>3073</lpage><pub-id pub-id-type="pmid">23311155</pub-id></element-citation></ref><ref id="CR125"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shoji</surname><given-names>M</given-names></name><name name-style="western"><surname>Arakaki</surname><given-names>Y</given-names></name><name name-style="western"><surname>Esumi</surname><given-names>T</given-names></name><name name-style="western"><surname>Kohnomi</surname><given-names>S</given-names></name><name name-style="western"><surname>Yamamoto</surname><given-names>C</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>Y</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>E</given-names></name><name name-style="western"><surname>Konishi</surname><given-names>S</given-names></name><name name-style="western"><surname>Kido</surname><given-names>H</given-names></name><name name-style="western"><surname>Kuzuhara</surname><given-names>T</given-names></name></person-group><article-title>Bakuchiol Is a Phenolic Isoprenoid with Novel Enantiomer-selective Anti-influenza A Virus Activity Involving Nrf2 Activation</article-title><source>J Biol Chem</source><year>2015</year><volume>290</volume><issue>46</issue><fpage>28001</fpage><lpage>28017</lpage><pub-id pub-id-type="doi">10.1074/jbc.M115.669465</pub-id><pub-id pub-id-type="pmid">26446794</pub-id><pub-id pub-id-type="pmcid">PMC4646038</pub-id></element-citation></ref><ref id="CR126"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haidari</surname><given-names>M</given-names></name><name name-style="western"><surname>Ali</surname><given-names>M</given-names></name><name name-style="western"><surname>Casscells</surname><given-names>SW</given-names><suffix>III</suffix></name><name name-style="western"><surname>Madjid</surname><given-names>M</given-names></name></person-group><article-title>Pomegranate (<italic toggle="yes">Punica granatum</italic>) purified polyphenol extract inhibits influenza virus and has a synergistic effect with oseltamivir</article-title><source>Phytomedine</source><year>2009</year><volume>16</volume><issue>12</issue><fpage>1127</fpage><lpage>1136</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2009.06.002</pub-id><pub-id pub-id-type="pmid">19586764</pub-id></element-citation></ref><ref id="CR127"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jeong</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Ryu</surname><given-names>YB</given-names></name><name name-style="western"><surname>Park</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Kim</surname><given-names>JH</given-names></name><name name-style="western"><surname>Kwon</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Kim</surname><given-names>JH</given-names></name><name name-style="western"><surname>Park</surname><given-names>KH</given-names></name><name name-style="western"><surname>Rho</surname><given-names>MC</given-names></name><name name-style="western"><surname>Lee</surname><given-names>WS</given-names></name></person-group><article-title>Neuraminidase inhibitory activities of flavonols isolated from <italic toggle="yes">Rhodiola rosea</italic> roots and their in vitro anti-influenza viral activities</article-title><source>Bioorg Med Chem</source><year>2009</year><volume>17</volume><issue>19</issue><fpage>6816</fpage><lpage>6823</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2009.08.036</pub-id><pub-id pub-id-type="pmid">19729316</pub-id></element-citation></ref><ref id="CR128"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Knox</surname><given-names>YM</given-names></name><name name-style="western"><surname>Suzutani</surname><given-names>T</given-names></name><name name-style="western"><surname>Yosida</surname><given-names>I</given-names></name><name name-style="western"><surname>Azuma</surname><given-names>M</given-names></name></person-group><article-title>Anti-influenza virus activity of crude extract of <italic toggle="yes">Ribes nigrum</italic> L</article-title><source>Phytother Res</source><year>2003</year><volume>17</volume><issue>2</issue><fpage>120</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1002/ptr.1053</pub-id><pub-id pub-id-type="pmid">12601672</pub-id></element-citation></ref><ref id="CR129"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Knox</surname><given-names>YM</given-names></name><name name-style="western"><surname>Hayashi</surname><given-names>K</given-names></name><name name-style="western"><surname>Suzutani</surname><given-names>T</given-names></name><name name-style="western"><surname>Ogasawara</surname><given-names>M</given-names></name><name name-style="western"><surname>Yoshida</surname><given-names>I</given-names></name><name name-style="western"><surname>Shiina</surname><given-names>R</given-names></name><name name-style="western"><surname>Tsukui</surname><given-names>A</given-names></name><name name-style="western"><surname>Terahara</surname><given-names>N</given-names></name><name name-style="western"><surname>Azuma</surname><given-names>M</given-names></name></person-group><article-title>Activity of anthocyanins from fruit extract of Ribes nigrum L. against influenza A and B viruses</article-title><source>Acta Virol</source><year>2001</year><volume>45</volume><issue>4</issue><fpage>209</fpage><lpage>215</lpage><pub-id pub-id-type="pmid">11885927</pub-id></element-citation></ref><ref id="CR130"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roschek</surname><given-names>B</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Fink</surname><given-names>RC</given-names></name><name name-style="western"><surname>McMichael</surname><given-names>MD</given-names></name><name name-style="western"><surname>Li</surname><given-names>D</given-names></name><name name-style="western"><surname>Alberte</surname><given-names>RS</given-names></name></person-group><article-title>Elderberry flavonoids bind to and prevent H1N1 infection in vitro</article-title><source>Phytochemistry</source><year>2009</year><volume>70</volume><issue>10</issue><fpage>1255</fpage><lpage>1261</lpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2009.06.003</pub-id><pub-id pub-id-type="pmid">19682714</pub-id></element-citation></ref><ref id="CR131"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>R</given-names></name><name name-style="western"><surname>Ooi</surname><given-names>LS</given-names></name><name name-style="western"><surname>But</surname><given-names>PP</given-names></name><name name-style="western"><surname>Ooi</surname><given-names>VE</given-names></name></person-group><article-title>Antiviral triterpenoids from the medicinal plant <italic toggle="yes">Schefflera heptaphylla</italic></article-title><source>Phytother Res</source><year>2007</year><volume>21</volume><fpage>466</fpage><lpage>470</lpage><pub-id pub-id-type="doi">10.1002/ptr.1962</pub-id><pub-id pub-id-type="pmid">17357972</pub-id></element-citation></ref><ref id="CR132"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ding</surname><given-names>Y</given-names></name><name name-style="western"><surname>Dou</surname><given-names>J</given-names></name><name name-style="western"><surname>Teng</surname><given-names>Z</given-names></name><name name-style="western"><surname>Yu</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>T</given-names></name><name name-style="western"><surname>Lu</surname><given-names>N</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>C</given-names></name></person-group><article-title>Antiviral activity of baicalin against influenza A (H1N1/H3N2) virus in cell culture and in mice and its inhibition of neuraminidase</article-title><source>Arch Virol</source><year>2014</year><volume>159</volume><issue>12</issue><fpage>3269</fpage><lpage>3278</lpage><pub-id pub-id-type="doi">10.1007/s00705-014-2192-2</pub-id><pub-id pub-id-type="pmid">25078390</pub-id></element-citation></ref><ref id="CR133"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nagai</surname><given-names>T</given-names></name><name name-style="western"><surname>Miyaichi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tomimori</surname><given-names>T</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yamada</surname><given-names>H</given-names></name></person-group><article-title>Inhibition of influenza virus sialidase and anti-influenza virus activity by plant flavonoids</article-title><source>Chem Pharm Bull</source><year>1990</year><volume>38</volume><issue>5</issue><fpage>1329</fpage><lpage>1332</lpage><pub-id pub-id-type="doi">10.1248/cpb.38.1329</pub-id><pub-id pub-id-type="pmid">2393958</pub-id></element-citation></ref><ref id="CR134"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nagai</surname><given-names>T</given-names></name><name name-style="western"><surname>Miyaichi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tomimori</surname><given-names>T</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yamada</surname><given-names>H</given-names></name></person-group><article-title>In vivo anti-influenza virus activity of plant flavonoids possessing inhibitory activity for influenza virus sialidase</article-title><source>Antiviral Res</source><year>1992</year><volume>19</volume><issue>3</issue><fpage>207</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1016/0166-3542(92)90080-O</pub-id><pub-id pub-id-type="pmid">1444327</pub-id></element-citation></ref><ref id="CR135"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nagai</surname><given-names>T</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tomimori</surname><given-names>T</given-names></name><name name-style="western"><surname>Yamada</surname><given-names>H</given-names></name></person-group><article-title>Antiviral activity of plant flavonoid, 5,7,4&#8242;-trihydroxy-8-methoxyflavone, from the roots of <italic toggle="yes">Scutellaria baicalensis</italic> against influenza A (H3N2) and B viruses</article-title><source>Biol Pharm Bull</source><year>1995</year><volume>18</volume><fpage>295</fpage><lpage>299</lpage><pub-id pub-id-type="doi">10.1248/bpb.18.295</pub-id><pub-id pub-id-type="pmid">7742801</pub-id></element-citation></ref><ref id="CR136"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nagai</surname><given-names>T</given-names></name><name name-style="western"><surname>Moriguchi</surname><given-names>R</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tomimori</surname><given-names>T</given-names></name><name name-style="western"><surname>Yamada</surname><given-names>H</given-names></name></person-group><article-title>Mode of action of the anti-influenza virus activity of plant flavonoid, 5, 7, 4&#8242;-trihydroxy-8-methoxyflavone, from the roots of <italic toggle="yes">Scutellaria baicalensis</italic></article-title><source>Antiviral Res</source><year>1995</year><volume>26</volume><issue>1</issue><fpage>11</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/0166-3542(94)00062-D</pub-id><pub-id pub-id-type="pmid">7741518</pub-id></element-citation></ref><ref id="CR137"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seong</surname><given-names>RK</given-names></name><name name-style="western"><surname>Kim</surname><given-names>JA</given-names></name><name name-style="western"><surname>Shin</surname><given-names>OS</given-names></name></person-group><article-title>Wogonin, a flavonoid isolated from <italic toggle="yes">Scutellaria baicalensis</italic>, has anti-viral activities against influenza infection via modulation of AMPK pathways</article-title><source>Acta Virol</source><year>2018</year><volume>62</volume><issue>1</issue><fpage>78</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.4149/av_2018_109</pub-id><pub-id pub-id-type="pmid">29521106</pub-id></element-citation></ref><ref id="CR138"><label>138.</label><mixed-citation publication-type="other">Hour MJ, Huang SH, Chang CY, Lin YK, Wang CY, Chang YS (2013) Lin CW (2013) Baicalein, ethyl acetate, and chloroform extracts of <italic toggle="yes">Scutellaria baicalensis</italic> inhibit the neuraminidase activity of pandemic 2009 H1N1 and seasonal influenza A viruses. Evid Based Complement Alternat Med. 10.1155/2013/750803<pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2013/750803</pub-id><pub-id pub-id-type="pmcid">PMC3705751</pub-id><pub-id pub-id-type="pmid">23864896</pub-id></mixed-citation></ref><ref id="CR139"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hayashi</surname><given-names>K</given-names></name><name name-style="western"><surname>Mori</surname><given-names>M</given-names></name><name name-style="western"><surname>Matsutani Knox</surname><given-names>Y</given-names></name><name name-style="western"><surname>Suzutan</surname><given-names>T</given-names></name><name name-style="western"><surname>Ogasawara</surname><given-names>M</given-names></name><name name-style="western"><surname>Yoshida</surname><given-names>I</given-names></name><name name-style="western"><surname>Hosokawa</surname><given-names>K</given-names></name><name name-style="western"><surname>Tsukui</surname><given-names>A</given-names></name><name name-style="western"><surname>Azum</surname><given-names>M</given-names></name></person-group><article-title>Anti influenza virus activity of a red-fleshed potato anthocyanin</article-title><source>Food Sci Technol Res</source><year>2003</year><volume>9</volume><issue>3</issue><fpage>242</fpage><lpage>244</lpage><pub-id pub-id-type="doi">10.3136/fstr.9.242</pub-id></element-citation></ref><ref id="CR140"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Jung</surname><given-names>K</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>L</given-names></name><name name-style="western"><surname>Lai</surname><given-names>W</given-names></name><name name-style="western"><surname>Xie</surname><given-names>H</given-names></name><name name-style="western"><surname>Lee</surname><given-names>KH</given-names></name><name name-style="western"><surname>Huang</surname><given-names>L</given-names></name><name name-style="western"><surname>Chen</surname><given-names>CH</given-names></name></person-group><article-title>Identification and synthesis of quinolizidines with anti-influenza A virus activity</article-title><source>ACS Med Chem Lett</source><year>2014</year><volume>5</volume><issue>8</issue><fpage>942</fpage><lpage>946</lpage><pub-id pub-id-type="doi">10.1021/ml500236n</pub-id><pub-id pub-id-type="pmid">25147619</pub-id><pub-id pub-id-type="pmcid">PMC4137370</pub-id></element-citation></ref><ref id="CR141"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Li</surname><given-names>JY</given-names></name><name name-style="western"><surname>Liu</surname><given-names>XW</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>JY</given-names></name><name name-style="western"><surname>Liu</surname><given-names>YR</given-names></name><name name-style="western"><surname>Li</surname><given-names>B</given-names></name></person-group><article-title>A non-biological method for screening active components against influenza virus from traditional Chinese medicine by coupling a LC column with oseltamivir molecularly imprinted polymers</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><issue>12</issue><fpage>e84458</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0084458.g001</pub-id><pub-id pub-id-type="pmid">24386385</pub-id><pub-id pub-id-type="pmcid">PMC3873415</pub-id></element-citation></ref><ref id="CR142"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ryu</surname><given-names>YB</given-names></name><name name-style="western"><surname>Curtis-Long</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Kim</surname><given-names>JH</given-names></name><name name-style="western"><surname>Jeong</surname><given-names>SH</given-names></name><name name-style="western"><surname>Yang</surname><given-names>MS</given-names></name><name name-style="western"><surname>Lee</surname><given-names>KW</given-names></name><name name-style="western"><surname>Lee</surname><given-names>WS</given-names></name><name name-style="western"><surname>Park</surname><given-names>KH</given-names></name></person-group><article-title>Pterocarpans and flavanones from <italic toggle="yes">Sophora flavescens</italic> displaying potent neuraminidase inhibition</article-title><source>Bioorg Med Chem Lett</source><year>2008</year><volume>18</volume><issue>23</issue><fpage>6046</fpage><lpage>6049</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2008.10.033</pub-id><pub-id pub-id-type="pmid">18938076</pub-id></element-citation></ref><ref id="CR143"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chiou</surname><given-names>WF</given-names></name><name name-style="western"><surname>Chen</surname><given-names>CC</given-names></name><name name-style="western"><surname>Wei</surname><given-names>BL</given-names></name></person-group><article-title>8-Prenylkaempferol suppresses influenza A virus-induced RANTES production in A549 cells via blocking PI3K-mediated transcriptional activation of NF-&#954;B and IRF3</article-title><source>Evid Based Complement Alternat Med</source><year>2011</year><volume>2011</volume><fpage>920828</fpage><pub-id pub-id-type="doi">10.1093/ecam/nep066</pub-id><pub-id pub-id-type="pmid">19592477</pub-id><pub-id pub-id-type="pmcid">PMC3137797</pub-id></element-citation></ref><ref id="CR144"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>JY</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>DR</given-names></name><name name-style="western"><surname>Yang</surname><given-names>T</given-names></name><name name-style="western"><surname>Liu</surname><given-names>D</given-names></name><name name-style="western"><surname>Li</surname><given-names>RT</given-names></name><name name-style="western"><surname>Li</surname><given-names>HM</given-names></name></person-group><article-title>Prenylflavanones isolated from <italic toggle="yes">Sophora flavescens</italic></article-title><source>Phytochem Lett</source><year>2019</year><volume>29</volume><fpage>138</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1016/j.phytol.2018.11.025</pub-id></element-citation></ref><ref id="CR145"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hsieh</surname><given-names>CF</given-names></name><name name-style="western"><surname>Chen</surname><given-names>YL</given-names></name><name name-style="western"><surname>Lin</surname><given-names>CF</given-names></name><name name-style="western"><surname>Ho</surname><given-names>JY</given-names></name><name name-style="western"><surname>Huang</surname><given-names>CH</given-names></name><name name-style="western"><surname>Chiu</surname><given-names>CH</given-names></name><name name-style="western"><surname>Hsieh</surname><given-names>PW</given-names></name><name name-style="western"><surname>Horng</surname><given-names>JT</given-names></name></person-group><article-title>An extract from <italic toggle="yes">Taxodium distichum</italic> targets hemagglutinin- and neuraminidase-related activities of influenza virus in vitro</article-title><source>Sci Rep</source><year>2016</year><volume>6</volume><fpage>36015</fpage><pub-id pub-id-type="doi">10.1038/srep36015</pub-id><pub-id pub-id-type="pmid">27796330</pub-id><pub-id pub-id-type="pmcid">PMC5086851</pub-id></element-citation></ref><ref id="CR146"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ibrahim</surname><given-names>AK</given-names></name><name name-style="western"><surname>Youssef</surname><given-names>AI</given-names></name><name name-style="western"><surname>Arafa</surname><given-names>AS</given-names></name><name name-style="western"><surname>Foad</surname><given-names>R</given-names></name><name name-style="western"><surname>Radwan</surname><given-names>MM</given-names></name><name name-style="western"><surname>Ross</surname><given-names>S</given-names></name><name name-style="western"><surname>Hassanean</surname><given-names>HA</given-names></name><name name-style="western"><surname>Ahmed</surname><given-names>SA</given-names></name></person-group><article-title>Anti-H5N1 virus new diglyceride ester from the Red Sea grass <italic toggle="yes">Thallasodendron ciliatum</italic></article-title><source>Nat Prod Res</source><year>2013</year><volume>27</volume><issue>18</issue><fpage>1625</fpage><lpage>1632</lpage><pub-id pub-id-type="doi">10.1080/14786419.2012.742082</pub-id><pub-id pub-id-type="pmid">23163517</pub-id></element-citation></ref><ref id="CR147"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mohammed</surname><given-names>MM</given-names></name><name name-style="western"><surname>Hamdy</surname><given-names>AH</given-names></name><name name-style="western"><surname>El-Fiky</surname><given-names>NM</given-names></name><name name-style="western"><surname>Mettwally</surname><given-names>WS</given-names></name><name name-style="western"><surname>El-Beih</surname><given-names>AA</given-names></name><name name-style="western"><surname>Kobayashi</surname><given-names>N</given-names></name></person-group><article-title>Anti-influenza A virus activity of a new dihydrochalcone diglycoside isolated from the Egyptian seagrass <italic toggle="yes">Thalassodendron ciliatum</italic> (Forsk.) den Hartog</article-title><source>Nat Prod Res</source><year>2014</year><volume>28</volume><issue>6</issue><fpage>377</fpage><lpage>382</lpage><pub-id pub-id-type="doi">10.1080/14786419.2013.869694</pub-id><pub-id pub-id-type="pmid">24443884</pub-id></element-citation></ref><ref id="CR148"><label>148.</label><mixed-citation publication-type="other">Hu SQ, Hu G (2011) Extraction of isothiocyanate in Wasabi Japonica Matsum and its effects to influenza virus. In: 2011 IEEE International Symposium on IT in Medicine and Education, December 2011. Vol 1, Guangzhou, China, pp 45&#8211;48. 10.1109/ITiME.2011.6130780</mixed-citation></ref><ref id="CR149"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cai</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>G</given-names></name><name name-style="western"><surname>Tang</surname><given-names>B</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Fu</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name></person-group><article-title>Promising Anti-influenza Properties of Active Constituent of <italic toggle="yes">Withania somnifera</italic> Ayurvedic Herb in Targeting Neuraminidase of H1N1 Influenza: Computational Study</article-title><source>Cell Biochem Biophysics</source><year>2015</year><volume>72</volume><issue>3</issue><fpage>727</fpage><lpage>739</lpage><pub-id pub-id-type="doi">10.1007/s12013-015-0524-9</pub-id><pub-id pub-id-type="pmid">25627548</pub-id></element-citation></ref><ref id="CR150"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hong</surname><given-names>EH</given-names></name><name name-style="western"><surname>Song</surname><given-names>JH</given-names></name><name name-style="western"><surname>Kang</surname><given-names>KB</given-names></name><name name-style="western"><surname>Sung</surname><given-names>SH</given-names></name><name name-style="western"><surname>Ko</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Yang</surname><given-names>H</given-names></name></person-group><article-title>Anti-influenza activity of betulinic acid from <italic toggle="yes">Zizyphus jujuba</italic> on influenza A/PR/8 virus</article-title><source>Biomol Ther</source><year>2015</year><volume>23</volume><fpage>345</fpage><lpage>349</lpage><pub-id pub-id-type="doi">10.4062/biomolther.2015.019</pub-id><pub-id pub-id-type="pmcid">PMC4489829</pub-id><pub-id pub-id-type="pmid">26157551</pub-id></element-citation></ref><ref id="CR151"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gangopadhyay</surname><given-names>AD</given-names></name><name name-style="western"><surname>Ganguli</surname><given-names>SA</given-names></name><name name-style="western"><surname>Datta</surname><given-names>AB</given-names></name></person-group><article-title>Inhibiting H5N1 hemagglutinin with samll molecule ligands</article-title><source>Int J Bioinformatics Res</source><year>2011</year><volume>3</volume><fpage>185</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.9735/0975-3087.3.1.185-189</pub-id></element-citation></ref><ref id="CR152"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tiwari</surname><given-names>S</given-names></name></person-group><article-title>Plants: A rich source of herbal medicine</article-title><source>J Nat Prod</source><year>2008</year><volume>1</volume><fpage>27</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.2174/1874848100801010027</pub-id></element-citation></ref><ref id="CR153"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trouvelot</surname><given-names>S</given-names></name><name name-style="western"><surname>H&#233;loir</surname><given-names>MC</given-names></name><name name-style="western"><surname>Poinssot</surname><given-names>B</given-names></name><name name-style="western"><surname>Gauthier</surname><given-names>A</given-names></name><name name-style="western"><surname>Paris</surname><given-names>F</given-names></name><name name-style="western"><surname>Guillier</surname><given-names>C</given-names></name><name name-style="western"><surname>Combier</surname><given-names>M</given-names></name><name name-style="western"><surname>Trd&#225;</surname><given-names>L</given-names></name><name name-style="western"><surname>Daire</surname><given-names>X</given-names></name><name name-style="western"><surname>Adrian</surname><given-names>M</given-names></name></person-group><article-title>Carbohydrates in plant immunity and plant protection: roles and potential application as foliar sprays</article-title><source>Front Plant Sci</source><year>2014</year><volume>5</volume><fpage>592</fpage><pub-id pub-id-type="doi">10.3389/fpls.2014.00592</pub-id><pub-id pub-id-type="pmid">25408694</pub-id><pub-id pub-id-type="pmcid">PMC4219568</pub-id></element-citation></ref><ref id="CR154"><label>154.</label><mixed-citation publication-type="other">Berg JM, Tymoczko JL, Stryer L (2002) In: Freeman WH (ed) Monosaccharides are aldehydes or ketones with multiple hydroxyl groups. Biochemistry, 5th edn, New York Available from: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK22547/">https://www.ncbi.nlm.nih.gov/books/NBK22547/</ext-link>.&#160;Accessed 20 Sep 2020</mixed-citation></ref><ref id="CR155"><label>155.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Shariatinia</surname><given-names>Z</given-names></name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Hasnain</surname><given-names>MS</given-names></name><name name-style="western"><surname>Nayak</surname><given-names>AK</given-names></name></person-group><article-title>Pharmaceutical applications of natural polysaccharides</article-title><source>Natural Polysaccharides in Drug Delivery and Biomedical Applications.</source><year>2019</year><publisher-name>Academic Press</publisher-name><fpage>15</fpage><lpage>57</lpage></element-citation></ref><ref id="CR156"><label>156.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Redasani</surname><given-names>VK</given-names></name><name name-style="western"><surname>Bari</surname><given-names>SB</given-names></name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Redasani</surname><given-names>VK</given-names></name><name name-style="western"><surname>Bari</surname><given-names>SB</given-names></name></person-group><article-title>Approaches for Prodrugs</article-title><source>Prodrug Design</source><year>2015</year><publisher-loc>PP</publisher-loc><publisher-name>Academic Press</publisher-name><fpage>33</fpage><lpage>49</lpage></element-citation></ref><ref id="CR157"><label>157.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Habtemariam</surname><given-names>S</given-names></name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Habtemariam</surname><given-names>S</given-names></name></person-group><article-title>Medicinal Foods As Potential Therapies for Type-2 Diabetes and Associated Diseases</article-title><source>Introduction to plant secondary metabolites&#8212;From biosynthesis to chemistry and antidiabetic action</source><year>2019</year><publisher-name>Academic Press</publisher-name><fpage>109</fpage><lpage>132</lpage></element-citation></ref><ref id="CR158"><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghosh</surname><given-names>S</given-names></name><name name-style="western"><surname>Chisti</surname><given-names>Y</given-names></name><name name-style="western"><surname>Banerjee</surname><given-names>UC</given-names></name></person-group><article-title>Production of shikimic acid</article-title><source>Biotechnol Adv</source><year>2012</year><volume>30</volume><issue>6</issue><fpage>1425</fpage><lpage>1431</lpage><pub-id pub-id-type="doi">10.1016/j.biotechadv.2012.03.001</pub-id><pub-id pub-id-type="pmid">22445787</pub-id></element-citation></ref><ref id="CR159"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bochkove</surname><given-names>DV</given-names></name><name name-style="western"><surname>Sysolyatin</surname><given-names>SV</given-names></name><name name-style="western"><surname>Kalashnikov</surname><given-names>AI</given-names></name><name name-style="western"><surname>Surmachena</surname><given-names>IA</given-names></name></person-group><article-title>Shikimic acid: review of its analytical, isolation and purification techniques from plant and microbial sources</article-title><source>J Chem Biol</source><year>2011</year><volume>5</volume><fpage>5</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1007/s12154-011-0064-8</pub-id><pub-id pub-id-type="pmid">22826715</pub-id><pub-id pub-id-type="pmcid">PMC3251648</pub-id></element-citation></ref><ref id="CR160"><label>160.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Franzoni</surname><given-names>G</given-names></name><name name-style="western"><surname>Trivellini</surname><given-names>A</given-names></name><name name-style="western"><surname>Bulgari</surname><given-names>R</given-names></name><name name-style="western"><surname>Cocetta</surname><given-names>G</given-names></name><name name-style="western"><surname>Ferrante</surname><given-names>A</given-names></name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Khan</surname><given-names>MIR</given-names></name><name name-style="western"><surname>Reddy</surname><given-names>PS</given-names></name><name name-style="western"><surname>Ferrante</surname><given-names>A</given-names></name><name name-style="western"><surname>Khan</surname><given-names>NA</given-names></name></person-group><article-title>Bioactive Molecules as Regulatory Signals in Plant Responses to Abiotic Stresses</article-title><source>Plant Signaling Molecules</source><year>2019</year><publisher-name>Woodhead Publishing</publisher-name><fpage>169</fpage><lpage>182</lpage></element-citation></ref><ref id="CR161"><label>161.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pott</surname><given-names>DM</given-names></name><name name-style="western"><surname>Osorio</surname><given-names>S</given-names></name><name name-style="western"><surname>Vallarino</surname><given-names>JG</given-names></name></person-group><article-title>From central to specialized metabolism: an overview of some secondary compounds derived from the primary metabolism for their role in conferring nutritional and organoleptic characteristics to fruit</article-title><source>Front Plant Sci</source><year>2019</year><volume>10</volume><fpage>835</fpage><pub-id pub-id-type="doi">10.3389/fpls.2019.00835</pub-id><pub-id pub-id-type="pmid">31316537</pub-id><pub-id pub-id-type="pmcid">PMC6609884</pub-id></element-citation></ref><ref id="CR162"><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ncube</surname><given-names>B</given-names></name><name name-style="western"><surname>Van Staden</surname><given-names>J</given-names></name></person-group><article-title>Tilting Plant Metabolism for Improved Metabolite Biosynthesis and Enhanced Human Benefit</article-title><source>Molecules</source><year>2015</year><volume>20</volume><issue>7</issue><fpage>12698</fpage><lpage>12731</lpage><pub-id pub-id-type="doi">10.3390/molecules200712698</pub-id><pub-id pub-id-type="pmid">26184148</pub-id><pub-id pub-id-type="pmcid">PMC6331799</pub-id></element-citation></ref><ref id="CR163"><label>163.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shoker</surname><given-names>RM</given-names></name></person-group><article-title>A Review Article: The Importance of the Major groups of Plants Secondary Metabolism Phenols, Alkaloids, and Terpenes</article-title><source>Int J Appl Sci Biotechnol</source><year>2020</year><volume>7</volume><issue>5</issue><fpage>354</fpage><lpage>358</lpage><pub-id pub-id-type="doi">10.31033/ijrasb.7.5.47</pub-id></element-citation></ref><ref id="CR164"><label>164.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>B</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>RA</given-names></name></person-group><article-title>Plant terpenes: defense responses, phylogenetic analysis, regulation and clinical applications. 3</article-title><source>Biotech</source><year>2015</year><volume>5</volume><fpage>129</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1007/s13205-014-0220-2</pub-id><pub-id pub-id-type="pmcid">PMC4362742</pub-id><pub-id pub-id-type="pmid">28324581</pub-id></element-citation></ref><ref id="CR165"><label>165.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Perveen</surname><given-names>S</given-names></name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Perveen</surname><given-names>S</given-names></name><name name-style="western"><surname>Al-Taweel</surname><given-names>A</given-names></name></person-group><article-title>Introductory Chapter: Terpenes and Terpenoids</article-title><source>Terpenes and Terpenoids</source><year>2018</year><publisher-loc>London, UK</publisher-loc><publisher-name>IntechOpen</publisher-name><fpage>1</fpage><lpage>13</lpage></element-citation></ref><ref id="CR166"><label>166.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Connolly</surname><given-names>JD</given-names></name><name name-style="western"><surname>Hill</surname><given-names>RA</given-names></name></person-group><source>Dictionary of terpenoids</source><year>1991</year><publisher-loc>London</publisher-loc><publisher-name>Chapman and Hall</publisher-name></element-citation></ref><ref id="CR167"><label>167.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>G</given-names></name><name name-style="western"><surname>Tang</surname><given-names>W</given-names></name><name name-style="western"><surname>Bidigare</surname><given-names>RR</given-names></name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Demain</surname><given-names>AL</given-names></name></person-group><article-title>Terpenoids as therapeutic drugs and pharmaceutical agents</article-title><source>Zhang L</source><year>2005</year><publisher-loc>Natural Products Drug Discovery and Therapeutic Medicine</publisher-loc><publisher-name>Humana Press</publisher-name><fpage>197</fpage><lpage>227</lpage></element-citation></ref><ref id="CR168"><label>168.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Nguyen</surname><given-names>TD</given-names></name><name name-style="western"><surname>MacNevin</surname><given-names>G</given-names></name><name name-style="western"><surname>Ro</surname><given-names>DK</given-names></name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Hopwood</surname><given-names>DA</given-names></name></person-group><article-title>De novo synthesis of high-value plant sesquiterpenoids in yeast</article-title><source>Methods in enzymology, vol 517</source><year>2012</year><publisher-name>Academic Press</publisher-name><fpage>261</fpage><lpage>278</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/B978-0-12-404634-4.00013-9</pub-id><pub-id pub-id-type="pmid">23084943</pub-id></element-citation></ref><ref id="CR169"><label>169.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Jones</surname><given-names>B</given-names></name></person-group><source>Diterpenoids: Types, Functions and Research</source><year>2017</year><publisher-loc>New York</publisher-loc><publisher-name>Nova Science Publishers</publisher-name></element-citation></ref><ref id="CR170"><label>170.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zerbe</surname><given-names>P</given-names></name><name name-style="western"><surname>Chiang</surname><given-names>A</given-names></name><name name-style="western"><surname>Dullat</surname><given-names>H</given-names></name><name name-style="western"><surname>O&#8217;Neil-Johnson</surname><given-names>M</given-names></name><name name-style="western"><surname>Starks</surname><given-names>C</given-names></name><name name-style="western"><surname>Hamberger</surname><given-names>B</given-names></name><name name-style="western"><surname>Bohlmann</surname><given-names>J</given-names></name></person-group><article-title>Diterpene synthases of the biosynthetic system of medicinally active diterpenoids in <italic toggle="yes">Marrubium vulgare</italic></article-title><source>Plant J</source><year>2014</year><volume>79</volume><issue>6</issue><fpage>914</fpage><lpage>927</lpage><pub-id pub-id-type="doi">10.1111/tpj.12589</pub-id><pub-id pub-id-type="pmid">24990389</pub-id></element-citation></ref><ref id="CR171"><label>171.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Garg</surname><given-names>A</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>R</given-names></name><name name-style="western"><surname>Dey</surname><given-names>P</given-names></name><name name-style="western"><surname>Kundu</surname><given-names>A</given-names></name><name name-style="western"><surname>Kim</surname><given-names>HS</given-names></name><name name-style="western"><surname>Bhakta</surname><given-names>T</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>A</given-names></name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Silva</surname><given-names>AS</given-names></name><name name-style="western"><surname>Nabavi</surname><given-names>SF</given-names></name><name name-style="western"><surname>Saeedi</surname><given-names>M</given-names></name><name name-style="western"><surname>Nabavi</surname><given-names>SM</given-names></name></person-group><article-title>Analysis of triterpenes and triterpenoids</article-title><source>Recent Advances in Natural Products Analysis</source><year>2020</year><publisher-name>Elsevier</publisher-name><fpage>393</fpage><lpage>426</lpage></element-citation></ref><ref id="CR172"><label>172.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Richard</surname><given-names>T</given-names></name><name name-style="western"><surname>Temsamani</surname><given-names>H</given-names></name><name name-style="western"><surname>Cantos-Villar</surname><given-names>E</given-names></name><name name-style="western"><surname>Monti</surname><given-names>JP</given-names></name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Rolin</surname><given-names>D</given-names></name></person-group><article-title>Chapter Two - Application of LC&#8211;MS and LC&#8211;NMR Techniques for Secondary Metabolite Identification</article-title><source>Advances in botanical research, vol 67</source><year>2013</year><publisher-name>Academic Press</publisher-name><fpage>67</fpage><lpage>98</lpage></element-citation></ref><ref id="CR173"><label>173.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Lattanzio</surname><given-names>V</given-names></name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Ramawat</surname><given-names>KG</given-names></name><name name-style="western"><surname>Merillon</surname><given-names>JM</given-names></name></person-group><article-title>Phenolic compounds: introduction</article-title><source>Nat Prod</source><year>2013</year><publisher-loc>Berlin</publisher-loc><publisher-name>Springer-Verlag</publisher-name><fpage>1543</fpage><lpage>1580</lpage></element-citation></ref><ref id="CR174"><label>174.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>S</given-names></name><name name-style="western"><surname>Sumner</surname><given-names>B</given-names></name><name name-style="western"><surname>Sumner</surname><given-names>LW</given-names></name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Liu</surname><given-names>HW</given-names></name><name name-style="western"><surname>Begley</surname><given-names>TP</given-names></name></person-group><article-title>Modern plant metabolomics for the discovery and characterization of natural products and their biosynthetic genes</article-title><source>Compr Nat Prod III</source><year>2020</year><publisher-name>Elsevier</publisher-name><fpage>156</fpage><lpage>188</lpage></element-citation></ref><ref id="CR175"><label>175.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheynier</surname><given-names>V</given-names></name></person-group><article-title>Phenolic compounds: from plants to foods</article-title><source>Phytochem Rev</source><year>2012</year><volume>11</volume><fpage>153</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1007/s11101-012-9242-8</pub-id></element-citation></ref><ref id="CR176"><label>176.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rauter</surname><given-names>AP</given-names></name><name name-style="western"><surname>Ennis</surname><given-names>M</given-names></name><name name-style="western"><surname>Hellwich</surname><given-names>KH</given-names></name><name name-style="western"><surname>Herold</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Horton</surname><given-names>D</given-names></name><name name-style="western"><surname>Moss</surname><given-names>GP</given-names></name><name name-style="western"><surname>Schomburg</surname><given-names>I</given-names></name></person-group><article-title>Nomenclature of flavonoids (IUPAC recommendations 2017)</article-title><source>Pure Appl Chem</source><year>2018</year><volume>90</volume><issue>9</issue><fpage>1429</fpage><lpage>1486</lpage><pub-id pub-id-type="doi">10.1515/pac-2013-0919</pub-id></element-citation></ref><ref id="CR177"><label>177.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Jan</surname><given-names>S</given-names></name><name name-style="western"><surname>Abbas</surname><given-names>N</given-names></name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Jan</surname><given-names>S</given-names></name><name name-style="western"><surname>Abbas</surname><given-names>N</given-names></name></person-group><article-title>Chapter 4&#8212;Chemistry of himalayan phytochemicals</article-title><source>Himalayan Phytochemicals Amsterdam</source><year>2018</year><publisher-name>Elsevier</publisher-name><fpage>121</fpage><lpage>166</lpage></element-citation></ref><ref id="CR178"><label>178.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>HP</given-names></name><name name-style="western"><surname>Park</surname><given-names>H</given-names></name><name name-style="western"><surname>Son</surname><given-names>KH</given-names></name><name name-style="western"><surname>Chang</surname><given-names>HW</given-names></name><name name-style="western"><surname>Kang</surname><given-names>SS</given-names></name></person-group><article-title>Biochemical pharmacology of biflavonoids: implications for anti-inflammatory action</article-title><source>Arch Pharm Res</source><year>2008</year><volume>31</volume><issue>3</issue><fpage>265</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1007/s12272-001-1151-3</pub-id><pub-id pub-id-type="pmid">18409037</pub-id></element-citation></ref><ref id="CR179"><label>179.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name><name name-style="western"><surname>Mukwaya</surname><given-names>E</given-names></name><name name-style="western"><surname>Wong</surname><given-names>MS</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name></person-group><article-title>A systematic review on biological activities of prenylated flavonoids</article-title><source>Pharm Biol</source><year>2014</year><volume>52</volume><issue>5</issue><fpage>655</fpage><lpage>660</lpage><pub-id pub-id-type="doi">10.3109/13880209.2013.853809</pub-id><pub-id pub-id-type="pmid">24256182</pub-id></element-citation></ref><ref id="CR180"><label>180.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Amawi</surname><given-names>H</given-names></name><name name-style="western"><surname>Ashby</surname><given-names>CR</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Tiwari</surname><given-names>AK</given-names></name></person-group><article-title>Cancer chemoprevention through dietary flavonoids: what&#8217;s limiting?</article-title><source>Chin J Cancer</source><year>2017</year><volume>36</volume><issue>1</issue><fpage>50</fpage><pub-id pub-id-type="doi">10.1186/s40880-017-0217-4</pub-id><pub-id pub-id-type="pmid">28629389</pub-id><pub-id pub-id-type="pmcid">PMC5477375</pub-id></element-citation></ref><ref id="CR181"><label>181.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zakaryan</surname><given-names>H</given-names></name><name name-style="western"><surname>Arabyan</surname><given-names>E</given-names></name><name name-style="western"><surname>Oo</surname><given-names>A</given-names></name><name name-style="western"><surname>Zandi</surname><given-names>K</given-names></name></person-group><article-title>Flavonoids: promising natural compounds against viral infections</article-title><source>Arch Virol</source><year>2017</year><volume>162</volume><issue>9</issue><fpage>2539</fpage><lpage>2551</lpage><pub-id pub-id-type="doi">10.1007/s00705-017-3417-y</pub-id><pub-id pub-id-type="pmid">28547385</pub-id><pub-id pub-id-type="pmcid">PMC7087220</pub-id></element-citation></ref><ref id="CR182"><label>182.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Panche</surname><given-names>AN</given-names></name><name name-style="western"><surname>Diwan</surname><given-names>AD</given-names></name><name name-style="western"><surname>Chandra</surname><given-names>SR</given-names></name></person-group><article-title>Flavonoids: an overview</article-title><source>J Nutr Sci</source><year>2016</year><volume>5</volume><fpage>e47</fpage><pub-id pub-id-type="doi">10.1017/jns.2016.41</pub-id><pub-id pub-id-type="pmid">28620474</pub-id><pub-id pub-id-type="pmcid">PMC5465813</pub-id></element-citation></ref><ref id="CR183"><label>183.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Glanz</surname><given-names>VY</given-names></name><name name-style="western"><surname>Myasoedova</surname><given-names>VA</given-names></name><name name-style="western"><surname>Grechko</surname><given-names>AV</given-names></name><name name-style="western"><surname>Orekhov</surname><given-names>AN</given-names></name></person-group><article-title>Inhibition of sialidase activity as a therapeutic approach</article-title><source>Drug Des Devel Ther</source><year>2018</year><volume>12</volume><fpage>3431</fpage><lpage>3437</lpage><pub-id pub-id-type="doi">10.2147/DDDT.S176220</pub-id><pub-id pub-id-type="pmid">30349196</pub-id><pub-id pub-id-type="pmcid">PMC6186905</pub-id></element-citation></ref><ref id="CR184"><label>184.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yiannakopoulou</surname><given-names>EC</given-names></name></person-group><article-title>Recent patents on antibacterial, antifungal and antiviral properties of tea</article-title><source>Recent Pat Antiinfect Drug Discov</source><year>2012</year><volume>7</volume><issue>1</issue><fpage>60</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.2174/157489112799829738</pub-id><pub-id pub-id-type="pmid">22353001</pub-id></element-citation></ref><ref id="CR185"><label>185.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chacko</surname><given-names>SM</given-names></name><name name-style="western"><surname>Thambi</surname><given-names>PT</given-names></name><name name-style="western"><surname>Kuttan</surname><given-names>R</given-names></name><name name-style="western"><surname>Nishigaki</surname><given-names>I</given-names></name></person-group><article-title>Beneficial effects of green tea: a literature review</article-title><source>Chin Med</source><year>2010</year><volume>5</volume><fpage>13</fpage><pub-id pub-id-type="doi">10.1186/1749-8546-5-13</pub-id><pub-id pub-id-type="pmid">20370896</pub-id><pub-id pub-id-type="pmcid">PMC2855614</pub-id></element-citation></ref><ref id="CR186"><label>186.</label><mixed-citation publication-type="other">Kosugi Y (2020) Green tea consumption In: World Green Tea Association Available at: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.o-cha.net/english/teacha/distribution/greentea3.html">https://www.o-cha.net/english/teacha/distribution/greentea3.html</ext-link>.&#160;Accessed 15 Aug 2020.</mixed-citation></ref><ref id="CR187"><label>187.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>M</given-names></name><name name-style="western"><surname>Yamada</surname><given-names>H</given-names></name><name name-style="western"><surname>Matsushita</surname><given-names>K</given-names></name><name name-style="western"><surname>Kaji</surname><given-names>S</given-names></name><name name-style="western"><surname>Goto</surname><given-names>T</given-names></name><name name-style="western"><surname>Okada</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kosuge</surname><given-names>K</given-names></name><name name-style="western"><surname>Kitagawa</surname><given-names>T</given-names></name></person-group><article-title>Green tea consumption is inversely associated with the incidence of influenza infection among schoolchildren in a tea plantation area of Japan</article-title><source>J Nutrit</source><year>2011</year><volume>141</volume><issue>10</issue><fpage>1862</fpage><lpage>1870</lpage><pub-id pub-id-type="doi">10.3945/jn.110.137547</pub-id><pub-id pub-id-type="pmid">21832025</pub-id></element-citation></ref><ref id="CR188"><label>188.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Malla</surname><given-names>A</given-names></name><name name-style="western"><surname>Ramalingam</surname><given-names>S</given-names></name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Grumezescu</surname><given-names>AM</given-names></name><name name-style="western"><surname>Holban</surname><given-names>AM</given-names></name></person-group><article-title>Chapter 11&#8212;Health Perspectives of an Isoflavonoid Genistein and its Quantification in Economically Important Plants</article-title><source>Role of Materials Science in Food Bioengineering</source><year>2018</year><publisher-loc>Cambridge</publisher-loc><publisher-name>Academic Press</publisher-name><fpage>353</fpage><lpage>379</lpage></element-citation></ref><ref id="CR189"><label>189.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Foudah</surname><given-names>AI</given-names></name><name name-style="western"><surname>Abdel-Kader</surname><given-names>MS</given-names></name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Justino</surname><given-names>J</given-names></name></person-group><article-title>Isoflavonoids</article-title><source>Flavonoids - From Biosynthesis to Human Health</source><year>2017</year><publisher-loc>London</publisher-loc><publisher-name>UK IntechOpen Ltd</publisher-name><fpage>61</fpage><lpage>95</lpage></element-citation></ref><ref id="CR190"><label>190.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Sharma</surname><given-names>V</given-names></name><name name-style="western"><surname>Ramawat</surname><given-names>KG</given-names></name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Ramawat</surname><given-names>K</given-names></name><name name-style="western"><surname>M&#233;rillon</surname><given-names>JM</given-names></name></person-group><article-title>Isoflavonoids</article-title><source>Natural Products</source><year>2013</year><publisher-loc>Berlin</publisher-loc><publisher-name>Heidelberg, Springer</publisher-name></element-citation></ref><ref id="CR191"><label>191.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mottaghipisheh</surname><given-names>J</given-names></name><name name-style="western"><surname>Stuppner</surname><given-names>H</given-names></name></person-group><article-title>A Comprehensive Review on Chemotaxonomic and Phytochemical Aspects of Homoisoflavonoids, as Rare Flavonoid Derivatives</article-title><source>Int J Mol Sci</source><year>2021</year><volume>22</volume><issue>5</issue><fpage>2735</fpage><pub-id pub-id-type="doi">10.3390/ijms22052735</pub-id><pub-id pub-id-type="pmid">33800482</pub-id><pub-id pub-id-type="pmcid">PMC7962952</pub-id></element-citation></ref><ref id="CR192"><label>192.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Vicente</surname><given-names>AR</given-names></name><name name-style="western"><surname>Manganaris</surname><given-names>GA</given-names></name><name name-style="western"><surname>Sozzi</surname><given-names>GO</given-names></name><name name-style="western"><surname>Crisosto</surname><given-names>CH</given-names></name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Florkowski</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Prussia</surname><given-names>SE</given-names></name><name name-style="western"><surname>Shewfelt</surname><given-names>SL</given-names></name><name name-style="western"><surname>Brueckner</surname><given-names>B</given-names></name></person-group><article-title>Nutritional quality of fruits and vegetables</article-title><source>Postharvest handling: a systems approach, Food Science and Technology Series</source><year>2009</year><publisher-loc>New York, USA</publisher-loc><publisher-name>Academic Press, Elsevier Inc</publisher-name><fpage>57</fpage><lpage>106</lpage></element-citation></ref><ref id="CR193"><label>193.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>YQ</given-names></name><name name-style="western"><surname>Zhen</surname><given-names>YQ</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><name name-style="western"><surname>Lin</surname><given-names>CC</given-names></name><name name-style="western"><surname>Chen</surname><given-names>LX</given-names></name></person-group><article-title>Diarylheptanoid: A privileged structure in drug discovery</article-title><source>Fitoterapia</source><year>2020</year><volume>142</volume><fpage>104490</fpage><pub-id pub-id-type="doi">10.1016/j.fitote.2020.104490</pub-id><pub-id pub-id-type="pmid">32017968</pub-id></element-citation></ref></ref-list></back></article></pmc-articleset>